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Abstract 
 
Bacterial conjugation is the transport of a DNA molecule from a donor cell to a 
recipient. Since bacteria do not reproduce sexually, conjugation is a major 
contributor to prokaryotic genome plasticity and the spread of antibiotic 
resistance genes.  
A Type IV Secretion System (T4SS) mediates the DNA transport during 
conjugation. T4SSs are large macromolecular assemblies embedded in the 
membrane of bacteria, and are associated with pathogenesis, bacterial 
conjugation and natural transformation. They are a versatile family of secretion 
systems, who transport a wide variety of substrates, such as virulence proteins, 
DNA––protein complexes as well as only DNA.  
Here, we investigate the minimal requirements for conjugation, and the T4SS’s 
localisation within the cell. We show that the conjugative T4SS of the plasmid 
pR388 requires a total of 14 genes to efficiently mobilise DNA from a donor 
cell to a recipient cell and is arranged around the cell circumfence in a helical 
array. 
Our study of two reconstituted and fully functional conjugative T4SSs opens 
doors for further structural and functional analysis. 
 
 
  
 5 
Table of Contents 
 
Declaration 2!
Abstract 4!
Table of Contents 5!
Acknowledgements 9!
Abbreviations 12!
Table of Figures 15!
Table of Tables 19!
1! INTRODUCTION ON BACTERIAL CONJUGATION 20!
1.1! Overview of the process of bacterial conjugation 20!
1.2! Bacterial conjugation systems may be divided into two categories 22!
1.3! The nomenclature of Gram-negative conjugation systems 23!
1.4! Substrate recognition and processing in bacterial conjugation systems 24!
1.4.1! The relaxase enhancer protein contains dual function 25!
1.4.2! The relaxase initiates the conjugation process 26!
1.4.3! The T4CP shuttles the substrate to the T4SS 27!
1.5! Substrate transfer is dependent on a Type IV Secretion System 28!
1.5.1! Two cytoplasmatic ATPases fuel the system 31!
1.5.2! The T4SS core complex forms the secretion pore 35!
1.5.3! The inner membrane channel remains elusive 37!
1.5.4! The pilus is essential for conjugation 38!
1.5.5! VirB1 and VirB3 proteins 40!
1.6! The DNA pathway through the T4SS 41!
1.7! Project Aim 43!
 6 
1.7.1! Determining the minimal genetic requirement for conjugation 44!
1.7.2! Generate a genetically tractable T4SS 45!
2! METHODS 49!
2.1! Standard buffers and solutions 49!
2.2! Escherichia coli strains and plasmids used in this study 50!
2.3! Oligonucleotide primers used in this study 53!
2.4! Standard methods in microbiology 55!
2.4.1! Cultivation of Escherichia coli 55!
2.4.2! Transformation of Escherichia coli 56!
2.4.3! Conjugation assay 57!
2.4.4! Phage assay and phage purification 58!
2.4.5! Assessing pilus visibility by negative stain EM 59!
2.5! Standard methods in molecular biology 60!
2.5.1! DNA purification, electrophoresis & imaging methods 60!
2.5.2! Polymerase chain reaction 60!
2.5.3! Restriction digest, dephosphorylation and ligation of DNA 62!
2.5.4! Western blot to detect a Strep or FLAG tag 62!
2.6! Cloning T4SS and Relaxosome plasmids 64!
2.6.1! InFusionTM cloning method 65!
2.6.2! Site-directed, ligase-independent mutagenesis (SLIM) 67!
2.6.3! Mutation by homologous recombination using PCR products 69!
2.6.4! Reconstituting the pR388 conjugation machinery 70!
2.6.5! Reconstituting the pKM101 conjugation machinery 72!
2.7! Fluorescence Microscopy and Immunolabelling 75!
2.7.1! Microscopy 77!
 7 
2.7.2! Deconvolution 77!
2.7.3! Experimental procedures 79!
3! RESULTS I – THE INCN CONJUGATION SYSTEM PKM101 82!
3.1! The overexpression construct pKT4SS_B10cS 85!
3.1.1! The expression vectors 85!
3.1.2! The constructs pKoriT, pKRelax and pKT4SS_B10cS 86!
3.1.3! Conjugation assay pKT4SS_B10cS, pKRelax and pKoriT 91!
3.1.4! Generating pKT4SS_B10cS_oriT-rm 97!
3.1.5! Conjugation assays with pKT4SS_B10cS_oriT-rm, pKRelax and pKoriT 98!
3.2! The pKM101 deletion construct pKM101-XmaI 102!
3.2.1! Generating pKM101-XmaI 104!
3.2.2! Conjugation assay with pKM101-XmaI, pKRelax and pKoriT 107!
3.3! Further minimisation attempts of pKM101 110!
3.4! The wild-type promoter construct pWT_KT4SS 112!
3.4.1! Generating pWT_KT4SS 114!
3.4.2! Conjugation assay with pWT_KT4SS, pKRelax and pKoriT 115!
3.5! Discussion 116!
4! RESULTS II – THE INCW CONJUGATION SYSTEM PR388 122!
4.1! Examining the minimal requirements for conjugative transfer: generating the 
construct pRT4SS, pRRelax, and pRoriT 124!
4.2! Conjugation assay with pRT4SS, pRRelax and pRoriT 127!
4.3! Additional functional studies: assessing pilus assembly 132!
4.3.1! Assessing T4SS pilus visibility 133!
4.3.2! Phage susceptibility 135!
4.4! Discussion 137!
 8 
5! RESULTS III – LOCALISATION STUDIES WITH THE INCW 
CONJUGATION SYSTEM PR388 140!
5.1! Finding functional fluorescence fusions of the T4SS 142!
5.1.1! eGFP-TrwG/VirB8 143!
5.1.2! Further fluorescence fusion constructs 148!
5.2! Immunofluorescence with the pR388 T4SS 151!
5.2.1! FLAG-TrwG/VirB8 151!
5.2.2! TrwI/VirB6-FLAG 153!
5.3! Discussion 155!
6! CONCLUSIONS & OUTLOOK 158!
7! BIBLIOGRAPHY 163!
 
  
 9 
 
Acknowledgements 
 
First and foremost, I would like to thank my supervisor Professor Gabriel 
Waksman, whose support and encouragement got me through the endeavour 
of my PhD. He always believed in me, even after yet another conjugation assay 
with no transconjugants. Further, I would like to thank him for giving me the 
amazing opportunity to work in his lab, and for helping me on the way to 
become and independent scientist. I would also like to thank the members of 
my Thesis Committee, my second supervisor Dr Maya Topf and Professor 
Helen Saibil, for reading endless reposts about cloning and their support and 
advice during our meetings.  
My thanks also go to Dr Richard Hayward, Dr Maud Dumoux and Susan 
Andrew who supported me with my fluorescence microscopy experiments. 
Your support was invaluable and I couldn’t have done that extra step without 
you. 
Very special thanks go to my fantastic lab mates. You are a crazy and fantastic 
bunch and I had a whale of a time with you! Especially, I would like to thank 
Dr Harry Low for teaching me so much in the lab, as well as in project design. 
Also, I would like to thank Dr Adam Redzej, Dr Danai Papaioannou and Sofie 
Vonlanthen for endless conversations about my life and my project, their 
honest opinions and for always having an ear for my complaints and worries. 
My friends Vanessa Krug, Rebecca Sulzmann, Kristin Basjmeleh, Aylin Türer-
Strzelczyk, Zlata Bayar and Diana Conners have made the most wonderful 
 10 
impact on my life and I want to thank them for being my second family, even 
though they are far away. 
My family are most important to me, and I would like to thank my parents for 
their love and support during my education and my choices in life.  My sister, I 
would like to thank for being my best friend. My grandma, I want to thank for 
being my great inspiration. Her life experience is precious to me.  
The person who has walked through my PhD with me every step of the way 
and supported my every single day of it, and therefore deserves my utmost 
gratitude, is my wonderful husband Andrew Connery. Every day, I feel so lucky 
to have you in my life and this is why I would like to dedicate this work to you. 
 
  
 11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To my wonderful husband 
  
 12 
Abbreviations 
 
Å Ångström 
ADP Adenosine Diphosphate 
Amp Ampicillin 
approx. Approximately 
ATP Adenosine Triphosphate 
ATPase Adenosine Triphosphatase 
bp Base Pair 
Cam Chloramphenicol 
D Donors 
Da Dalton 
DIC Differential Interference Contrast 
DNA Deoxyribonucleic Acid 
DR Direct Repeat 
ds Double Stranded 
e.g. Example Given 
EDTA Ethylenediamine Trifluoroacetic Acid 
EM Electron Microscopy 
et al.  Et Alii (and others) 
g Gram 
h Hour 
i.e. In Effect 
 13 
ICE Integrative and Conjugative Element 
Inc Incompatibility Group 
IPTG Isopropyl Thiogalactoside 
IR Inverted Repeat 
k Kilo 
Kan Kanamycin 
kbp Kilo Base Pairs 
kDa Kilodalton 
KoriT pKM101 orign-of-transfer sequence 
l Liter 
m Minute 
M Molar (mol/liter) 
m Milli 
mDa Megadalton 
mRNA Messenger Ribonucleic Acid 
n Nano 
n.d. Not Determined 
Nal Nalidixic Acid 
nr. Number 
nt Nucleotide 
NTP Nucleotide Triphosphate 
oriT Origin-of-transfer 
PCR Polymerase Chain Reaction 
R Recipients 
 14 
RoriT pR388 origin-of-transfer sequence 
rpm Revolutions Per Minute 
RT Room Temperature 
s Second 
SDS-PAGE Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
Spec Spectinomycin 
ss Single Stranded 
T-strand Transfer Strand 
T3SS Type III Secretion System 
T4CP Type IV Secretion System Coupling Protein 
T4SS Type IV Secretion System 
TC Transconjugants 
Tyr Tyrosine 
V Voltage 
xg Times Gravitational Force 
? Micro 
 
  
 15 
Table of Figures 
 
Figure 1. An overview of the process of conjugation. In the donor cell, the self-transmissible 
plasmid encodes all genes necessary for it’s own transfer. The Relaxosome processes the 
DNA, and the relaxase stays covalently bound to the single stranded DNA. The Type IV 
Secretion System elaborates the pilus and transports the DNA relaxase complex into the 
recipient cell, which then becomes a donor cell itself. 21!
Figure 2. The relationship between Type IV Secretion Systems of conjugative systems pKM101 
and R388 to the arechetypical Agrobacterium tumefaciens Ti-system. Homologous genes 
are coloured in similarly. 24!
Figure 3. Type IV secretion Systems can be categorised into three distinct types according to 
their function. First, effector-translocation T4SSs translocate virulence proteins to 
eukaryotic host cells. Second, conjugative T4SSs translocate DNA––protein substrates 
from a donor cell to a recipient cell. Third, T4SSs facilitate natural transformation by 
either secreting DNA into the extracellular milieu, or mediating the uptake of free DNA. 
Figure re-drawn from Fronzes et al. (2009a). 30!
Figure 4. Advances in the imaging of the pKM101 Type IV Secretion System (T4SS). A) Side-
view of the three- dimensional cryo-electron microscopy structure of the T4SS core 
complex, formed by TraF/VirB10 (green), TraN/VirB7 (magenta) and TraO/VirB9 (cyan) as 
shown in diagram below (Figure modified from Rivera-Calzada et al. (2013)). B) Ribbon 
diagram of the pKM101 T4SS outer membrane complex, formed by TraN/VirB7 
(magenta), and the C-terminal domains of TraF/VirB10 (green) and TraO/VirB (cyan) 
(Figure modified from Chandran et al. (2009)). 36!
Figure 5. Complete working model of the Type IV Secretion System. Schematic summary of 
experimentally derived localisation studies of T4SS components. Arrows indicate the 
postulated substrate pathway from data published in Cascales & Christie (2004). The 
substrate is passed on from the coupling protein VirD4 to the traffic ATPase VirB11. It is 
then passed through the inner membrane channel via the Proteins VirB6 and VirB8, and 
the VirB4 ATPase aids this process. The proteins VirB9 and VirB10 then form the channel 
through which the substrate is passed through the outer membrane. The pilus subunits 
VirB2 and VirB5 also interact with the substrate and presumably pass it on to the 
recipient. Figure taken from Wallden et al. (2010). 42!
Figure 6. Schematic depicting the Gibson assembly. Figure taken from Gibson et al. (2009). 66!
Figure 7. Schematic of the SLIM cloning method. A) Primer design for PCRs 1 and 2. B) 
Amplification of the plasmid in PCRs 1 and 2 C) Hybridisation of PCD products 1 and 2.
 68!
Figure 8. One-step inactivation of chromosomal genes using PCR products. H1 and H2 refer to 
homologous regions of the deletion target; P1 and P2 are the priming sites on the 
template plasmid. Figure taken from Datsenko & Wanner (2000). 70!
Figure 9. Plasmid map of pKM101. The T4SS region is displayed in pink and the relaxosome 
region in green. 82!
Figure 10. Schematic depicting the organisation of tra genes in pKM101. 84 
Figure 10-1. Plasmid map depicting the features of pKoriT. The plasmid contains the oriT 
region of the pKM101 plasmid (purple), and confers Kanamycin resistance (green). It 
further contains two T7 promoters and two lac operator sequences, as well as the coding 
sequence of the lac repressor lacI (blue). 86 
Figure 10-2. Plasmid map depicting the features of pKRelax. The plasmid contains the traIJK 
region, which is thought to form the relaxosome of the pKM101 plasmid under the 
 16 
control of T7 promoter, and confers spectinomycin resistance (green). It further contains 
the lac operator sequence, as well as the coding sequence of the lac repressor lacI (blue).
 87 
Figure 11. PCR products generated from pKM101 using (A) primers OpKoriT_AscI_1F and 
OpKoriT_AscI_2B and (B) traIJK_AscI_1F and traIJK_XhoI_2B. The expected sizes of KoriT 
and the Relaxosome operon are 650 bp and 5198 bp, respectively. 89 
Figure 11-1. Plasmid map depicting the features of pKT4SS_B10cS. The plasmid contains the 
tra region, which is thought to form the Type IV Secretion System of the pKM101 plasmid 
under the control of the tet promoter, and confers chloramphenicol resistance. It further 
contains the tet repressor sequence, as well as the oriT nick site. 89 
Figure 12. Western Blot using anti-Strep antibodies of samples taken during conjugation assay 
with varying concentrations of inducer. Lanes 1-3: 0.5 mM IPTG and 0.7 µg 4-
epitetracycline (lane 1), 0.5 µg 4-epitetracycline (lane 2), 0.1 µg 4-epitetracycline 
(lane 3). Lanes 4-6: 0.5 µg AHT and 0.7 mM IPTG (lane 4), 0.5 mM IPTG (lane 5), 
0.1 mM IPTG (lane 6). Lanes 7-9: 0.5 mM IPTG and 0.7 µg AHT (lane 7), 0.5 µg AHT 
(lane 8), 0.1 µg AHT (lane 9). 94!
Figure 13. Analysis of transconjugant clones after conjugation assay with pKT4SS_B10cS, 
pKRelax and pKoriT. +C is the positive control where pKoriT was used as template DNA. 
A) Colony PCR with KoriT specific primers. Lanes 1-5 corresponds to clones 1-5. B) AscI 
restriction digest of plasmid isolated from transconjugants clones 1-5 (lanes 1-5). 96!
Figure 14. Cloning of pKT4SSB10cS_oriT-rm. A) PCR products obtained using primers oFt_oriT-
rm and oRs_oriT-rm for PCR 1 (lane 1), and oFs_oriT-rm and oRt_oriT-rm for PCR 2 
(lane 2) with template pKT4SS_B10cS, expected size is 13,246 bp. B) NdeI control digest 
of pKT4SS_B10cS_oriT-rm clones 1-7 (lanes 1-7, respectively) and positive control +C 
pKT4SS_B10cS. The expected pattern for pKT4SS_B10cS is 4212, 3319, 2493, 1975 and 
1247 bp. 97!
Figure 15. Control digest of pKT4SS_B10cS_oriT-rm isolated from BL21StarTM clones 1, 2, 3 
and 4 with NdeI. The expected pattern for pKT4SS_B10cS_oriT-rm is 4212, 3319, 2493, 
1975 and 1247 bp. 100!
Figure 16. AscI restriction digest of plasmid isolated from transconjugant colonies. Clones 1 
and 2 were produced from induced cells, while clones 3 and 4 were produced from not 
induced cells. The positive control (+C) is pKoriT. Expected fragments for pKoriT: 3829 
bp, 659 bp 102!
Figure 17. Plasmid map of pKM101 and the deletion variant pKM101-XmaI showing the 
differences of these two plasmids (T4SS tra region is displayed in pink/purple, and 
relaxosome oriT and tra regions are displayed in blue/cyan). Red arrow indicates the area 
in pKM101 which is not present in pKM101-XmaI. 103!
Figure 18. Generating pKM101-XmaI. A) pKM101 DNA after digestion with XmaI (lane 1: 
before isopropanol precipitation, lane 2: after isopropanol precipitation). B) traD/virB6- 
and traI-specific PCR reaction. Lanes 1 and 2: traD/virB6 and traI PCR clone 1, lanes 3 
and 4: traD/virB6 and traI PCR clone 2, lanes 5 and 6: traD/virB6 and traI PCR clone 3, 
lanes 7 and 8: traD/virB6 and traI PCR clone 4, lanes 9 and 10: traD/virB6 and traI PCR 
pKM101 (positive control). Lanes 11-14: KpnI restriction digest of plasmid isolated from 
potential pKM101-XmaI clones 1, 2, 3 and 4 (expected fragment size: 14437 and 
5999 bp). Lane 15: KpnI restriction digest of pKM101 (expected fragment size: 25654, 
5999 and 4619 bp). C) Repeated relaxosome specific PCR. traI and traJ specific PCR 
reactions for clone 1 (lanes 1 and 2), clone 2 (lanes 3 and 4), clone 3 (lanes 5 and 6) and 
clone 4 (lanes 7 and 8). Lanes 9 and 10: traI and traJ specific PCR reactions using 
pKRelax as template. Lanes 11 and 12: traI and traJ specific PCR reactions using pKM101 
as template. 106!
Figure 19. Four identical PCR products del-pKM101 to delete parts of pKM101 by homologous 
recombination (expected size 1135 bp). 111!
 17 
Figure 20. Plasmid map of pKM101-XmaI highlighting the PacI/AscI fragment (enclosed in red 
arrows) cloned into pETDuet-1 to form pWT_KT4SS. 113!
Figure 21. pWT_KT4SS restriction digest with AscI and PacI. Two fragments of 12,722 and 
5119 bp are expected. 114!
Figure 22. Relationship between conjugative plasmids pKM101 and pR388 with the Ti plasmid 
from Agrobacterium tumefaciens. Homologous genes are coloured similarly. 122!
Figure 23. Plasmid map of pR388. The region previously termed PilW is pictured in green 
colours, the region previously termed MobW is depicted in pink. 123!
Figure 24. Cloning of pRT4SS. A) Gel purified PCR product amplified from pR388 using 
primers otrwop_pAsk_IF_1F and otrwop_pAsk_IF_2B. B) PCR product amplified from 
pAskIBA-3C using primers opAsk-lin_ATG_1F and opAsk-lin_ATG_2B. C) NotI/PvuII 
restriction digest of plasmid isolated from clones 1, 6 and 9. Expected size for pRT4SS: 
5028, 3906, 2586 and 1603 bp. D) Colony PCR results for clones 1-9 using primers 
pASK-3C_1F_9100 and pAsk3C_SQ_2B. Expected size if pRT4SS is present: 1332 bp. 126!
Figure 25. Analysis of DNA isolated from transconjugants 1-4 obtained from conjugation assay 
with pRT4SS, pRRelax and pRoriT by AscI restriction digest and PCR specific for oriT. 
Expected pattern for AscI digest: 3829 and 412 bp. Expected size of PCR fragment 
amplified with oligonucleotides opRoriT_AscI_1F and opRoriT_AscI_2B: 428 bp. 128!
Figure 26. Negative-stain electron microscope images of whole E. coli cells. Arrows mark cell 
surface appendages. A) and B) Negative-stain electron microscope images of whole 
E. coli BL21StarTM DE3 cells expressing pRT4SS, pRRelax and pRoriT (scale bar 0.5 µm). 
C) Electron micrograph of E. coli CR34(R388) stained with antibodies against W-pili taken 
from Bradley & Cohen 1976. D), E) and F) Negative-stain electron microscope images of 
whole E. coli BL21StarTM DE3 cells expressing pRT4SS, pRRelax and pRoriT during 
conjugation with E. coli DH5! (scale bar 10 nm). 134 
Figure 26-1. Phage PRD1 susceptibility assay. Black arrows indicate plaques formed by PRD1 
infection. A. Plate containing a lawn of Escherichia coli BL21Star cells. B. Plate 
containing a lawn Escherichia coli BL21Star cells transformed with plasmid pR388. C. 
Plate containing a lawn Escherichia coli BL21Star cells transformed with plasmids pRT4SS 
+ pRRelax + pRoriT. 136 
Figure 27. Generating pRT4SS_eGFP-trwG/virB8. A) Schematic depicting the organisation of 
pRT4SS_eGFP-trwG/virB8. eGFP PCR (thin line in green) was amplified from pEGFP-C1 
using primers oeGFP_trwG_1F and oeGFP_trwG_2B. PCR 1 (orange) was amplified from 
pRT4SS using primers otrwG_RT4SS_lin_1F and ocat_lin_2B. PCR 2 (red) was generated 
from pRT4SS using primers otrwG_RT4SS_lin_2B and ocat_lin_1F. B) NotI/PvuII 
restriction digest of potential pRT4SS_eGFP-trwG/virB8 clone 1-4. +C is the positive 
control digesting pRT4SS with NotI/PvuII. 144!
Figure 28. Differential interference contrast (DIC) and green channel images of Escherichia coli 
cells expressing pRoriT + pRRelax and pRT4SS (A and B) or pRT4SS_eGFP-TrwG/VirB8 (C 
and D). E. Zoomed in image of D. Scale bar = 10 µm 146!
Figure 29. Escherichia coli ells expressing pRT4SS_eGFP-TrwG/VirB8 + pRRelax + pRoriT. A) 
Differential interference contrast (DIC) image, B) eGFP fluorescence image with zoomed 
in areas showing eGFP-TrwG/VirB8 spots in the bacterial membrane. C) Individual slices 
of a deconvolved Z-stack showing the helical arrangement of eGFP-TrwG/VirB8. 147!
Figure 30. Escherichia coli cells expressing pRT4SS_eGFP-TrwG/VirB8 + pRRelax-TrwC-
mCherry + pRoriT. A) Differential interference contrast image B) eGFP fluorescence 
image C) mCherry fluorescence D) and E) Enlarged areas as indicated showing eGFP-B8 
and TrwC-mCherry fluorescence. 149!
Figure 31. DIC and red channel images of immunofluorescence experiments using an 
anti_FLAG antibody produced in mouse and an anti-mouse antibody conjugated to Alexa 
Fluor 594 Escherichia coli cells expressing A) and B) pRT4SS + pRRelax + pRoriT C) and 
 18 
D) pRT4SS_FLAG-TrwG/VirB8 + pRRelax + pRoriT E) Individual slices of a deconvolved 
Z-stack of Escherichia coli cells expressing pRT4SS_FLAG-TrwG/VirB8 + pRRelax + 
pRoriT showing the helical arrangement of FLAG-TrwG/VirB8. Scale bar = 10 µm. 152!
Figure 32. Western blot experiment using the monoclonal ANTI-FLAG® M2 antibody produced 
in mouse (Sigma) on whole, lysed cell extract expressing pRT4SS_trwI/virB6-FLAG (lane 
1), pRT4SS_FLAG-trwG/virB8 (lane 2) or pRT4SS (lane 3). 155!
 
  
 19 
Table of Tables 
 
Table 1. List of standard buffers and solutions 49!
Table 2. Escherichia coli strains used in this study. 50!
Table 3. List of all plasmids used in this study (nt = nucleotide; RoriT = pR388 oriT; KoriT = 
pKM101 oriT) 51!
Table 4. List of all DNA oligonucleotides used in this study (bp = base pair) 53!
Table 5. Standard PCR reaction used if not stated otherwise. 61!
Table 6. PCR and hybridisation programme for SLIM cloning of pKT4SS_B10cS_oriT-rm. 74!
Table 7. Conjugation efficiency pKT4SS_B10cS_oriT-rm + pKRelax + pKoriT induced and not 
induced. Conjugation efficiency equals the amount of transconjugants colonies divided 
by the number of donor colonies. Dilutions of each repeat were averaged to derive 
conjugation efficiency. 101!
Table 8. Conjugation efficiency of the plasmid pKM101. 108!
Table 9. Transport efficiency for pKoriT. Conjugation assay results from E. coli BL21(DE3) 
pKM101-XmaI + pKRelax + pKoriT, pKM101-XmaI + pCDFDuet-1 + pKoriT and pKM101 
+ pKoriT. Conjugation efficiency equals the amount of transconjugants colonies divided 
by the number of donor colonies. Dilutions of each repeat were averaged to derive 
conjugation efficiency. 109!
Table 10. Conjugation efficiency with pWT_KT4SS, pKRelax and pKoriT Conjugation efficiency 
equals the amount of transconjugants colonies divided by the number of donor colonies. 
Dilutions of each repeat were averaged to derive conjugation efficiency. N.d. = not 
determined 116!
Table 11. Conjugation assay cell counts to assess plasmid loss in donor cultures after 
conjugation, and influence of inducer added prior to conjugation assay on donor and 
transconjugant cell counts. Cam = chloramphenicol, Kan = kanamycin, Nal = nalidixic 
acid, TC = Transconjugants, D = Donors 130!
Table 12. Conjugation experiment to compare efficiency numbers derived from division of 
transconjugant (TC) cell counts by either recipient (R) or donor (D) cell count, and to 
assess the influence of inducing agent 4-epitetracycline (EpiT) and IPTG. 131!
Table 13. Fluorescent protein fusion constructs generated with pRT4SS and pRRelax, indicating 
oligonucleotides used and their functionality on the conjugation assay. 150!
 
 
  
 20 
1 Introduction on Bacterial Conjugation 
 
Bacterial conjugation was first described by Joshua Lederberg and Edward L 
Tatum in 1953 as bacterial sexual reproduction (Lederberg & Tatum, 1953); 
however, the term describes the transfer process of deoxyribonucleic acid 
(DNA) from a bacterial donor cell to a recipient cell. Conjugation systems 
mediate DNA transfer between cells of the same species (Lawley et al., 2003); 
however, it has also been shown to occur between cells of different species 
and even into eukaryotic cells (Kienesberger et al., 2011; Fernández-González 
et al., 2011). In this context, conjugation is implied to contribute significantly 
to horizontal gene transfer and bacterial genome plasticity. Particularly the rise 
of multidrug resistant bacteria generated by the spread of resistance genes to 
commonly used antibiotics via conjugation machineries poses a major threat to 
human health (Douard et al., 2010). 
 
1.1 Overview of the process of bacterial conjugation 
The process of conjugation can be divided into three distinct biochemical 
processes: (i) substrate processing, (ii) substrate recruitment and (iii) substrate 
transfer. The nature of substrate processing is a highly conserved biochemical 
process among all types of conjugative elements. The conjugative DNA is 
recognised at a specific sequence termed origin-of-transfer (oriT), and 
enzymatically converted from a supercoiled state to a “relaxed” open–circular 
state. The enzyme catalysing this process is termed relaxase. The relaxase nicks 
 21 
the DNA at a specific nic-site within oriT and remains covalently bound to the 
transfer (T)-strand of the DNA throughout the translocation. Varying auxiliary 
proteins may be necessary for efficient recognition of oriT, and together with 
the relaxase, the complex formed is termed relaxosome. A coupling protein 
(T4CP) then recruits the relaxase–DNA complex to a Type IV Secretion System 
(T4SS). The T4SS is responsible for the translocation of the conjugative DNA 
from the donor to the recipient cell; a process also highly conserved among all 
conjugation systems. Figure 1 provides an overview of the process of 
conjugation. 
 
 
Figure 1. An overview of the process of conjugation. In the donor cell, the self-transmissible plasmid 
encodes all genes necessary for it’s own transfer. The Relaxosome processes the DNA, and the relaxase 
stays covalently bound to the single stranded DNA. The Type IV Secretion System elaborates the pilus 
and transports the DNA relaxase complex into the recipient cell, which then becomes a donor cell itself. 
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1.2 Bacterial conjugation systems may be divided into two categories 
Conjugative systems may be divided into two categories according to the 
nature of the transferred DNA. The most intensely studied systems are the self-
transmissible plasmids. 
The term self-transmissible describes the property that all genes necessary to 
mediate the conjugative transfer of the plasmid are encoded on the plasmid 
itself. Within this category, the plasmids pKM101 of the IncN, R388 (IncW), 
RP4 (IncP) and F (IncF) are the most intensely studied systems. 
Self-transmissible plasmids usually prevent other conjugative plasmids from 
entering the cell by a mechanism termed entry exclusion, where proteins are 
presented on the cell surface that prevent entry plasmids from similar 
backgrounds (Garcillán-Barcia & de la Cruz, 2008). According to their 
exclusivity, plasmids can be grouped in so called incompatibility groups (Inc), 
a term first coined by Hedges & Datta (1971). Incompatibility in this case 
means that plasmids fall in the same group if they cannot co-exist in the same 
cell.  
The second class termed as integrative and conjugative elements (ICEs) follows 
a similar secretion pathway; however, these genetic elements form a part of the 
genome and have to be excised by a recombinase/excisionase complex prior to 
undergoing the relaxase-mediated nicking reaction and transport via the T4SS. 
ICEs then integrate into the recipient-genome by homologous recombination or 
via ICE-encoded integrases. Please refer to Wozniak & Waldor (2010) for a 
more in-depth discussion of ICEs, since the text presented here will focus on 
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the conjugation systems of the self-transmissible plasmids pKM101 and pR388 
occurring in the Gram-negative enterobacteria Escherichia coli and Salmonella 
typhimurium. 
 
1.3 The nomenclature of Gram-negative conjugation systems 
Conjugation systems and especially the T4SS are related to the Ti-plasmid 
transfer system of Agrobacterium tumefaciens. This plasmid confers 
phytopathogenicity to A. tumefaciens and causes crown-gall disease in plants. 
The Ti-plasmid encodes all genes necessary for its own transfer, as do 
conjugative self-transmissible plasmids. Further, they show similar operon 
organization. In A. tumefaciens, the proteins VirD1 and VirD2 are involved in 
substrate processing, and the T4CP VirD4 mediates substrate recruitment. The 
proteins named VirB1-11 form the T4SS (see Figure 2). Since the Ti system is 
the archetype for T4SSs, this text will use the A. tumefaciens nomenclature in 
conjunction with its plasmid’s protein names in order to simplify the 
nomenclature and underline the homology of the systems. 
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Figure 2. The relationship between Type IV Secretion Systems of conjugative systems pKM101 and R388 to the 
arechetypical Agrobacterium tumefaciens Ti-system. Homologous genes are coloured in similarly. 
 
1.4 Substrate recognition and processing in bacterial conjugation 
systems 
The best-studied conjugative relaxosome is that of the plasmid pR388 (IncW) 
and will be used here to illustrate proceedings of conjugative substrate 
recognition and processing. The components of the relaxosome are encoded in 
an operon structure encoding the genes trwA (relaxase enhancer protein), trwB 
(T4CP) and trwC (relaxase). The oriT sequence immediately precedes the trwA 
gene. A complex of relaxase enhancer and relaxase was first observed by 
negative-stain electron microscopy (EM), formed by the relaxosome 
components of the conjugative system RP4 (Pansegrau et al., 1990a). In this 
system, a third protein (TraH) was necessary to stabilize the relaxosome 
complex on the DNA. 
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1.4.1 The relaxase enhancer protein contains dual function 
Substrate recognition is partly achieved by specific binding of the auxiliary 
protein TrwA to oriT. However, the relaxase TrwC can recognise and perform 
the nicking reaction without TrwA being present (Llosa et al., 1995). The oriT 
of plasmid pR388 is approximately 400 base pairs (bp) long and contains four 
inverted repeats (IRs) and one direct repeat (DR), which are important for 
recognition by the relaxosome components. TrwA specifically binds two 
regions within oriT, but exhibits different binding affinities for these regions. 
DNA footprinting experiments showed that with low amounts of protein from 
0.25 µg, TrwA binds efficiently to the single DR within oriT, whereas the 
second binding site located at IR4 was only protected from DNaseI digestion at 
concentration higher than 1 µg (Moncalián et al., 1997). TrwA has been shown 
to be tetrameric and to significantly enhance conjugation efficiency, as well as 
relaxase-mediated nicking efficiency (Moncalián et al., 1997; Moncalián & de 
la Cruz, 2004). It further displays regulatory effects by suppressing the 
expression of the trwABC operon (Moncalián & de la Cruz, 2004). Similar 
effects have been described for the TrwC homologue TraY of the F plasmid 
conjugation system (Lum et al., 2002). Its enhancing effect on the relaxase-
mediated nicking reaction led to TrwA’s description as the relaxase enhancer 
protein. 
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1.4.2 The relaxase initiates the conjugation process 
Relaxases are large proteins and most of them display phosphodiesterase and 
helicase activity, which are located on two distinct domains: an N-terminal 
“relaxase” domain and a C-terminal helicase domain (Llosa et al., 1996). The 
C-terminally located helicase domain, however, may be absent in some 
relaxases and additional domains can also be present in this family of proteins 
(Garcillán-Barcia et al., 2009). The relaxase TrwC specifically recognises the 
oriT nic-site. The x-ray crystal structure of the TrwC relaxase domain in 
complex with a 25mer oligonucleotide corresponding to IR2 of the pR388 oriT 
(RoriT) upstream of the nic-site, and additional affinity studies, showed the 
importance of a hairpin secondary structure for efficient binding of TrwC to 
oriT (Guasch et al., 2003). However, in vitro cleavage also occurs when IR2 is 
not present, indicating a distinct specificity of TrwC for specific recognition and 
cleavage of the DNA at nic (Lucas et al., 2010). Upon recognition, cleavage of 
the DNA is achieved by a nucleophilic attack of the catalytic tyrosine residue 
(Tyr18), which remains covalently attached to the 5’-end of the T-strand 
throughout DNA transfer, while the 3’-end is released (Pansegrau et al., 1990b; 
Draper et al., 2005). The helicase domain then unwinds the double-stranded 
(ds) DNA in an adenosine triphosphate (ATP)-dependent manner in the 
direction 5’ ! 3’, moving along the single stranded T-strand (Llosa et al., 
1996). The remaining circular strand is used as template for DNA replication in 
the donor cell, according to the rolling circle principle (Kingsman & Willetts, 
1978). A second catalytic tyrosine residue in TrwC (Tyr26) is thought to be 
responsible for re-circularization of the T-strand in the recipient cell (Gonzalez-
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Perez et al., 2007). 
 
1.4.3 The T4CP shuttles the substrate to the T4SS 
The T4CP is responsible for connecting the relaxase–DNA complex to the T4SS 
for transport to the recipient cell. The gene for the T4CP, trwB in the pR388 
system, is located within the same operon as the relaxosome components. The 
T4CP is an integral membrane ATPase, and the x-ray crystal structure of the 
soluble moiety of TrwB, lacking the N-terminal transmembrane helix, showed 
a nucleotide binding domain of RecA-like fold, which also displays similarity 
to DNA helicases (Gomis-Rüth et al., 2001). A second all-! domain was also 
present. Its ATPase activity is DNA-dependent, but not sequence specific, and 
higher oligomers are formed when ATPase activity can be detected in vitro 
(Tato et al., 2005). In the x-ray crystal structure, the TrwB monomers formed an 
almost spherical homohexamer with a 20 Å wide channel protruding though 
the centre of the hexamer (Gomis-Rüth et al., 2001). It displays striking 
resemblance to F1-ATPases, which leads to the assumption that TrwB-like 
proteins could function as pumps to facilitate DNA translocation from the 
donor to the recipient cell. Conformational changes observed in the TrwB 
homohexamer upon binding of different ATP analogues, and in the apo protein 
underline these expectations (Gomis-Rüth et al., 2002).  
TrwB exhibits specificity for interaction with its cognate relaxosome; in pull-
down assays, immobilized TrwB retained the R388 relaxosome components 
TrwA and TrwC (Llosa et al., 2003). The pKM101 T4CP, however, could not 
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retain TrwA. Results from bacterial two-hybrid studies indicate that the 
interaction of TrwB with the T4SS is mediated through contact with VirB10-like 
proteins, which form an integral part of the T4SS and insert into the inner and 
outer membrane of Gram-negative bacteria (Llosa et al., 2003; Chandran et al., 
2009). The membrane-associated domains of both proteins mediate this 
interaction; on deletion of the N-terminal trans-membrane segments of either 
TrwB or TrwE/VirB10, no in vivo interaction could be observed (Llosa et al., 
2003). These studies further showed that TrwC also interacts with VirB10-like 
proteins of other conjugative systems, such as pKM101 and R6K. Overall, the 
assumption was made that T4CPs exhibit strong specificity for their cognate 
relaxosome, but weaker specificity for their cognate T4SS. The interaction of 
TrwB with TrwA was stronger than TrwB’s interaction with the relaxase TrwC, 
which indicates that TrwB recognises its cognate relaxosome via interaction 
with TrwA. This potentially explains TrwA’s enhancing effect on conjugation 
efficiency. However, in the relaxase TraI of the conjugative plasmid R1, certain 
domains within the protein were determined to be important for recognition of 
the relaxosome by its T4CP TraD (Lang et al., 2010; Redzej et al., 2013). 
 
1.5 Substrate transfer is dependent on a Type IV Secretion System 
Conjugative transfer is mediated by a large macromolecular complex 
embedded in the cell envelope named Type IV Secretion System (T4SS). T4SSs 
are highly versatile, double-membrane spanning protein complexes (Fronzes et 
al., 2009b). They display a wide substrate range that includes DNA, proteins 
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and DNA–protein complexes and occur in both Gram-negative and Gram-
positive bacteria, as well as in the archaeal phylum Crenachaeota. 
All occurring T4SSs can be divided into three categories according to their 
function. First, they mediate conjugative DNA transfer, as has been described 
previously. Secondly, T4SSs mediate the uptake (natural transformation) and 
release of DNA from or to the extracellular milieu (Chen & Dubnau, 2004). 
Apart from conjugation, the occurrence of naturally competent bacteria 
through T4SSs further contributes to bacterial genome plasticity. Thirdly, T4SSs 
are involved in effector translocation of plant and animal pathogens. Type IV 
secretion also contributes to virulence in human pathogens such as 
Helicobacter pylori, Legionella pneumophila and Brucella suis, where T4SSs are 
utilized to translocate virulence factors into eukaryotic cells (Juhas et al., 2008). 
The best-studied system in this context is the VirB/VirD4 system of 
A. tumefaciens that injects DNA into plant cells and thereby causes Crown Gall 
disease (Bomhoff et al., 1976). Figure 3 illustrates the three types of T4SSs. 
The most intensely studied T4SS are those of the conjugative plasmid pKM101, 
the archetypical A. tumefaciens Ti-plasmid, and to some extent the T4SS of 
plasmid pR388 (Winans & Walker, 1985b; Bolland et al., 1990). The further 
discussion will focus on the conjugative T4SSs. As previously mentioned, the 
components of these T4SS are closely related to those of the archetypal 
A. tumefaciens T4SS. Therefore, the nomenclatures will be jointly in this text 
(for example, TraD/VirB6 for pKM101 components or TrwI/VirB6 for pR388 
components).  
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Figure 3. Type IV secretion Systems can be categorised into three distinct types according to their 
function. First, effector-translocation T4SSs translocate virulence proteins to eukaryotic host cells. Second, 
conjugative T4SSs translocate DNA––protein substrates from a donor cell to a recipient cell. Third, T4SSs 
facilitate natural transformation by either secreting DNA into the extracellular milieu, or mediating the 
uptake of free DNA. Figure re-drawn from Fronzes et al. (2009a). 
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TraL through to TraO (VirB1-11) are thought to comprise the T4SS, including 
an extracellular pilus that is formed by TraM/VirB2 and TraC/VirB5 and two 
ATPases (TraB/VirB4 and TraG/VirB11) to fuel the transport (Fronzes et al., 
2009a). The T4SS of the pR388 plasmid is thought to be comprised of the 
proteins TrwD through to TrwN (VirB11-1) and its organization is similar to 
that of the pKM101 and Ti-systems (Alvarez-Martinez & Christie, 2009). 
 
1.5.1 Two cytoplasmatic ATPases fuel the system 
Apart from the T4CP, two further ATPases are associated to the T4SS to fuel the 
DNA transport across the membrane: the VirB4- and VirB11-like proteins. Both 
proteins contain Walker A and Walker B motifs, and have been shown to 
exhibit ATPase activity (Krause et al., 2000b; Durand et al., 2010). Purification 
from the membrane and the cytoplasm has been reported for both proteins, 
indicating that they localise to the cytoplasmic side of the inner membrane in 
Gram-negative bacteria (Dang & Christie, 1997; Rashkova et al., 1997).  
VirB4-like proteins are present in conjugative T4SSs from Gram-positive and 
Gram-negative bacteria (Fronzes et al., 2009a). From secondary structure 
predictions, the protein is organized into two distinct N- and C-terminal 
domains. Homology modelling results for TraB/VirB4 and VirB4 from 
A. tumefaciens predict that the C-terminal domain of VirB4-like proteins fold in 
a highly similar way as the T4CP TraJ/VirD4 and VirD4, and is also the most 
conserved domain among all VirB4-like proteins (Middleton et al., 2005). 
These findings were confirmed by the determination of the crystal structure of 
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the C-terminal domain of a VirB4-homologue from the organism 
Thermoanaerobacter pseudoethanolicus, and led to the expectation that VirB4-
like proteins form hexameric structures comparable to T4CPs (Walldén et al., 
2012).  
Earlier results from the size exclusion chromatography of TraB/VirB4 have 
shown that it forms homodimers when purified from the membrane; however, 
these dimeric assemblies do not possess ATPase activity. When TraB/VirB4 is 
purified from the cytoplasm, it adopts a hexameric quaternary structure and is 
then able to hydrolyze ATP (Durand et al., 2010). The Walker A and B motifs 
and a consensus NTP-binding site are located in the C-terminal domain of the 
protein. Upon separate expression and purification, the N- and C-terminal 
domains were both able to bind ATP, thereby showing that both domains 
retain NTP-binding properties and the N-terminal domain possesses a 
degenerate NTP-binding motif (Durand et al., 2010). The N-terminal domain 
possesses a single predicted transmembrane domain, but purification results 
showed that equal amounts of protein could be purified from the cytoplasm 
and the membrane. The C-terminal domain alone could not be purified from 
the membrane, thereby determining that the N-terminal domain is responsible 
for VirB4 membrane association (Durand et al., 2010).  
The homologous protein from plasmid pR388 TrwK/VirB4 was the first VirB4-
like protein to be shown to exhibit ATPase activity in vitro (Arechaga et al., 
2008). Biochemical analysis of this protein showed contrasting results to the 
properties defined for TraB/VirB4. The protein was located solely in the 
cytoplasm in a mainly monomeric state. Investigation of the oligomeric state of 
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TrwK/VirB4 showed, however, that under conditions where ATPase activity 
can be detected, higher oligomeric states, such as homo-dimers, -trimers and -
hexamers, are favoured. The authors therefore concluded that the 
biochemically active form of TrwK/VirB4 is the hexamer, much like the T4CPs 
and VirB11-like proteins (Arechaga et al., 2008). These assumptions have been 
validated by the recent electron microscopy (EM) reconstruction of the 
TrwK/VirB4 hexamer from the pR388 T4SS (Peña et al., 2012). 
VirB11-like proteins are structurally and biochemically well characterized. 
They belong to the family of “traffic” ATPases, and are associated to various 
secretion systems from Gram-negative bacteria, such as types II, III, IV and VI 
(Fronzes et al., 2009a). As previously mentioned, VirB11 from A. tumefaciens 
localises mainly to the inner membrane of Gram-negative bacteria, although it 
lacks continuous long stretches of hydrophobic amino acids (Rashkova et al., 
1997). ATPase activity is stimulated upon interactions with phospholipids, 
which further underlines the biological relevance of VirB11’s tight association 
with the bacterial membrane (Krause et al., 2000b). Upon EM visualization, 
VirB11-like proteins show a hexameric quaternary assembly, forming a ring-
like structure with a diameter of approximately 120 Å (Krause et al., 2000a). 
The x-ray crystal structure of the adenosine diphosphate (ADP)-bound VirB11 
homolog from the cag pathogenicity island of H. pylori revealed an 
organization into distinct N- and C-terminal domains, with the nucleotide-
binding site built at the interface of the two domains (Yeo et al., 2000; Savvides 
et al., 2003). Arrangements in the hexameric assembly show that each domain 
forms an individual ring, resulting in a chamber of approximately 50 Å in 
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diameter. The ring formed by the N-terminal domains is closed towards one 
side of the chamber, whereas the ring formed by the C-terminal domains is 
open. In the nucleotide-free state, the N-terminal domain is organized into 
separate rigid bodies, which are flexible towards each other and an asymmetric 
ring structure, whereas the C-terminal domain is more rigid and retains the 
hexameric assembly interfaces between the subunits. Three of the six subunits’ 
N-terminal domains change their conformation upon binding three ATP 
molecules to a rigid conformation, and upon ATP hydrolysis and binding of 
another three ATPs, the N-terminal ring transitions to a completely rigid and 
symmetrical conformation. The ring returns to its apo form upon nucleotide 
release (Savvides et al., 2003).  
In contrast to VirB4-like proteins, VirB11-like proteins are less well conserved 
and not part of all T4SSs (Alvarez-Martinez & Christie, 2009). The crystal 
structure of the VirB11 homolog of B. suis differs substantially to that of 
H. pylori due to a domain swap caused by a linker sequence that is inserted 
between the N- and C-terminal domains (Hare et al., 2006). This modifies the 
nucleotide binding site, as well as the domain interface; however, the overall 
ring-like structure of the hexameric assembly is retained. Sequence 
comparisons predict that most VirB11-like proteins adopt a fold similar to that 
of B. suis VirB11 homolog (Alvarez-Martinez & Christie, 2009). 
Yeast two-hybrid studies of peptides derived from the proteins of the Ti-
plasmid-encoded T4SS suggest protein–protein interactions between all three 
ATPases involved in type IV secretion (Ward et al., 2002). Further, VirB4 is 
thought to interact with VirB8 and VirB10, which are part of the pore forming 
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protein complex across both Gram-negative bacterial membranes (Ward et al., 
2002; Chandran et al., 2009). Co-purification experiments and a negative stain 
EM reconstruction of a TraB/VirB4 monomer have further identified the 
interaction of TraB/VirB4 with the core complex of the pKM101 system 
(Walldén et al., 2012). Additionally, recent pull-down experiments also suggest 
an interaction between TrwK/VirB4 and TrwD/VirB11 proteins from pR388 
(Ripoll-Rozada et al., 2013). VirB11 exhibited further interactions with the core 
complex forming protein VirB9, as well as with the pilus-forming protein 
VirB2. 
 
1.5.2 The T4SS core complex forms the secretion pore  
A major advance in our understanding of the structure of T4SSs is the 
identification and structure of the so called “core complex, formed of the 
proteins TraN/VirB7, TraO/VirB9 and TraF/VirB10 from the pKM101 T4SS. This 
macromolecular assembly spans the periplasm and inserts in both the inner 
and outer membranes of E. coli. The 15 Ångström (Å) resolution cryo-EM 
structure of this 1.1 megadalton (MDa) complex revealed a cylindrical shape in 
which each protein is present in 14 copies, forming a two-chambered channel 
(Fronzes et al., 2009b). The two chambers, termed as O- and I-layer, are 
thought to insert into the outer and inner membrane, respectively. The O-layer 
consists of a main body and cap formed by the C-terminal domains of the 
proteins TraO/VirB9 and TraF/VirB10, as well as full length TraN/VirB7, with 
the cap forming a 20 Å wide opening towards the extracellular milieu. The I-
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layer, formed of the N- termini of TraO/VirB9 and TraF/VirB10, resembles a 
cup with a 30 Å high and 55 Å diameter base structure. The whole complex is 
185 Å in diameter and length. Further insight into the structure of the complex 
could be gained by the recently solved crystal structure of the O-layer, as 
shown in Figure 4 (Chandran et al., 2009). Surprisingly, it identified 
TraF/VirB10 as the protein forming the outer membrane channel, thereby 
determining TraF/VirB10 as the only known protein spanning both the inner 
and outer membrane of Gram-negative bacteria.  
 
Figure 4. Advances in the imaging of the pKM101 Type IV Secretion System (T4SS). A) Side-view of the 
three- dimensional cryo-electron microscopy structure of the T4SS core complex, formed by TraF/VirB10 
(green), TraN/VirB7 (magenta) and TraO/VirB9 (cyan) as shown in diagram below (Figure modified from 
Rivera-Calzada et al. (2013)). B) Ribbon diagram of the pKM101 T4SS outer membrane complex, formed 
by TraN/VirB7 (magenta), and the C-terminal domains of TraF/VirB10 (green) and TraO/VirB (cyan) 
(Figure modified from Chandran et al. (2009)). 
 
Furthermore, it showed that the O-layer is composed of three proteins inserting 
into the outer membrane, a feature that is as well unprecedented. A unique 
made of TraO/VirB9NT (Figure 1). The expected molecular
weight of a 14-mer for this new truncated complex is
B830 kDa, which is very close to the measured molecular
weight indicated above.
For structural analysis, samples of the CCelastase complex
were vitrified and imaged using a FEG F20 microscope (FEI)
(Supplementary Figure 1a and Supplementary Information).
The structure of the CCelastase complex was solved at 8.5 A˚
resolution (Figure 2A, B and C, and Supplementary Figure 1,
see Materials and methods). This complex is 185 A˚ in dia-
meter and 140 A˚ in height. The characteristic separation into
the OL and IL is clearly seen in the map. The OL and IL are
connected by thin short linkers. The OL and IL contain
chambers that are separated by large protrusions spanning
inward from the main wall at the level of the linkers and
forming a middle platform (indicated in purple circles in
Figure 2C). These pro rusions narrow the p ssage within
the complex to B30 A˚ diameter. The O chamber is capped
at the top by a ring of density with a small cen ral opening of
B20 A˚ in diameter while the IL chamber is widely open at the
bottom with a diameter ofB65 A˚. Interestingly, the thickness
of the chamber walls varies significantly. In the OL, the
thickness of the wall isB50 A˚, whereas in the IL it isB30 A˚.
Cryo-EM structure of the full-length pKM101 CC at
12.4 A˚ resolution
The previous structure of the FLCC was obtained at 15 A˚
resolution using cryo images (Fronzes et al, 2009). The
resolution has been improved to 12.4 A˚ (Figure 2D, E and
F; see Materials and methods and Supplementary
Information). The overall dimensions of the refined structure
are 185 A˚ in both height and diameter. The OL has an inner
chamber that is open to the extracellular media through an
opening of B20 A˚ in the cap (Figure 2F). Interestingly, the
refined FLCC structure reveals new features that were not
apparent in the pr vious one (Figure 2D, E and F). This
structure shows the presence of an inner cylindrical wall of
B50–55 A˚ in diameter formed by 14 columns of density
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Figure 2 Cryo-EM structures of the CCelastase and FLCC complexes. (A, B) Side view and top view, respectively, of the cryo-EM structure of the
CCelastase complex. (C) Central section of the cryo-EM map shown in A and B. The density corresponding to the middle platform is indicated in
purple ci cles. (D–E) Side view d top view, respectively, of the cryo-EM structure of the FLCC. (F) Central section of the FLCC cryo-EM map.
The new density corresponding to the inner wall is outlined with red ellipses. (G) Cutaway view of the superposition of the cryo-EM maps of
the FLCC (blue) and CCelastase (orange) complexes. (H) Difference map between the FLCC and CCelastase cryo-EM maps. (I) Cutaway view of the
superposition of the difference map shown in H (green) and the cryo-EM structure of the CCelastase complex (orange). In H and I, arrows
indicate the extra ring at the base of the FLCC (‘base’) not present in the CCelastase map.
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Structure of the heterotrimer unit
A unique feature of the T4S system outer-me brane complex is that
it is made of three proteins (instead of one for all outer-membrane
structures previously determined), all three being indispensable for
complex assembly and channel formation12. The heterotrimer
formed by TraFCT, TraOCT and TraN is shown in Fig. 2 (see also Sup-
plementary Fig. 2d). The interfaces between Tra CT and TraOCT and
between TraOCT and TraN bury 2861 A˚
2 and 2024 A˚2 of surface area,
respectively. TraN does not interact with TraFCT in the heterotrimer.
The core structure of the TraOCT–TraN complex bound to TraFCT is
similar to th previously determined NMR structure of the TraOCT–
TraN complex alone (Fig. 2; details in Supplementary Information
and Supplementary Fig. 3a, b)11. However, there are also important
differences. First, in TraOCT bound to TraFCT, residues 162–173 at
the N terminus form the a1 helix (Fig. 2). In the tetradecamer, 14 a1
helices form 14 pillars onto which the entire complex sits on the I
layer (Fig. 1a). Second, at the C terminus, residues 286–289 have
become ordered in TraOCT bound to TraFCT to form the b10 strand.
b10 of TraOCT is part of the TraFCT–TraOCT interface as it forms a
two-stranded b-sheet with b8 of TraFCT (see Fig. 2 where, for clarity,
only b8 of TraFCT is indicated). In TraN, sequences at the N (residues
15–25) and C (residues 37–42) termini have become ordered in the
heterotrimer. Remarkably, TraN almost entirely wraps around
TraOCT, forming an interface with TraOCT that is much more exten-
sive than that observed in the NMR structure (see details in Sup-
plementary Information and Supplementary Fig. 3c).
The structure of the apo form of the C-terminal domain of
ComB10 (ComB10CT), a TraF/VirB10 homologue, has been solved
14.
It consists of an atypical b-barrel flanked by an a-helix, ontowhich an
‘antenna’-like structure is mounted (Supplementary Fig. 3d). TraFCT
in the heterotrimer differs from ComB10CT in three major ways: (1)
the flanking helix of ComB10CT is missing in TraFCT; (2) the antenna
structure of TraFCT is more extended; and (3) the N terminus of
TraFCT forms an extended N-terminal arm (or lever arm; residues
171–199) that projects out to interact with three consecutive neigh-
bouring heterotrimers in the tetradecameric assembly (Figs 2 and 3,
and Supplementary Figs 3e and 4).
Tetradecameric assembly
The interactions between heterotrimers in the tetradecameric outer-
membrane complex are extensive (details are provided in Supplemen-
tary Figs 4–7 and Supplementary Information). To help orientate the
reader, a consistent colour scheme summarized in Fig. 3a, e is provided,
in which the TraF/VirB10, TraO/VirB9 and TraN/VirB7 subunits are
numbered clockwise F1–F14, O1–O14 and N1–N14, respectively.
Of the 13,000 A˚2 of total surface area of TraFCT, 11% is involved in
intra-heterotrimeric interactions and 51.5% is involved in interactions
between heterotrimers (Supplementary Fig. 8a, b). TraFCT of one
heterotrimer (for example F1 in green in Fig. 3a, b) interacts not only
with two adjacent TraFCT subunits (F2 and F14), but also, because of
the long N-terminal lever arm, with four neighbouring TraFCT sub-
units located further afield (F3, F4 on one side and F13 and F12 on the
other; Fig. 3b). In addition,TraFCT interactswith theTraOCTandTraN
subunits of an adjacent heterotrimer (O14 and N14 in Fig. 3a)
The interface between TraFCT subunits includes 2320 A˚
2 of surface
area and is described in detail in the Supplementary Information and
in Supplementary Fig. 6. Strand additions and numerous loop–loop
interactions constitute important parts of the interface. Yet, its most
notable feature is the N-terminal lever arm of the TraFCT subunit,
which makes its own extensive interaction network. The arm of sub-
unit FX (1#X# 14) interacts with the subunit FX1 1, FX1 2 and
FX1 3 (for example, see Fig. 3b, c where the F1 lever arm interacts
with subunits F2, F3 and F4). FX2 FX1 1, FX2 FX1 2 and
FX2 FX1 3 contacts involve residues in the bn1 strand, the
bn12an1 linker, and an1 helix of the FX subunit lever arm, respec-
tively (Fig. 3c and Supplementary Fig. 6c, d). Overall, the N-terminal
lever arms form a continuous inner shelf at the base of the outer-
membrane complex (Fig. 3d).
a
b
Outer membrane
Periplasm 172 Å
Cap 24 Å
Main
body
57 Å
Figure 1 | The T4S system outer-membrane complex. Ribbon diagram
(a) and space-filling cut-away (b) of the tetradecameric complex. TraFCT,
TraOCT and TraN subunits are colour-coded green, cyan and magenta,
respectively. In b, dimensions and labelling of the various parts of the
complex are provided.
N-terminal arm
Antenna
N
N
C
β8
α3
α1
α2
C
N
Figure 2 | Ribbon diagram of the heterotrimer unit. Structures mentioned
in the main text are indicated. The insert locates the shown heterotrimer
within the tetradecameric structure. A stereo version of this figure with full
secondary structure labelling is provided in Supplementary Fig. 2d.
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made of TraO/VirB9NT (Figure 1). The expected molecular
weight of a 14-mer for this new truncated complex is
B830 kDa, which is very close to the measured molecular
weight indicated above.
For structural analysis, samples of the CCelastase complex
were vitrified and imaged using a FEG F20 microscope (FEI)
(Supplementary Figure 1a and Supplementary Information).
The structure of the CCelastase complex was solved at 8.5 A˚
resolution (Figure 2A, B and C, and Supplementary Figure 1,
see Materials and methods). This complex is 185 A˚ in dia-
meter and 140 A˚ in height. The characteristic separation into
the OL and IL is clearly seen in the map. The OL and IL are
connected by thin short linkers. The OL and IL contain
chambers that are separated by large protrusions spanning
inward from the main wall at the level of the linkers and
forming a middle platform (indicated in purple circles in
Figure 2C). These protrusions narrow the passage within
the complex to B30 A˚ diameter. The O chamber is capped
at the top by a ring of density with a small central opening of
B20 A˚ in diameter while the IL chamber is widely open at the
bottom with a diameter ofB65 A˚. Interestingly, the thickness
of the chamber walls varies significantly. In the OL, the
thickness of the wall isB50 A˚, whereas in the IL it isB30 A˚.
Cryo-EM structure of the full-length pKM101 CC at
12.4 A˚ resolution
The previous structure of the FLCC was obtained at 15 A˚
resolution using cryo images (Fronzes et al, 2009). The
resolution has been improved to 12.4 A˚ (Figure 2D, E and
F; see Materials and methods and Supplementary
Information). The overall dimensions of the refined structure
are 185 A˚ in both height and diameter. The OL has an inner
chamber that is open to the extracellular media through an
opening of B20 A˚ in the cap (Figure 2F). Interestingly, the
refined FLCC structure reveals new features that were not
pparent in the previous one (Figure 2D, E and F). This
structure shows the presence of an inner cylindrical wall of
B50–55 A˚ in diameter formed by 14 columns of density
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Figure 2 Cryo-EM structures of the CCela tase and FLCC complexes. (A, B) Side view and top view, respectively, of the cryo-EM structure of the
CCelastase complex. (C) Central section of the cryo-EM ap shown in A and B. The density corresponding to the middle platform is indicated in
purple circles. (D–E) Side view and top view, respectively, of the cryo-EM tructure of the FLCC. (F) Central section of the FLCC cryo-EM map.
The new density corresponding to the inner wall is outlined with red ellipses. (G) Cutaway view of the superposition of the cryo-EM maps of
the FLCC (blue) and CCelastase (orange) complexes. (H) Difference map between the FLCC and CCelastase cryo-EM maps. (I) Cutaway view of the
superposition of the difference map shown in H (green) and the cryo-EM structure of the CCelastase complex (orange). In H and I, arrows
indicate the extra ring at the base of the FLCC (‘base’) not present in the CCelastase map.
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made of TraO/VirB9NT (Figure 1). The expected molecular
weight of a 14-mer for this new truncated complex is
B830 kDa, which is very close to the measured molecular
weight indicated above.
For structural analysis, samples of the CCelastase complex
were vitrified and imaged using a FEG F20 microscope (FEI)
(Supplementary Figure 1a and Supplementary Information).
The structure of the CCelastase complex was solved at 8.5 A˚
resolution (Figure 2A, B and C, and Supplementary Figure 1,
see Materials and methods). This complex is 185 A˚ in dia-
meter and 140 A˚ in height. The characteristic separation into
the OL and IL is clearly seen in the map. The OL and IL are
connected by thin short linkers. The OL and IL contain
chambers that are separated by large protrusions spanning
inward from the main wall at the level of the linkers and
forming a middle platform (indicated in purple circles in
Figure 2C). These protrusions narrow the passage within
the complex to B30 A˚ diameter. The O chamber is capped
at the top by a ring of density with a small central opening of
B20 A˚ in diameter while the IL chamber is widely open at the
bottom with a diameter ofB65 A˚. Interestingly, the thickness
of the chamber walls varies significantly. In the OL, the
thi kn s of the wall isB50 A˚, whereas in the IL it isB30 A˚.
Cryo-EM structure of the full-length pKM101 CC at
12.4 A˚ resolution
The previous structure of the FLCC was obtained at 15 A˚
resolution using cryo images (Fronzes et al, 2009). The
resolution has been improved to 12.4 A˚ (Figure 2D, E and
F; see Materials and methods and Supplementary
Information). The overall dimensions of the refined structure
are 185 A˚ in both height and diameter. The OL has an inner
chamber that is open to the extracellular media through an
opening of B20 A˚ in the cap (Figure 2F). Interestingly, the
refined FLCC structure reveals new features that were not
apparent in the previous one (Figure 2D, E and F). This
structure shows the presence of an inner cylindrical wall of
B50–55 A˚ in diameter formed by 14 columns of density
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discussed later (Fig. 2A). Both layers are either in
part (the I layer) or entirely (the O lay r) com-
posed of two walls (Fig. 2B).
The O layer consists of two regions: the
cap, which is 110 Å in diameter and 40 Å high,
and the main body, which is 185 Å in diameter
and 60 Å high (Fig. 2A). In the cap, the internal
wall forms a 20 Å hole that tapers off to a 10 Å
diameter constriction at the main body (Fig. 2B).
In the main body, the internal wall forms a
chamber (Fig. 2B) that is 110 Å wide and 30 Å
high. Internal protuberances are clearly visible at
the bottom of the chamber; these leave a large
opening of 55 Å.
The I layer resembles a cup. It is linked to the
O layer by thin stretches of density. The two
walls of the cup merge into single wall near the
base. The internal wall defines a chamber that is
as wide as the chamber in the O layer, but double
the height at 60 Å. This chamber tapers off at the
bottom to a diameter of 55Å, where it reaches the
30 Å high base from which 14 fingers of density
extend downwards.
To locate specific proteins in the core com-
plex, we used limited proteolysis followed by
imaging of the resulting complexes by either
negative-stain or cryo-EM (10). A limited pro-
teolysis performed at low trypsin concentration
(2 mg/ml) generated a first subcomplex (D1)
of ~700 kD, where the residues 1 to 129 of
TraF/VirB10 were removed from the core com-
plex (Fig. 1). More extensive digestion with
2 mg/ml t ypsin produced a second subcomplex
of ~500 kD (D2) in which residues 1 to 155 of
TraF/VirB10 an residues 1 to 149 of the
mature TraO/VirB9 were removed (Fig. 1).
Both the D1 and D2 complexes were visu-
alized using negative-stain, and a cryo-EM struc-
ture was determined for D2 (figs. S2 and S4).
Particles in the D1 negative-stain and D2
negative-stain EM data sets exhibited clear
14-fold symmetry (fig. S2E). The only differ-
ence between the negative-stained wild-type
and D1 complex structures is the disappearance
of the base in the I layer, indicating that the
base is made of the N terminus of TraF/VirB10
(Fig. 3, A and B). As this part of TraF/VirB10
is known to insert in the inner membrane, this
observation was used to orient the complex and
positioned the I layer toward the inner mem-
br ne and the O layer toward the outer membrane.
Comparison of the cryo-EM structures of
the wild-type and D2 complexes (Fig. 3, C
and D) demonstrates that the structure of the
O layer in the wild-type core complex is sim-
ilar to that of the D2 complex. Thus, given that
the composition of the D2 complex is known
(Fig. 1), we can conclude that the O layer is
mainly composed of the C-terminal domain of
TraF/VirB10 (TraF/VirB10Cterm residues 156
to 386), the C terminus of TraO/VirB9 (TraO/
VirB9Cterm residues 150 to 271 of the mature
protein), and TraN/VirB7 (Figs. 1 and 3E).
Fourteen of each of these would give a mass
of 602 kD, consistent with the complex mass
calculated from the cryo-EM map (647 kD when
the volume is calculated on the basis of a mass of
1050 kD for the whole structure). This implies
that the I layer is composed of the N-terminal
regions of TraF/VirB10 and TraO/VirB9, a con-
clusion also supported by the small difference
between the wild-type and D1 negative-stain struc-
tures in the base region of the I layer.
To confirm t placement of the N terminus
of TraF/VirB10 at or near the base of the I layer,
a sequence encoding a His6-tag was introduced
at the 5′ end of the traF/virB 0 gene (resulting
Fig. 2. Cryo-EM struc-
ture of the TraN/VirB7,
TraO/VirB9, and TraF/
VirB10C-ST core complex.
(A) Side view. (B) Cut-
away side view. Electron
density is color-coded
from red to blue to in-
dicate regions of strong
to weaker density, re-
spectively. (C) Top view
(view from outside the
cell). (D) Bottom view
(view from the cyto-
plasm). All features and
dimensionsmentioned in
the text are indicated.
Fig. 3. Comparison of the structures of the wild-type complex, (A) and (C); D1, (B); and D2, (D); as
revealed by negative-stain EM (A) and (B) and cryo-EM (C) and (D). Parts removed by proteolysis
are shown in cyan. (E) Schematic diagrams of the composition of each of the complexes. TraN,
TraO, and TraF are in the same representation and color-coding as in fig. 1A. Numb ring for TraN
and TraO are for the mature proteins (signal sequence excluded). A black outline encloses the parts
of the proteins included in the various complexes.
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ring structure composed of 14 copies of a two !-helix bundle in each 
TraF/VirB10 subunit forms a 32 Å outer membrane pore. Higher resolution 
cryo-EM structures further elucidated the I-layer of the pKM101 core complex; 
these findings showed that the N-terminus of TraO/VirB9 is most likely located 
on the periphery of the I-layer, while the N-terminus of TraF/VirB10 forms the 
inner channel of the I-layer (Rivera-Calzada et al., 2013). 
 
1.5.3 The inner membrane channel remains elusive 
The structural studies of The T4SS core complex revealed that the inner 
membrane channel is partly formed by the N-terminal domains of the proteins 
VirB9 and VirB10 (Rivera-Calzada et al., 2013). However, two additional 
proteins are thought to be involved into forming this pore; the proteins VirB6 
and VirB8. 
The polytopic membrane protein VirB6 is essential for substrate transfer in 
A. tumefaciens. Experimental topology models and computational analysis of 
the structural features of VirB6 from A. tumefaciens suggest that it possess five 
transmembrane helices and a C-terminal cytoplasmic domain (Jakubowski et 
al. 2004). Similar structural predictions exist for the H. pylori VirB6-like protein 
(Karnholz et al. 2006). A large periplasmic loop is also present on both VirB6 
and VirB8, which is essential for substrate contact (Jakubowski et al., 2004). 
The structures of the periplasmic domain of the B. suis VirB8 homolog and 
VirB8 from A. tumefaciens have been determined by x-ray crystallography 
(Terradot et al., 2005; Bailey et al., 2006). They show similar folds and are 
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bitopic inner membrane proteins, whose N-terminal domains are embedded in 
the inner membrane. The C-terminal domain was shown to localise to the 
periplasm and direct interactions with the DNA substrate in A. tumefaciens 
have been reported (Cascales & Christie, 2004).  
Complex formation of these proteins with the core complex has been difficult 
to prove experimentally and the stoichiometry of these proteins to the core 
complex is also not known to date. However, indications exist that VirB6 is 
important for substrate transfer from itself to VirB8 and additionally to VirB9 at 
the outer membrane (Jakubowski et al., 2004). Furthermore, both proteins are 
in direct contact with the substrate (Cascales & Christie, 2004). Their 
association with the inner membrane and these functional assessments 
underline the proposition that VirB6- and VirB8-like proteins form the inner 
membrane channel. 
 
1.5.4 The pilus is essential for conjugation 
In Gram-negative bacteria, the T4SS operon encodes a small protein 
structurally similar to the pilus-forming subunit TraM of the F-plasmid and 
VirB2 of The Ti-plasmid. An additional component of the pilus is the ViB5-like 
proteins; however, these proteins are present in lower quantities. It has been 
proposed that the pilus could serve as a hollow tube for DNA transfer from the 
donor to the recipient cell, but this assumption remains controversial. Further, 
the pilus is important for cell–cell contact. However, it has been demonstrated 
that DNA can be transferred between cells without apparent direct physical 
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contact during conjugation but impossible in mutants lacking the pilin subunit 
(Babic et al., 2008). In T4SSs not involved in conjugation, the pilus is not 
always essential for substrate transfer (Fronzes et al., 2009a). 
The VirB2 protein from A. tumefaciens and TrbC/VirB2 from the RP4 
conjugative plasmid (IncP) exhibit post-translational modification, resulting in a 
cyclic peptide (Eisenbrandt et al., 1999). After translation, a signal peptide of 
approximately 30-50 amino acids in length is cleaved off by a specific protease 
and the N- and C-termini are covalently joined (Haase & Lanka, 1997). F-like 
pilins have not been shown to undergo cyclisation, but are acetylated prior to 
insertion into the inner membrane (Moore et al., 1993; Majdalani & Ippen-
Ihler, 1996).  
VirB5 has been structurally characterized (Yeo et al., 2003). In A. tumefaciens, 
VirB5 localises to the tip of the pilus (Aly & Baron, 2007). In connection with 
mutational analyses performed on the TraL protein from pKM101, VirB5 is 
expected to serve as an adhesin (Yeo et al., 2003). 
The morphology of the conjugative pilus is distinct for different types of 
conjugative systems. Classifications describe that pili can be grouped into F-
like and P-like pili, where F-like pili are long and flexible and P-like pili short 
and rigid. Cryo-EM analysis of the F-plasmid pilus have shown the presence of 
a lumen, which is approximately 30 Å in diameter (Wang et al., 2009). This 
lumen could accommodate single stranded DNA but would be too small to 
allow passage of the relaxase–DNA substrate, if the protein remains in its 
folded state. Live cell imaging of fluorescently labelled F-pili further showed 
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their ability to polymerise and retract in response to an unknown signal (Clarke 
et al., 2008). This function may serve to enable the physical cell-to-cell contact 
required. 
 
1.5.5 VirB1 and VirB3 proteins  
VirB1 is thought to play an accessory rather than essential role within the 
secretion process. It shows a lysozyme-like fold and belongs to a large 
subfamily of proteins involved in the assembly of macromolecular complexes 
on the bacterial surface, such as flagella and other DNA uptake systems 
(Koraimann, 2003). It is proposed that they assist macromolecular assembly in 
the membrane by loosening the peptidoglycan-meshwork. In A. tumefaciens, 
VirB1-dysfunction diminishes Ti-DNA transfer, but does not abolish it (Berger 
& Christie, 1994). 
The role and localization of VirB3-like proteins remains controversial. It was 
first postulated to be located in the both, but dominantly in the outer 
membrane (Jones et al., 1994). Hydropathy analysis point towards its 
association with the inner membrane, and its stabilizing effect on VirB4 
proteins further underline this postulation (Alvarez-Martinez & Christie, 2009). 
Further, some T4SSs harbour chimeric VirB3/VirB4 proteins, suggesting a 
strong link between these two proteins (Batchelor et al., 2004). 
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1.6 The DNA pathway through the T4SS 
A breakthrough in our understanding of substrate transfer through a T4SS was 
the work published by Cascales & Christie (2004). This work demonstrated the 
interaction of the Ti DNA substrate of the A. tumefaciens T4SS with various 
subunits of the T4SS by co-immunoprecipitation of the proteins cross-linked to 
the Ti DNA. In combination with deletion mutants of these subunits, a pathway 
of the DNA substrate through the T4SS channel was delineated.  
The relaxase homologue VirD2 processes the DNA and remains covalently 
bound to the DNA throughout transfer. In the above-mentioned work, the 
DNA––Relaxase complex was co-precipitated from cells even if none of the 
other T4SS components were present, indicating that the initial step for 
secretion is the relaxase processing the Ti DNA.  
Complexes of T4CP VirD4 and the Ti DNA could be observed only when the 
relaxase VirD2 was present, but their formation was independent from the 
presence of any other T4SS components. The T4CP VirD4 was thereby 
identified as the second protein to interact with the substrate.  
The traffic ATPase VirB11 was determined to mediate contact between the 
substrate––T4CP complex and the secretion channel, since VirB11––Ti DNA 
complexes were only observed if VirD4 was present, but unaffected by the 
deletion of any other T4SS component.  
The inner membrane proteins VirB6 and VirB8 were also shown to directly 
form complexes with the Ti DNA; it was, however, impossible to determine a 
sequence in which the Ti DNA is passed on between these two proteins. This 
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complex formation was dependent on VirB11 and VirB4 ATPases, but 
unaffected by VirB9 or VirB2 absence. 
 
 
Figure 5. Complete working model of the Type IV Secretion System. Schematic summary of 
experimentally derived localisation studies of T4SS components. Arrows indicate the postulated substrate 
pathway from data published in Cascales & Christie (2004). The substrate is passed on from the coupling 
protein VirD4 to the traffic ATPase VirB11. It is then passed through the inner membrane channel via the 
Proteins VirB6 and VirB8, and the VirB4 ATPase aids this process. The proteins VirB9 and VirB10 then 
form the channel through which the substrate is passed through the outer membrane. The pilus subunits 
VirB2 and VirB5 also interact with the substrate and presumably pass it on to the recipient. Figure taken 
from Wallden et al. (2010). 
Some components of the T4SS did not interact directly with the Ti DNA 
substrate; however, they could still co-precipitate small amounts of Ti DNA 
through their interaction with components that directly interact with the Ti 
DNA. The proteins VirB4, VirB5, VirB7 and VirB10 comprised this category. In 
mutants lacking the VirB4 protein, no VirB6/VirB8––Ti DNA complexes can be 
archetypical T4SSs belong: that encoded by the Ti
plasmid of A. tumefaciens and that encoded by the
Escherichia coli pKM101 plasmid. The Ti plasmid system
contains 12 proteins, VirB1–VirB11 and VirD4, which later
in the review are referred to as the VirB/D4 proteins. Other
type IVA systems have closely related homologues of
most or all of these components. The structural knowl-
edge of type IVA systems is summarized in Fig. 1.
The bulk of the proteins (VirB6–VirB10, and possibly
VirB3) are likely to form the scaffold of the substrate
translocation channel that spans the entire cell envelope
(Fig. 1A). Structural studies have shown that VirB7, VirB9
and VirB10 assembles into a tightly associated ‘core
complex’ containing 14 copies of each of the proteins
(Chandran et al., 2009; Fronzes et al., 2009b) spanning
the two membranes of Gram-negative bacteria. The struc-
ture of the core complex formed by the TraN, TraO and
TraF proteins, the VirB7, VirB9 and VirB10 homologues,
respectively, from the conjugative pKM101 T4SS, was
determined at 15 Å using cryo-electron microscopy
Fig. 1. Schematic model of the VirB/D4 system of A. tumefaciens and structures of T4SS components determined to date.
A. The experimentally predicted locations of VirB/D4 components of A. tumefaciens. Arrows indicate the sequential translocation steps
identified during substrate secretion through the VirB/D4 system in A. tumefaciens (Cascales and Christie, 2004).
B. Crystal structure of the TrwB hexamer, VirD4 homologue of the E. coli conjugative plasmid R388 (Gomis-Ruth et al., 2001).
C. Single subunit of the TrwB hexamer with modelled plausible location of the N-terminal transmembrane domain.
D. Crystal structure of the HP5025 hexamer, VirB11 homologue of H. pylori (Savvides et al., 2003).
E. Single subunit of the HP0525 hexamer. The N-terminal (NTD) and C-terminal (CTD) domains are indicated.
F. Cryo-electron microscopy structure of the T4SS core complex of the E. coli conjugative plasmid pKM101 (Fronzes et al., 2009b), comprising
the full-length TraN, TraO and TraF, which correspond to the VirB7, VirB9 and VirB10 homologues of A. tumefaciens respectively.
G. Crystal structure of the outer membrane complex, comprising the O-layer (Chandran et al., 2009). The inset shows the characteristic
two-helix bundle of TraF that traverses the outer membrane. TraN, TraO and TraF are coloured red, blue and green respectively.
H and I. Crystal structures of TraC, the VirB5 homologue encoded by pKM101 (Yeo et al., 2003), and the periplasmic C-terminal domain of
VirB8 from B. suis respectively (Terradot et al., 2005).
Colour-coding of subunits in (A) is preserved for the indiv dual subunits shown in (B)–(E) and (G)–(I). OM, oute membrane; IM, inner
membrane; TMS, transmembrane segment; Cyt., cytosol.
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detected. Therefore, it is likely that VirB4 assists in the substrate transfer from 
VirB11 to the inner membrane proteins VirB6 and VirB8.Similarly to VirB6 and 
VirB8, direct contact between the Ti DNA and the proteins VirB2 and VirB9 
was detected but it was impossible to distinguish a sequence between these 
two. As both these proteins localise to the outer membrane, it is likely that the 
substrate is passed on to VirB2/VirB9 from VirB6/VirB8. This assumption was 
confirmed, since no VirB2/VirBB9––Ti DNA complexes could be observed 
upon deletion of VirB6 or VirB8.  
 
VirB10 and VirB7 proteins were determined to not directly interact with the 
DNA substrate. Upon deletion of VirB7, however, no VirB11––Ti DNA 
complexes were observed. Combined with more recent findings that 
VirB7/VirB9/VirB10-homologues form the tightly associated core complex, it is 
possible that the VirB11––Ti DNA complex requires the association to the core 
complex to efficiently receive the DNA––relaxase substrate from the T4CP. 
Figure 5 summarises the above-described findings and puts them into context 
with more recent findings from structural data. 
 
1.7 Project Aim 
The aims of this thesis are to (i) determine the minimal genetic requirements for 
conjugation; (ii) to generate a genetically tractable T4SS, which can (iii) be 
produced for imaging purposes and (iv) to provide a simple assay with which 
structure–function relationships derived from structure can be assessed by site-
 44 
directed mutagenesis of various T4SS components. 
 
1.7.1 Determining the minimal genetic requirement for conjugation 
As reviewed above, 14 proteins have been postulated to be involved in 
conjugative transfer of plasmid DNA. However, there are many other genes in 
plasmids, and their involvement in conjugation has never been clarified.  
A study by Bolland et al. (1990) identified a 14.9 kbp region on the pR388 
plasmid that mediates conjugation. However, this study precedes sequencing 
of the pR388 and the identification of all the trw/vir operon genes. 
For the plasmid pKM101, a study by Winans & Walker (1985a) identified 11 
complementation groups involved in conjugation, and located them to three 
distinct regions on the pKM101. Here again, the effort preceded the 
sequencing of pKM101 plasmid and the localisation of the tra/vir genes.  
We propose here to take the 14 genes believed to be involved in conjugative 
transfer out of their genetic context and investigate whether conjugation is still 
possible. If conjugation still occurs, then this will establish for the first time that 
no other genes are required to mobilise an oriT-containing vector and transfer it 
into recipient cells. More specifically, the approach I have chosen is to clone 
the T4SS-encoding genes and the Relaxosome-encoding genes separately in 
different, well-established laboratory vectors and reconstitute the entire 
machinery by expressing these genes (under inducible promoters) in E. coli in 
the presence of a third vector containing the cognate oriT. The transfer of this 
oriT-containing plasmid will be monitored using a conjugation assay. 
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1.7.2 Generate a genetically tractable T4SS 
Once the minimal conjugative transfer machinery is obtained, we aim to use it 
for several purposes: firstly, to overproduce the functional T4SSs in order to 
obtain their structure by either electron microscopy and by x-ray 
crystallography; secondly, to tag the system with fluorescent proteins so that it 
can be imaged in vivo by fluorescence microscopy, and thirdly, to introduce 
single site mutations at will anywhere in the genes to study the structure-
function relationship in detail. 
 
Overproduction of a functional T4SSs for structural study 
The ultimate aim of the work on T4SSs is to determine the structure of entire 
T4SSs complexes arrested at various stages of the transfer process. The studies 
by Cascales & Christie (2004) described in section 1.6 provides the conceptual 
framework onto which approaches can be designed to block substrate at 
various stages of transport. However structural biological techniques rely on 
the production of functional complexes that can be purified in large quantities. 
Thus, to achieve our ultimate aim, we need to obtain a genetically tractable 
over-expression system where all components can be 
mutated/deleted/modified at will, and where the resulting system variants be 
overproduced and purified. A minimal conjugative transfer system as described 
above in the above section will satisfy all requirements to successfully achieve 
our long-term goals of imaging T4SSs at various stages of conjugative transfer. 
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Tag the system with fluorescent proteins so that it can be imaged in vivo by 
fluorescence microscopy 
Another goal of T4SS research is to understand how T4SS assemble, i.e. in 
which order the various components of the system come together to form the 
entire machinery. As demonstrated in various published studies, this can be 
achieved by tagging the various component of the system with fluorescent 
proteins. Cornelis and co-workers used such an approach to decipher the 
assembly of the Yersinia Type III Secretion System (T3SS) in vivo (Diepold et al., 
2010). In this study, fluorescent protein fusion constructs of T3SS components 
were used to localise the T3SS in the Yersinia membrane. Upon deletion of 
certain other components, the localisation of the fluorescently tagged 
component was re-assessed. If the localisation pattern remained unchanged, 
the deleted component has no influence on the correct assembly of the 
fluorescently tagged protein and the tagged component will, therefore, 
assemble before the deleted component. If, however, the fluorescently tagged 
component’s localisation within the cell changes upon deletion of another 
component, it is clear that the deleted component has to assemble prior to the 
fluorescently tagged component so that this component can assemble 
correctly. In combination with functionality (substrate secretion) and needle 
assembly assessment (EM studies), the assembly of the T3SS was successfully 
dissected. 
However, introducing sequences encoding tagging proteins within gene 
clusters is not easily achieved. The most intensely studied conjugative T4SSs 
are found on large, naturally occurring plasmids. The most convenient way to 
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genetically modify specific genes are DNA-polymerase chain reaction (PCR)-
based methods, which allow the easy introduction of protein tags for affinity 
purification steps or localisation studies. These methods are, however, limited 
by the size of the fragment that is to be amplified, with fragment length of 
approximately 15,000 bp being the upper limit for efficient and error-free 
amplification. Although techniques have been developed to manipulate larger 
DNAs such as large plasmids, for example the ?Red manipulation system 
developed by Doubet et al. (2008), these methods are cumbersome and rather 
difficult to achieve. In contrast, a minimal conjugative transfer system such as 
the one described in previously has the distinct advantage of being easily 
manipulated.  
 
Introduce single site mutations at will anywhere in the T4SS genes 
Following the same rationale, a minimal conjugative transfer system as 
described above would be also be ideal to introduce mutations and dissect the 
meaning of protein––protein interactions observed in the various structures of 
the complexes obtained by x-ray crystallography or high-resolution cryo-EM. 
This will not only constitute an important validation tool for structural studies, 
but will also provide the platform on which a host of experiments can be 
conducted aiming to elucidate the mechanism of transport by T4SSs. 
In this thesis, I present a body of work that establishes, for the first time, the 
minimal requirements for conjugative transfer, and use this system to explore 
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the possibility of fluorescently tagging T4SS components in view of monitoring 
their assembly in vivo. 
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2 Methods 
In this chapter, an introduction to the methods used will be given, and will be 
brought into context with the literature. Further, the considerations taken into 
account whist determining the methods of choice will be presented. 
2.1 Standard buffers and solutions 
Table 1 lists all standard buffers and solution used if not stated otherwise. 
Table 1. List of standard buffers and solutions 
Solution Composition 
Luria Bertani (LB) media 0.5 g NaCl, 20 g tryptone, 5 g yeast extract in 1 l 
H2O 
LB Agar 1% Agar (w/v), 0.5 g NaCl, 20 g tryptone, 5 g yeast 
extract in 1 l H2O 
Water MilliQ (Millipore) -filtered water was used for all 
applications 
SDS PAGE loading dye NuPAGE® LDS Sample Buffer (4X) 
TBE running buffer (10x) for agarose gel 
electrophoresis 
890 mM Tris, 890 mM boric acid, 20 mM EDTA, 
pH 8.0 
Agarose gel for electrophoresis 1% (w/v) agarose in 0.5x TBE running buffer 
DNA loading dye (10x) 40% (w/v) sucrose, 0.5% bromphenol blue in H2O  
MES SDS PAGE running buffer (20x) 50 mM MES, 50 mM Tris, 0.1% SDS, 1 mM EDTA, 
pH 7.3  
Phosphate buffered saline (PBS) 4.3 mM Na2HPO4, 137 mM NaCl, 2.7 mM KCl, 
1.4 mM KH2PO4, pH 7.4 
PBS-Tween (PBST) 0.1% Tween-20 in PBS pH 7.4 
PBS-Glucose-Tween (PBSGT) 50 mM glucose, 0.1% Tween-20 in PBS pH 7.4 
16% Paraformaldehyde (PFA) 16% (w/v) PFA in PBS pH 7.4 
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Table 1. Continued 
4-88 mounting media (4-88) 20% MOWIOL 4-88 (Sigma Aldrich), 30% (v/v) 
glycerol in PBS 
NuPAGE® transfer buffer 500 mM Bicine, 500mM Bis-Tris, 20.5mM EDTA, 
pH 7.2 
 
2.2 Escherichia coli strains and plasmids used in this study 
Table 2 lists all E. coli strains used in this study. 
Table 2. Escherichia coli strains used in this study. 
Strain Genotype Source 
DH5!  F- endA1 glnV44 thi-1 recA1 
relA1 gyrA96 deoR nupG 
"80dlacZ#M15 #(lacZYA-
argF)U169, hsdR17(rK
- mK+), $
– 
Grant et al. (1990) 
Top10 F- mcrA #(mrr-hsdRMS-mcrBC) 
"80dlacZ#M15 #lacX74 nupG 
recA1 araD139 #(ara-leu)7697 
galE15 galK16 rpsL(StrR) endA1 $- 
Invitrogen 
HB101 F- mcrB mrr hsdS20(rB
- mB
-) 
recA13 leuB6 ara-14 proA2 
lacY1 galK2 xyl-5 mtl-1 
rpsL20(SmR) glnV44 $- 
Mann et al. (1978) 
BL21Star™ F- ompT hsdSB (rB
- mB
-) gal dcm 
rne131 (DE3) 
Invitrogen 
OverExpress™ C41(DE3) F– ompT hsdSB (rB
- mB
-) gal dcm 
(DE3) 
Lucigen 
 
All plasmids produced in this study were analysed by Sanger DNA sequencing 
(Sanger et al., 1977). The company GATC Biotech performed all reactions. 
Table 3 lists all plasmids used in this study. 
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Table 3. List of all plasmids used in this study (nt = nucleotide; RoriT = pR388 oriT; KoriT = pKM101 oriT) 
Plasmid Description Source 
pKM101 Wild-type conjugative plasmid, a 
deletion variant of plasmid R46  
McCann et al. (1975) 
Langer & Walker (1981) 
pKM101-XmaI Deletion variant of pKM101 promoted by 
restriction digest with XmaI and intra-
molecular re-ligation 
This study 
pKT4SS_B10cS pASK_IBA-3C vector containing the 
genes traL/virB1, traM/virB2, traA/virB3, 
traB/virB4, traC/virB5, traD/virB6, 
traN/virB7, traE/virB8, traO/virB9, 
traF/virB10 and traG/virB11 with a Strep 
tag on the C-terminus of traF//virB10. The 
plasmid further contains the pKM101 oriT 
(KoriT) nic site following the gene 
traG/virB11 from pKM101. 
 
Dr Harry Low 
pKT4SS_B10cS_oriT-
rm 
Identical to pKT4SS_B10cS but KoriT was 
removed 
This study 
pWT_KT4SS pETDuet-1 vector containing the 
AscI/PacI fragment of pKM101-XmaI (nt 
positions 325-13047) 
This study 
pKRelax pCDFDuet-1 vector containing the 
relaxosome  genes traIH, traJ and traK. 
This study 
pKoriT pRSFDuet-1 vector containing KoriT This study 
pMAK3 Wild-type conjugative plasmid, a variant 
of pR388 with the T4SS DNA sequences 
being 97.3% identical 
Bradley & Cohen (1976) 
Revilla et al. (2008) 
pRT4SS pAsk-IBA3C vector containing the genes 
trwN/virB1, trwL/virB2, trwM/virB3, 
trwK/virB4, trwJ/virB5, trwI/virB6, 
trwH/virB7, trwG/virB8, trwF/virB9, 
trwE/virB10 and trwD/virB11 from 
pMAK3.  
This study 
pRT4SS_TrwK/VirB4-
eGFP 
Identical to pRT4SS but with a C-terminal 
eGFP fusion to TrwK/VirB4  
This study 
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Table 3. continued 
pRT4SS_TrwJ/VirB5-
eGFP 
Identical to pRT4SS but with a C-terminal 
eGFP fusion to TrwJ/VirB5  
This study 
pRT4SS_TrwI/VirB6-
eGFP 
Identical to pRT4SS but with a C-terminal 
eGFP fusion to TrwI/VirB6  
This study 
pRT4SS_eGFP-
TrwG/VirB8 
Identical to pRT4SS but with an N-
terminal eGFP fusion to TrwG/VirB8 
This study 
pRT4SS_TrwE/VirB10-
mCherry 
Identical to pRT4SS but with a C-terminal 
mCherry fusion to TrwE/VirB10  
This study 
pRT4SS_TrwI/VirB6-
FLAG 
Identical to pRT4SS but with a C-terminal 
FLAG tag fusion to TrwI/VirB6  
This study 
pRT4SS_FLAG-
TrwG/VirB8  
Identical to pRT4SS but with an N-
terminal FLAG tag fusion to TrwG/VirB8  
This study 
pRRelax pCDFDuet-1 vector containing the genes 
trwA, trwB and trwC 
This study 
pRRelax_TrwC-
mCherry 
Identical to pRRelax but with a C-
terminal mCherry fusion to TrwC 
This study 
pRoriT pRSFDuet-1 vector containing the pR388 
oriT sequence (RoriT) 
This study 
pAsk-IBA3C Cloning vector providing Cam resistance. 
Protein production is under control of the 
tet promoter 
IBA Lifesciences 
pCDFDuet-1 Cloning vector providing Spec resistance. 
Protein production is under control of the 
T7 promoter 
Novagen 
pRSFDuet-1 Cloning vector providing Kan resistance. 
Protein production is under control of the 
T7 promoter 
Novagen 
pETDuet-1 Cloning vector providing Amp resistance. 
Protein production is under control of the 
T7 promoter 
Novagen 
pEGFP-C1 Vector containing the egfp gene Clontech 
pRVCHC-5 Vector containing the mCherry gene Shaner et al. (2004) 
pKD3 Template plasmid for deletions using PCR 
products with the ? Red recombinase 
Datsenko & Wanner 
(2000) 
pKD46-Gm Helper plasmid expressing the ?  Red 
recombinase 
Doublet et al. (2008) 
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2.3 Oligonucleotide primers used in this study 
Oligonucleotide primers were ordered from MWG Eurofins, dissolved in water 
to a concentration of 100 pmol/µl and stored at -20° C. Table 4 lists all 
oligonucleotide primers used in this study, including their sequence. 
 
Table 4. List of all DNA oligonucleotides used in this study (bp = base pair) 
Name Nucleotide sequence (5’ !  3’ direction) 
oFs_oriT-rm taagcttgacctgtgaagtgaaaaatg 
oFt_oriT-rm (tail region in capital letters) GTGAACGGGAGCCTGTAAtaagcttgacctgtgaagtgaaaaatg 
oRs_oriT-rm acactgcattttatattcagggtc 
oRt_oriT-rm (tail region in capital letters) TTACAGGCTCCCGTTCACacactgcattttatattcagggtc 
otraIJK_AscI_1F (AscI restriction site in 
capital letters) 
ctaGGCGCGCCatgccaataataac 
otraIJK_XhoI_2B (XhoI restriction site in 
capital letters) 
gatCTCGAGTCATCAgatttcatggc 
opKoriT_AscI_1F (AscI restriction site in 
capital letters) 
tataGGCGCGCCaccggcaacatcaactg 
opAsk-lin_ATG_1F GGAGACCGCGGTCCCGAATTC 
opAsk-lin_ATG_2B CATTTTTTGCCCTCGTTATC 
otrwop_pAsk_IF_1F (15 bp pAsk-IBA3c 
overhang in capital letters) 
CGAGGGCAAAAAATGgcactggcagagttcgcggtgatcg 
otrwop_pAsk_IF_2B (15 bp pAsk-IBA3c 
overhang in capital letters) 
GGGACCGCGGTCTCCctaagccatcttggacttgg 
ocat_lin_1F CTCTGGAGTGAATACCAC 
ocat_lin_2B GTATTCACTCCAGAGCG 
oeGFP_trwG_1F (15 bp trwG/virB8 
overhang in capital letters) 
AGGGGCACTATGAGCgtgagcaagggcgaggag 
oeGFP_trwG_2B (15 bp trwG/virB8 
overhang in capital letters) 
TTTTGGTTGCTTCTTcttgtacagctcgtccat 
otrwG_RT4SS_lin_1F aagaagcaaccaaaaccggtcaag 
otrwG_RT4SS_lin_2B gctcatagtgcccctcgctg 
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Table 4. Continued 
oIF_trwE-mCh_1F (15 bp trwE/virB10 
overhang in capital letters) 
GATCTGGATTTCAGCgtgagcaagggcgaggag 
oIF_trwE-mCh_2B (15 bp trwE/virB10 
overhang in capital letters) 
GAGACTGTAGACATCcttgtacagctcgtccatg 
olin_c-trwE_1F gatgtctacagtctcgaaag 
olin_c-trwE_2B gctgaaatccagatcacgg 
oIF_trwI-eGFP_1F (15 bp trwI/virB6 
overhang in capital letters) 
GGACGCAAAGCAGGGgtgagcaagggcgaggag 
oIF_trwI-eGFP_2B (15 bp trwI/virB6 
overhang in capital letters) 
ACACCCTGACAACTActtgtacagctcgtccatgc 
olin_trwI-cT_1F tagttgtcagggtgtaaagcgg 
olin_trwI-cT_2B ccctgctttgcgtccccg 
oIF_trwK-eGFP_1F (15 bp trwK/virB4 
overhang in capital letters) 
GCCGAAAGGAGCGACgtgagcaagggcgaggagctg 
oIF_trwK-eGFP_2B (15 bp trwK/virB4 
overhang in capital letters) 
CCAGCTTCTTCATACcttgtacagctcgtccatg 
oIF_trwJ-eGFP_1F (15 bp trwJ/virB5 
overhang in capital letters) 
GGAATGCCGACTATCgtgagcaagggcgaggagc 
oIF_trwJ-eGFP_2B (15 bp trwJ/virB5 
overhang in capital letters) 
GTATCTTTTTCATTGcttgtacagctcgtccatg 
oIF_trwG-FLAG_1F (FLAG tag sequence in 
capital letters) 
GACTACAAAGACGATGACGACAAGtgaggggggcaccatgaag 
oIF_trwG-FLAG_2B (15 bp overhang to 
FLAG tag sequence in capital letters) 
ATCGTCTTTGTAGTCgttattgagtatttccgggtcagcgc 
oIF_trwI-FLAG_1F (FLAG tag sequence in 
capital letters) 
GACTACAAAGACGATGACGACAAGtagttgtcagggtgtaaag 
oIF_trwI-FLAG_2B (15 bp overhang to 
FLAG tag sequence in capital letters) 
ATCGTCTTTGTAGTCccctgctttgcgtccccggaag 
otrwABC_AscI_1F (AscI restriction site in 
capital letters) 
ctaGGCGCGCCatgctaggattgaac 
otrwABC_XhoI_2B (XhoI restriction site in 
capital letters) 
gatCTCGAGTCAttaccttccggcctc 
oIF_trwC-mCh_F (15 bp trwC overhang in 
capital letters) 
ATGGAGGCCGGAAGGgtgagcaagggcgaggag 
 oIF_trwC-mCh_B (15 bp trwC overhang in 
capital letters) 
ACCAGACTCGAGTTActtgtacagctcgtccatg 
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Table 4. Continued 
olin_c-trwC_F Taactcgagtctggtaaagaaac 
olin_c-trwC_B ccttccggcctccatgcc 
opRoriT_AscI_1F (AscI restriction site in 
capital letters) 
tataGGCGCGCCactcattttctgcatcattg 
opRoriT_AscI_2B (AscI restriction site in 
capital letters) 
aattGGCGCGCCaccgcctcgtcctc 
virB6/traD_RT_1F gattacgtcaatggtgagcgc 
virB6/traD_RT_2B gaggccacccagcacaac 
traI_RT_1F ctactttccgccacgaaacg 
traI_RT_2B cagcttctggcgttcaaagc 
traJ_RT_1F gcaattactttgcctccagtg 
traJ_RT_2B caatatttttgccgcctctaatg 
pAsk3C_SQ_2B GACGCAGTAGCGGTAAACG 
pASK-3C_1F_9100 ccgcccactctgtataaaaaccaaggc 
odel-pKM101_1F (homologous region to 
pKM101 in capital letters) 
CGTCTAAGGTGGGCCAATTCCCATAACAAGGTGGGCTA 
ATTCCCATAGTAAGGgtgtaggctggagctgcttc 
odel-pKM101_2B (homologous region to 
pKM101 in capital letters) 
CGCGGCAAATCCGGAAAAATGGAATGCACAATACACATG 
GAAGGATGCCatgggaattagccatggtcc 
 
 
2.4 Standard methods in microbiology 
2.4.1 Cultivation of Escherichia coli 
Escherichia coli was cultivated in liquid and solid culture using Luria Bertani 
(LB) broth at 37° Celsius (C), if not indicated otherwise. Liquid cultures were 
shaken at 170 revolutions per minute (rmp). All culture media were autoclaved 
and sterile technique was used for inoculation and handling of cultures. 
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The optical density (OD) of cell cultures was measured photometrically at 
600 nm (OD600). 
Antibiotics were sterile filtered and added to the medium. The following 
concentrations were used in solid and liquid medium: Ampicillin (Amp) 
100 µg/ml; Chloramphenicol (Cam) 30 µg/ml, Spectinomycin (Spec) 100 µg/ml; 
Nalidixic acid (Nal) 10 µg/ml, Kanamycin (Kan) 50 µg/ml. 
Expression of recombinant proteins was induced using 1 mM isopropyl-%-
thiogalactoside (IPTG), 200 µg/l anhydrotetracycline (AHT) or 200 µg/l 4-
epitetracycline if not stated otherwise. 
 
2.4.2 Transformation of Escherichia coli  
Electroporation after Fiedler & Wirth (1988) was performed to transform E. coli 
cells with plasmid DNA, PCR reactions or ligations. Electroporation cuvettes 
with 1 mm gap width (Flowgen) were used in a Biorad Gene Pulser Xcell 
electroporator (Voltage: 1800 V, Capacitance: 25 ?F, Resistance: 200 ?). 
Typically, a total of 40 ng of plasmid DNA was used for transformation. 
Ligation reactions were transformed using no more than 1.5 µl of a 10 µl 
reaction, and PCR reactions were transformed using up to 4.5 µl of a 50 µl 
reaction for restriction-free cloning.  
Chemically competent cells were either purchased from Invitrogen (One Shot® 
BL21 Star™ (DE3) Chemically Competent E. coli) or generated using a modified 
protocol after Mandel & Higa (1970), which is described here. Cells were 
grown to an OD600 of approx. 0.3-0.5. Cells were then harvested at 4000 rmp at 
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4° C and resuspended in ! the culture volume of ice-cold 100 mM CaCl2. The 
cells were then incubated for 20 minutes (min) on ice, and harvested at 
4000 rmp 4° C. Subsequently, they were resuspended 1/10 the culture volume of 
ice-cold 100 mM CaCl2 and incubated for 1 hour (h) prior to adding sterile 
glycerol to a final concentration of 15% (v/v). Cell aliquots were prepared and 
frozen at -80° C. For standard transformations, approx. 80 ng plasmid DNA 
was used. Up to 10 µl ligation reaction was used to transform competent cells. 
InFusionTM reactions were transformed using 2.5 µl (as per manufacturer’s 
recommendation), as well as the residual 7.5 µl of the 10 µl reaction. 
 
2.4.3 Conjugation assay 
The conjugation assay is the method of choice for assessing the functionality of 
the reconstituted T4SS. It assesses the transport of an oriT containing plasmid 
from a donor cell to a recipient cell. Choosing a recipient strain that carries an 
antibiotic resistance not present in the genomic background of the donor strain 
facilitates the selection for the amount of donor and recipient cells. The 
conjugation (or transfer) efficiency of a plasmid and strain is determined by 
counting the colony formation on agar plates selective for donors or recipients. 
Reconstitution experiments with the conjugation machinery will be pursued by 
dividing the needed machinery on two plasmids; one carrying the T4SS and 
one carrying the Relaxosome components. A third plasmid carrying the oriT 
will be used to analyse mobility. Donor strains will therefore be resistant to 
three antibiotics. The recipient strain DH5! carries the Nal resistance on its 
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genome. 
Over-night cultures of donor and recipient E. coli strains were used to inoculate 
5 ml LB cultures with or without antibiotics. Different donor strains were used 
and E. coli DH5! was used as recipient strain. 
The cultures were grown to an OD600 of approximately 0.4 and protein 
production was induced for 1 h at 37° C, if not indicated otherwise. A total of 
1.5 ml of donor culture, and the equivalent amount of recipient culture 
according to OD600 measurements were filtered on a hydrophilic MF-Millipore 
Membrane (Merck Millipore), made of mixed cellulose esters with a pore size 
of 0.45 µm. The filters were then incubated for 1 h lying on a LB agar plate, 
cells facing upwards. The cells were subsequently washed off the filter paper 
using 750 µl LB and 100 µl of different dilutions were plated LB agar plates 
containing Nal (selecting for E. coli DH5! recipient strains) and a second 
antibiotic, whose resistance is encoded on the transported plasmid (Kan in this 
study). Appropriate dilutions of the conjugation culture were also plated on 
antibiotics selecting for donors or total DH5! recipients.  
The transfer efficiency was calculated by dividing transconjugant colony count 
by either donor or recipient colony count (Cellini et al., 1997). 
 
2.4.4 Phage assay and phage purification 
The phage or plaque assay tests the susceptibility of a bacterial strain to 
bacteriophage infection. A bacterial culture is infected with bacteriophage, and 
grown in a soft agar over night. If the bacteria are susceptible to infection, 
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small plaques will appear in a lawn of bacteria formed in the soft agar. 
The bacterial strain is grown over night, and 200 µl of culture are mixed with 
100 µl of phage-containing, sterile bacterial lysate. A total of 3 ml 0.7% LB 
agar, which was previously melted and cooled down to approx. 40° C, was 
poured into of the phage-bacteria mixture, and gently mixed. The soft agar was 
then immediately poured on top of a previously set 1% LB agar plate, and 
spread evenly without creating any air bubbles. The plates were then incubated 
at 37 °C over night until a lawn of bacteria appears in the soft agar. 
Phage purification was performed by cutting the plaque from the soft agar 
using a sterile scalpel and placing the agar in a sterile Eppendorf tube. The agar 
was then topped with 500 µl sterile LB media supplemented with 1 mM CaCl2 
and incubated for 1 h at RT, vortexing occasionally. The LB media was then 
sterile filtered into a clean tube, and used to infect BL21Star® cells and cells 
transformed with plasmids pRT4SS + pRRelax + pRoriT. 
 
2.4.5 Assessing pilus visibility by negative stain EM 
Cells were grown under inducing conditions, and applied to copper grids. The 
negative stain agent phosphotungstic acid, titrated to pH 7 using potassium 
hydroxide (K-PTA), was applied for 30 s. After a wash step in water, the grids 
were air-dried and images were acquired on the Tecnai T10 microscope. 
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2.5 Standard methods in molecular biology 
2.5.1 DNA purification, electrophoresis & imaging methods 
All DNA was stored dissolved in water at -20° C. 
Plasmids were prepared using the Wizard® Plus SV Miniprep DNA Purification 
System (Promega) and stored dissolved in water at -20° C. 
DNA fragments were purified from agarose gels or after polymerase chain 
reactions (PCRs) using the QIAquick gel extraction or PCR purification kit 
(Qiagen), respectively, according to the manufacturer’s protocol. 
DNA concentrations were measured using a Nano Drop® ND-1000 
spectrophotometer. The software ND-1000 V3.5.2 performed the calculation of 
the DNA concentration. 
DNA gel electrophoresis was performed using 1% agarose gels containing 
SYBR® Safe DNA stain (Invitrogen). The DNA was then visualized under ultra 
violet (UV)-light (254 nm) and photographed. 
The restriction endonuclease DpnI (New England Biolabs) was used to digest 
methylated DNA. For this purpose, 9 µl PCR product were incubated with 1 µl 
DpnI for 1 h at 37°C. 
 
2.5.2 Polymerase chain reaction 
The amplification of DNA fragments was performed using PCR after Mullis et 
al. (1986) using an MJ Research PTC-200 Reltier Thermal Cycler. The standard 
PCR cycle shown in Table 5 was adapted for each reaction according to the 
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primers (annealing temperature), the amplified gene (elongation time) and the 
type of polymerase used (elongation time and temperature). A total of 2.5 units 
of PfuUltraTM high-fidelity DNA polymerase (Stratagene) were used to amplify 
whole plasmids for restriction-free cloning after Van den Ent & Löwe (2006). 
The KOD hot start polymerase (Novagen) or the Phusion polymerase (New 
England Biolabs) were used for standard DNA amplifications, both at 1 unit per 
reaction. Only the Phusion polymerase was used for SLIM and InFusionTM 
cloning procedures, using 1 unit per reaction using the high fidelity buffer 
according to the manufacturers protocol. 
 
Table 5. Standard PCR reaction used if not stated otherwise. 
PCR 
Step Temperature [° C] Time  
1. Denaturation 98 1 min 
2. Denaturation 95 30 s 
3. Primer annealing 60 10 s 
4. Elongation 68 (PfuUltraTM) or 72 (Kod or 
Phusion) 
Kod (10 s/kbp), 
PfuUltra (2 min/kbp) 
Phusion (15-30 s/kbp) 
25 cycles (step 2-4) 
5. Elongation 72 10 min 
6. Store 4 " 
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2.5.3 Restriction digest, dephosphorylation and ligation of DNA 
Restriction enzymes were purchased from New England Biolabs, and buffer 
conditions were adjusted according to the manufacturer’s protocol and 
incubated at 37° C for 1-3 h. Preparative restriction digests were conducted in 
a 50 µl volume, using 10 units of enzyme. Analytical digestion was conducted 
in a 10 µl volume, using 2 units of enzyme. Dephosphorylation of the digested 
vector was performed by adding 5 units of antarctic phosphatase (New England 
Biolabs) to the restriction digest and incubation at 37° C for 1 h. 
DNA fragments created by restriction digest were gel purified prior to any 
ligation. Both vector and insert were added in a 1:1 molar ratio, if not indicated 
otherwise. A total of 400 units of T4 DNA ligase (New England Biolabs) was 
added to a 10 µl reaction, which was incubated at 4° C over night or 1.5 h at 
room temperature. 
 
2.5.4 Western blot to detect a Strep or FLAG tag 
Cells were grown under inducing conditions. Varying amounts of cells at 
different stages of growth were harvested by centrifugation and resuspended in 
varying amounts of water according to the cell density. Sodium dodecyl 
sulphate containing loading dye (Invitrogen) was added, and cells were boiled 
for 10 min. Varying amounts of sample were separated using denaturing 
sodiumdodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) after 
Laemmli (1970). For this purpose, NuPAGE® 4-12% polyacrylamide bis-tris 
gels were used. A total of 7 µl pre-stained protein marker (Invitrogen) was used. 
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The protocol was performed according to the NuPAGE® western blot protocol 
(Invitrogen), using PVDF membrane (Invitrogen). The transfer was performed at 
30 V for 1. 
For Strep tag detection, a total of 2 µl monoclonal StrepMAB-Immo anti-strep 
antibody produced in mouse (IBA Lifesciences) was used in 10 ml 3% 
(w/v) milk in PBS for Strep tag detection. 
FLAG-tag detection was performed using 2 µl anti-FLAG® M2 antibody 
produced in mouse (Sigma Aldrich) in 10 ml 3% (w/v) milk in PBS. 
The PVDF membrane was incubated with the primary antibody for 1 h at RT, 
or over-night at 4° C, and subsequently washed twice with PBST buffer. 
The secondary antibody in both cases was Anti-Mouse IgG (whole molecule) 
Alkaline Phosphatase antibody produced in goat (Sigma Aldrich). A total of 
4 ?l was added to 10 ml 3% milk in PBS to detect the primary anti-FLAG or 
anti-Strep antibodies, and the membranes were then incubated at RT for 1 h at 
RT prior to detection. 
After 2 further wash steps in PBS, the detection of the alkaline phosphatase 
coupled to the anti mouse IgG was performed using the alkaline phosphatase 
precipitating substrate SIGMA FAST™ BCIP/NBT. One tablet was dissolved in 
10 ml water, then added to the PVDF membrane and incubated for a 
maximum of 5 min.  
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2.6 Cloning T4SS and Relaxosome plasmids 
Traditional cloning of DNA sequences relies on digesting the relevant insert 
and vector with restriction endonucleases. Thereby, complementary, single 
stranded DNA ends at the 5’ and 3’ ends of the fragment are generated. A 
ligase enzyme will then join the phosphodiester bond between the 3’ hydroxyl 
and the 5’ phosphate moieties of the complementary ends contained in the 
vector insert. The in vitro generated circular DNA can be transformed into 
genetically competent E. coli for replication (Cohen et al., 1973).  
Restriction enzymes recognise specific target sequences and cut DNA at 
specific points within the recognised sequence. Cloning using this method 
therefore requires the presence of a restriction site at a specific point within the 
vector, as well as the gene of interest. Introducing specific restriction sites into 
the insert is easily achieved by introducing the restriction site into the primer 
used for amplification of the insert by PCR. The restriction site of choice must 
however not be present in the insert itself.  
In the case of cloning large inserts into a replication and antibiotic resistance 
background, the chance of a restriction site being present in the insert rises. 
Further, introducing additional bp for a restriction site to the 3’-end of an 
operon structure may influence its expression by altering the distance between 
the promoter and the start codon. It is particularly difficult to create fusion 
proteins using restriction enzyme based methods, since the protein fusion has 
to be in frame. Achieving this using a restriction enzyme based method may 
result in several sub-cloning steps, as well as the introduction of additional 
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residues to keep the reading frame intact. 
PCR-based, restriction-free cloning methods, as well as assembly-cloning 
methods using homologous stretches of DNA sequence, allow for seamless 
addition of sequence to any existing vector at any specific point (van den Ent & 
Löwe, 2006; Zhu et al., 2007; Gibson et al., 2009). This is of advantage, 
especially when creating fusion proteins.  
 
2.6.1 InFusionTM cloning method 
The InFusionTM method relies on an assembly cloning methods, where 
overlapping ss DNA cohesive ends are created between insert and linearized 
vector. The principle is termed Gibson assembly (Gibson et al., 2009).  
Two DNA fragments (green and magenta in Figure 6) with overlapping ends 
are created, either both by PCR or restriction digest, and incubated with T5 
exonuclease, Phusion polymerase and Taq ligase. The exonuclease creates 
single-stranded cohesive ends. Subsequent annealing of the cohesive ends 
allows the DNA polymerase to fill potential gaps and nicks are ligated by the 
Taq ligase. Figure 6 was taken from Gibson et al. (2009) and shows a 
schematic depiction of the Gibson assembly process. The enzyme T5 
exonuclease removes nucleotides from the 5’ end of the end of the PCR 
products and thereby creates cohesive ends, which then spontaneously anneal. 
The DNA polymerase will then fill gaps that might occur due to the 
exonuclease treatment and the reaction can be transformed into chemically 
competent E. coli immediately. The InFusionTM cloning kit supplied by 
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Clontech, a similar method to the above described, was used in this project. 
The company supplies a 5x concentrated InFusionTM Enzyme and buffer mix, 
which is then added to the generated PCR products. The exact contents are not 
disclosed. 
 
Figure 6. Schematic depicting the Gibson assembly. Figure taken from Gibson et al. (2009). 
 
The following procedure was used for generating all InFusionTM clones 
produced in this study. 
The overlapping ends were added to the 5’ ends of gene-specific or vector 
specific PCR primers. In the case of fusing tags to a protein, the tag DNA 
sequence was added to the forward or backward primer, depending on the 
location of the tag. The tag sequence was then also added to the 
correspondingly appropriate primer for vector amplification o create the 
overlapping 15 bp sequence.  
The sequence to be cloned is amplified by standard PCR techniques (PCR 1), as 
Enzymatic assembly of
DNA molecules up to
several hundred kilobases
Daniel G Gibson1, Lei Young1, Ray-Yuan Chuang1,
J Craig Venter1,2, Clyde A Hutchison III2 &
Hamilton O Smith2
We describe an isothermal, single-reaction method for
assembling multiple overlapping DNA molecules by the
concerted action of a 5¢ exonuclease, a DNA polymerase
and a DNA ligase. First we recessed DNA fragments, yielding
single-stranded DNA overhangs that specifically annealed, and
then covalently joined them. This assembly method can be used
to seamlessly construct synthetic and natural genes, genetic
pathways and entire genomes, and could be a useful molecular
engineering tool.
For nearly 40 years, scientists have had the ability to join DNA
sequences and produce combinations that are not present in
nature. This ‘recombinant DNA technology’ was initiated soon
after the discovery of DNA ligase1 and restriction endonucleases2.
Since then, multiple approaches for joining DNA molecules
through the use of restriction enzymes3,4 and PCR5–8 have been
adapted. Ligation-independent cloning strategies have also been
developed9,10. We had recently described an in vitro recombination
method that we had used to join 101 DNA cassettes into four
quarter molecules of the Mycoplasma genitalium genome, each
136–166 kilobases (kb)11 (Supplementary Figs. 1–3 and Supple-
mentary Results online). Because we performed this recombina-
tion method in a thermocycler (to which we refer as ‘thermocycled’
here), individual reactions were carried out in only two steps. Here
we improved this two-step thermocycled method by using exo-
nuclease III and antibody-bound Taq DNA polymerase, which
allow for one-step thermocycled in vitro recombination (Supple-
mentary Fig. 4 and Supplementary Results online).
We now present an in vitro recombination system that differs
from the ones above by its capacity to assemble and repair over-
lapping DNA molecules in a single isothermal step. This approach
can be used to join DNAmolecules that are as large as 583 kb and to
clone joined products in Escherichia coli that are as large as 300 kb.
All reagents and enzymes are commercially available, and all that is
required for DNA assembly is for the reagent-enzyme mix (which
can be stored at !20 1C until needed) to be combined with
overlapping DNAmolecules and then incubated at 50 1C for as few
as 15 min (OnlineMethods). This approach dramatically simplifies
the construction of large DNA molecules from constituent parts.
Exonucleases that recess double-stranded DNA from 5¢ ends will
not compete with polymerase activity. Thus, all enzymes required
for DNA assembly can be simultaneously active in a single
isothermal reaction. Furthermore, circular products can be
enriched as they are not processed by any of the three enzymes in
the reaction. We optimized a 50 1C isothermal assembly system
using the activities of the 5¢ T5 exonuclease (Epicentre), Phusion
DNA polymerase (New England Biolabs (NEB)) and Taq DNA
ligase (NEB) (Fig. 1). Taq DNA polymerase (NEB) can be used in
place of Phusion DNA polymerase (data not shown), but the latter
is preferable as it has inherent proofreading activity for removing
noncomplementary sequences (for example, partial restriction
sites) from assembled molecules.
To test this system, we cleaved two restriction fragments that
overlapped byB450 base pairs (bp) from the 6-kb pRS415 vector
and then reassembled them into a circle (Fig. 2a). After 6–8 min at
50 1C, the linear substrate DNA was completely reacted, and the
major product was the 6-kb circle, which migrated just below the
4-kb linear position on an agarose gel. T5 exonuclease actively
degrades linear DNAmolecules, but closed circular DNAmolecules
are not degraded12. We confirmed the circularity of this assembled
product by treating it with additional T5 exonuclease (Fig. 2a). To
demonstrate that this assembled product was the predicted 6-kb
circle, we digested it with Not I (a single-cutter) and observed the
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Figure 1 | One-step isothermal in vitro recombination. Two adjacent DNA
fragments (magenta and green) sharing terminal sequence overlaps (black)
were joined into a covalently sealed molecule in a one-step isothermal
reaction. T5 exonuclease removed nucleotides from the 5¢ ends of double-
stranded DNA molecules, complementary single-stranded DNA overhangs
annealed, Phusion DNA polyme ase filled the gaps and Taq DNA ligase
sealed the nicks. T5 exonuclease is heat-labile and is inactivated during
the 50 1C incubation.
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is the vector (PCR VEC) into which the sequence is to be cloned. The PCR 
products were always gel purified prior to performing InFusionTM reactions, as 
template DNA can contaminate the InFusionTM reaction. Equal concentrations 
(approx. 60 ng each) of the PCR products were mixed and the volume was 
adjusted to 8 µl. If the PCR products were not concentrated enough after gel 
purification, water was evaporated from the PCR product using a vacuum 
centrifuge until the desired concentration was achieved. A total of 2 µl 5x 
enzyme and buffer mix was added and the reaction was incubated at 50°C for 
15 minutes.  
 
2.6.2 Site-directed, ligase-independent mutagenesis (SLIM) 
The SLIM method is designed for deleting sequences from existing plasmids (Chiu 
et al., 2004). The whole plasmid, apart from the deletion, is amplified in two 
separate PCRs. 
For the first PCR, a forward primer is designed that contains hybrid sequence 
from approximately 18 nt upstream of the deletion (tail region), and 
approximately 20 nt downstream of the deletion (primer FT). The reverse primer 
for the first PCR is complementary to approximately 20 nt immediately 
upstream of the tail region (primer RS). The resulting PCR product will therefore 
contain a hybrid 5’ end containing a sequence fusion of the up- and 
downstream regions of the deletion (see Figure 7A and B). 
The second PCR uses a forward primer FS that comprises the sequence of the 
20 nt downstream of the deletion (identical to the 3’ moiety of primer FT), and a 
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reverse primer RT that is complementary to the tail region (5’ end 18 nt of FT), 
as well as the region immediately upstream of the tail region (identical to RS). 
The resulting PCR product will contain all the sequence of the plasmid, apart 
from the sequence that is to be deleted (See Figure 7A and B). 
 
Figure 7. Schematic of the SLIM cloning method. A) Primer design for PCRs 1 and 2. B) Amplification of 
the plasmid in PCRs 1 and 2 C) Hybridisation of PCD products 1 and 2. 
DpnI digest eliminates any template plasmid. The two PCR products are 
hybridized in cycles of denaturating and hybridizing conditions. The tail 
regions of the 5’ end of PCR product 1 and the 3’ end of PCR product 2 will be 
complementary and ss when hybridized together, and therefore anneal to form 
(Figure 1A, vertical dotted line). Similarly, the longer tailed
primers FT and RT have the same 3
0 sequence as FS and RS
(indicated by gray arrow in FT and FS, and black arrow for RT
and RS) but contain the region to be inserted on their 5
0 ends.
Four different PCR products are produced using these primers
(Figure 1A, Products 1–4). Products 1 and 2 are identical,
except for the position of the inserted sequence which is
found on opposite termini (i.e. formed from either FT and
RS, or FS and RT). Product 3 contains the inserted sequence
on both termini (formed from FT and RT), while Product 4 does
not contain any sequence insertion (formed from FS and RS).
Denaturation and re-annealing of these four PCR products
generates 16 different double-stranded heteroduplex DNA
species. Two of the double-stranded heteroduplex hybrids
(generated from a DNA strand from Product 1 and the corres-
ponding strand from Product 2) create complementary 50 and
30 overhangs at opposite termini that can form stable, non-
covalently joined, DNA circles. Upon transformation into
E.coli, only the circular DNA molecules (containing the
desired mutation) give rise to colonies on selective media.
Sequence deletion from a plasmid is accomplished by
excluding the desired deletion region from the PCR amplifica-
tion. In order to delete a DNA sequence from a cloned gene,
three regions need to be considered in the design of PCR
primers. The first is the complementary region recognized
by the gene-specific portion of the primers. In Figure 1B,
this region is shown by the gray arrow for FT and FS and
black arrow for RT and RS. The second region to be considered
is the region of DNA sequence that will make up the overhang
(the hashed square in Figure 1B). This region must be adjacent
to the deleted sequence and in the example shown in Figure 1B,
is immediately 50 to the region deleted. The third region to
be considered is the region to be deleted (gray rectangle in
Figure 1B). The position of the deleted DNA sequence defines
the placement of the other regions. The 50-adapter of primers
FT and RT both contain DNA sequence complementary to the
hashe sequence (Figure 1B). Using this method, precisely
defined deletions of any size can be created by the selection
of appropriate amplification primers.
Similarly, substitution mutagenesis can be performed by the
design of primers containing the desired changes in the 50
region of FT and RT (Figure 1C). Using this strategy, it is
possible to replace one or more nucleotides simultaneously.
We have used this approach to create a single point mutation
(mutation of the T7 DNA Polymerase Tyr326 to Cys); however,
the entire region of the adapter (Figure 1C, hashed rectangle)
can be replaced by any sequence. In cases where one or two
nucleotides are altered, shorter primers of 18–20 bases com-
posed of just the 50-adapter sequence could be used in con-
junction with the gene-specific primers in the mutagenesis to
generate the desired overhangs.
Mutagenic efficiency of SLIM
The efficiency of SLIM was assessed by constructing a series
of insertion, deletion and substitution mutations of a 6.6 kb
expression clone of T7 DNA polymerase (J. Chiu, D. Tillett
and P. E. March, manuscript in preparation). The elements
present on this plasmid are presented in Materials and
Methods. The sequence deletion, insertions and alteration
were at different positions of the gene 5 open reading frame
A
B
C
Figure 1. Representation of SLIM. The gene-specific portion of each primer is
denoted by arrows. Forward and reverse primers are shown in gray and black,
respectively. The hash line represents the 50-adapter of the tailed primer.
(A) Sequence insertion. Template and four primers (FT, FS, RT, RS) were
mixed and the entire plasmid template was amplified. Four PCR products
were created (Products 1–4). The 50-adapter sequences were incorporated at
the opposite termin l ends of the Products 1 and 2. These are productive as they
contribute to a hybrid that can form a non-covalent closed circle. Products 3 and
4 are not productive in this regard. The PCR fragments were then subjected to
denaturation and re-annealing. Productive hybrids form when a strand from
Product 1 forms a hybrid with a strand fro Product 2 and creates a double-
stranded fragment with complementary overhangs that can circularize.
Fourteen non-clonable hybrids also form (data not shown). (B) Sequence
eletion. As for sequence insertion, inverse PCR was performed on the
circular plasmid template. To simplify the figure, only the initial primer
binding sites and the final deleted product are shown. The region to be
deleted is denoted by a gray rectangle. The 50 portion of the tailed forward
primer (FT) contains sequence complementary to DNA sequence (hash-lined
square) adjacent to the region to be deleted. The reverse tailed primer (RT)
contains a 50 tail complementary to the same region adjacent to the deletion. The
short gene-specific primers are located immediately 30 to the deletion (FS) and
50 to the adjacent region (RS). Four PCR products were created in the
amplification step, two of which were productive products. Following
denaturing and re-annealing, 16 possible hybrids form, two of which were
productive hybrids. The final product with the gray rectangle deleted is
obtained after transformation. (C) Sequence exchange (mutagenesis).
Inverse PCR was performed on circular plasmid template. To simplify the
figure, only the initial primer binding sites are shown. The region under-
going mutagenesis is represented by a hash-lined rectangle with the positions
ofmutation indicated by an asterisk. The 50 portion of each tailed primer (FT and
RT) carries the mutation(s) to be made on the target sequence. The resulting
linear PCR products carry the designed mutations on the adapters. PCR,
hybridization and transformation were performed as described for sequence
insertion.
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a circular, nicked DNA molecule (see Figure 7). The nic will be repaired in 
E. coli after transformation. 
2.6.3 Mutation by homologous recombination using PCR products 
 
Datsenko & Wanner (2000) developed a method to delete large fragments from 
a genome or other genetic entities in bacteria using a ? Red recombinase-
assisted approach. The method uses a PCR product with two 36 bp regions at 
its 5’ and 3’ ends (H1 and H2 in Figure 8) that are homologous to the flanking 
regions of the deletion site (Gene B in Figure 8), and an antibiotic resistance 
cassette, which then replaces the deletion site. The template plasmid for this 
PCR product is pKD3, containing the Kan resistance cassette flanked by 
recognition sites (FRT in Figure 8) for the site-specific recombinase FLT (the FLT 
recombinase can later be used to remove the Kan resistance cassette). The 
36 bp homologous regions are added to the PCR primers, as well as the 
priming regions for pKD3 (P1 and P2 in Figure 8). The resulting PCR product is 
then transformed into an E. coli strain expressing the $ Red recombinase system 
on a helper plasmid under the control of an arabinose-inducible promoter. The 
$ Red recombinase then assists in the homologous recombination of the 36 bp 
homologous regions and the deletion site. 
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Figure 8. One-step inactivation of chromosomal genes using PCR products. H1 and H2 refer to 
homologous regions of the deletion target; P1 and P2 are the priming sites on the template plasmid. 
Figure taken from Datsenko & Wanner (2000). 
 
 
2.6.4 Reconstituting the pR388 conjugation machinery 
The below section describes the cloning of the Relaxosome plasmid pRRelax 
and the oriT plasmid pRoriT. Please see the chapter “Results II – The IncW 
conjugation machinery” for a detailed description of the T4SS expressing 
plasmid pRT4SS. 
 
Cloning of pR388 oriT into pRSFDuet-1  – pRoriT 
The oriT sequence was amplified from pR388 (RoriT, 420 bp) by PCR using the 
oligonucleotide primers OpRoriT_AscI_1F and OpRoriT_AscI_2B. Both primers 
contain a restriction site for the enzyme AscI at their 5’-ends. The PCR product 
10:1 and used per Taq instructions to generate DNAs for cloning
andmutagenesis. Qiagen products (Hilden, Germany) were used
to isolate plasmid DNAs, gel-purify fragments, or purify PCR
products.
Bacteria. BW25113 (lacIq rrnBT14 ￿lacZWJ16 hsdR514 ￿araBA-
DAH33 ￿rhaBADLD78), BW25993 (lacIq hsdR514 ￿araBADAH33
￿rhaBADLD78), and BW25141 (lacIq rrnBT14 ￿lacZWJ16
￿phoBR580 hsdR514 ￿araBADAH33 ￿rhaBADLD78 galU95 end-
ABT333 uidA(￿MluI)::pir￿ recA1) are derivatives of the F-, ￿-, E.
coli K-12 strain BD792 [CGSC6159 (23)] and have no other
known mutations. The ￿araBADAH33, ￿phoBR580,
￿rhaBADLD78, uidA(￿MluI)::pir￿, and linked rrnBT14 ￿lacZWJ16
mutations were recombined onto the chromosome by allele
replacement (3, 24, 25). Conditional replicative oriR￿ plasmids
were maintained in the pir￿ host BW25141 or similar ones (25).
Several mutations were transferred by using P1kc transduction
(24). BT340 [DH5￿ carrying pCP20 (26)], MG1655 [CGSC6300
(27)], and the endABT333, galU95, and hsdR514 alleles have been
described (25).
Plasmids. pANTS￿ (28) and pINT-ts (29) were from M. Koob
(University of Wisconsin, Madison), pBAD18 (30) from L.
Guzman (Harvard Medical School, Boston), pCP15 (26) from
W. Wackernagel (Universitat Oldenburg, Oldenburg, Germa-
ny), pSC140 from S. Chiang (Harvard Medical School) and S.
Chiang and J. J. Mekalanos, personal communication; and
pTP223 fromK.Murphy (18). The Red helper plasmids (see Fig.
2) are derivatives of pINT-ts which contain araC-ParaB and ￿ ￿
exo (without or with tL3) DNA fragments that were PCR-
generated by using pBAD18 and ￿ DNA as template, respec-
tively. The template plasmids are derivatives of pANTS￿ that
contain an FRT-flanked kanamycin resistance (kan) or chlor-
amphenicol resistance (cat) gene from pCP15 or pSC140, re-
spectively. Synthetic DNAs containing FRT sites without or with
a juxtaposed ribosome-binding site were generated by PCR.
Details will be reported elsewhere. All relevant segments gen-
erated by PCR were sequenced on both strands in the Micro-
biology and Molecular Gen tics Core Facility at Harvard Med-
ical School.
Ge e Disruption. Transformants carrying a Red helper plasmid
were grown in 5-ml SOB cultures with ampicillin and L-arabinose
at 30°C to an OD600 of￿0.6 and then made electrocompetent by
concentrating 100-fold and washing three times with ice-cold
10% glycerol. PCR products were gel-purified, digested with
DpnI, repurified, and suspended in elution buffer (10 mM Tris,
pH 8.0). Electroporation was done by using a Cell-Porator with
a voltage booster and 0.15-cm chambers according to the
manufacturer’s instructions (GIBCO￿BRL) by using 25 ￿l of
cells and 10–100 ng of PCR product. Shocked cells were added
to 1-ml SOC, incubated 1 h at 37°C, and then one-half was spread
onto agar to select CmR or KmR transformants. If none grew
within 24 h, the remainder was spread after standing overnight
at room temperature. After primary selection, mutants were
maintained on medium without an antibiotic. They were colony-
purified once nonselectively at 37°C and then tested for ampi-
cillin sensitivity to test for loss of the helper plasmid. If it was not
lost, then a few were colony-purified once at 43°C and similarly
tested.
PCR Verification. Three PCRs were used to show that all mutants
have the correct structure. A freshly isolated colony was sus-
pended in 20-￿l water with a plastic tip from which 5-￿l portions
were used in separate 20-￿l PCRs following a 2-min preincu-
bation, ‘‘hot start,’’ at 95°C. Common test primers included: c1
(TTATACGCAAGGCGACAAGG) and c2 (GATCTTCCGT-
CACAGGTAGG) for cat, and k1 (CAGTCATAGCCGAAT-
AGCCT), k2 (CGGTGCCCTGAATGAACTGC), and kt (CG-
GCCACAGTCGATGAATCC) for kan. Two reactions were
done by using nearby locus-specific primers with the respective
common test primer (c1, c2, k1, or k2) to test for both new
junction fragments. A third reaction was carried out with the
flanking locus-specific primers to verify simultaneous loss of the
parental (nonmutant) fragment and gain of the new mutant-
specific fragment. The latter was repeated after elimination of
the resistance gene. A fourth reaction was sometimes done with
primers k2 and kt to test for a 471-nt kan fragment. Control
colonies were always tested side-by-side.
Eliminating Antibiotic Resistance Gene. pCP20 is an ampicillin and
CmR plasmid that shows temperature-sensitive replication and
thermal induction of FLP synthesis (26). CmR and KmR mutants
were transformed with pCP20, and ampicillin-resistant transfor-
mants were selected at 30°C, after which a few were colony-
purified once nonselectively at 43°C and then tested for loss of
all antibiotic resistances. The majority lost the FRT-flanked
resistance gene and the FLP helper plasmid simultaneously.
Nomenclature. One allele number signifies all mutations gener-
ated with a particular primer pair, as these are identical except
for the inserted DNA. An allele number followed by a double
colon and a descriptor for the inserted sequence indicates those
with an insertion. For example, DE(lacZYA)514::cat and
DE(lacZYA)514::kan refer to mutations made with the same
primers and pKD3 (cat) or pKD4 (kan) as template, respectively.
After eviction of the resistance gene, the mutation(s) is simply
called DE(lacZYA)514, as these are identical regardless of
history.
Results
Description of the Red Disruption System. The Red system includes
three genes: ￿, ￿, and exo, whose products are called Gam, Bet,
and Exo, respectively (18). Gam inhibits the host RecBCD
exonuclease V so that Bet and Exo can gain access to DNA ends
to promote recombination. In preliminary studies we attempted
to make chromosomal mutations by using the multicopy Red
plasmid pTP223 and PCR products with short homology exten-
sions, but were unsuccessful. We therefore made several low
copy plasmids such as pKD20 (Fig. 2) encoding the Red recom-
binase. pKD20 has an optimized ribosome-binding site for
Fig. 1. A simple gene disruption strategy. H1 and H2 refer to the homology
extensions or regions. P1 and P2 refer to priming sites.
Datsenko and Wanner PNAS ￿ June 6, 2000 ￿ vol. 97 ￿ no. 12 ￿ 6641
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was purified by elution from a 1% agarose gel and subsequently digested with 
5 units of the enzyme AscI in 1x Buffer 4 (New England Biolabs) for 3 h at 
37°C. The enzyme was then heat- inactivated by incubating the reaction at 
65° C for 20 min. The DNA was subsequently purified using the PCR 
Purification Kit (Qiagen). The vector pRSFDuet-1 was digested the enzyme AscI 
in 1x Buffer 4 (New England Biolabs). The enzyme was heat-inactivated by 
incubating the reaction at 65° C for 20 min and DNA was purified 
subsequently using the PCR Purification Kit. A molar vector:insert ratio of 1:2 
was used in a ligation reaction, which was incubated for 2 h at room 
temperature. The resulting plasmid was named pRoriT. 
The operon containing the genes trwA, trwB and trwC (4850 bp) was amplified 
from pR388 using the oligonucleotide primers trwABC_AscI_1F and 
trwABC_XhoI_2B. The primer trwABC_AscI_1F contains a AscI restriction site 
at it’s 5’-end, while the trwABC_XhoI_2B contains a XhoI restriction site at it’s 
5’-end to guarantee the appropriate orientation of the insert into pCDFDuet-1. 
All procedures were performed as described for the pKoriT cloning, using the 
enzymes AscI and XhoI. 
 
Cloning of the trwABC operon into pCDFDuet-1 – pRRelax  
The operon containing the genes trwA, trwB and trwC (4850 bp) were cloned 
into pCDFDuet-1 using the restriction sites AscI and XhoI according to standard 
methods described for pRoriT. The oligonucleotides otrwABC_AscI_1F and 
otrwABC_XhoI_2B were used to amplify the trwABC operon. 
 72 
2.6.5 Reconstituting the pKM101 conjugation machinery 
This section describes the cloning methods used for all pKM101-derived 
plasmids produced in this study. 
 
Cloning of pKRelax and pKoriT 
The oriT sequence was amplified from pKM101 (KoriT, 667 bp) by PCR using 
the oligonucleotide primers OpKoriT_AscI_1F and OpKoriT_AscI_2B for 
pKM101. Both primers contain a restriction site for the enzyme AscI at their 5’-
ends. Subsequent procedures were performed as described for pRoriT. 
The operon containing the genes traI, traK and traJ (5198 bp) was amplified 
from pKM101 using the oligonucleotide primers traIJK_AscI_1F and 
traIJK_XhoI_2B. A similar strategy was used as described for pRRelax. 
 
The deletion derivative pKM101-XmaI 
A total of 400 ng pKM101 DNA was digested with 0.5 u XmaI over-night at 
37˚ C. DNA was subsequently precipitated by adding 0.7-times the reaction-
volume of isopropanol and vortexing. The precipitate was then pelleted at 
16.000 xg at 4˚ C for 30 minutes. Then, the supernatant was discarded and the 
pellet washed with room-tempered 70% ethanol, centrifuged another 10 m at 
16000 xg and resuspended in 10 µl H2O.  
The ligation reactions were set up according to the manufacturer’s instructions 
at 4˚ C over night, using 1:10, 1:100 and 1:1000 dilutions of the XmaI-digested 
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pKM101 DNA, as well as undiluted XmaI-digested pKM101 DNA. The reaction 
was then transformed into E. coli DH5! cells. The transformation culture was 
plated on Amp-containing LB agar. 
 
The T4SS overexpression construct pKT4SS_B10cS_oriT-rm 
The SLIM cloning method as described above was used to delete a 25 bp oriT 
sequence present on the plasmid pASK-IBA3c_virB1-11_&B10cStrep (provided 
by Dr Harry Low). Oligonucleotides oFt_oriT-rm and oRs_oriT-rm were used to 
amplify PCR product 1, while oligonucleotides oRt_oriT-rm and oFs_oriT-rm 
were used to amplify PCR product 2. Table 6 lists the PCR program used. 
PCR products were gel-purified and DpnI digested, adding 5 µl of D-Buffer (20 
mM MgCl2, 20 mM Tris, pH 8.0 and 5 mM DTT) and 5 units of DpnI, then 
incubating for 1 h at 37 ° C. A total of 20 µl PCR products 1 and 2 each were 
mixed, adding 10 µl H-Buffer (300 mM NaCl, 50 mM Tris, pH 9.0, 20 mM 
EDTA, pH 8.0) and hybridized as listed in table 6. The hybridisation reaction 
was transformed into chemically competent E. coli DH5! cells and plated on 
LB agar containing Cam. 
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Table 6. PCR and hybridisation programme for SLIM cloning of pKT4SS_B10cS_oriT-rm. 
PCR 
Step Temperature [° C] Time  
1. Denaturation 97 2 m 
2. Denaturation 97 30 s 
3. Primer annealing 65 10 s 
4. Elongation 72 2 m 20 s 
25 cycles (step 2-4) 
5. Elongation 72 10 m 
6. Store 4 " 
Hybridisation 
Denaturation 97 3 m 
1. Hybridisation 65 5 m 
2. Hybridisation 30 15 m 
 
Deletion of pKM101 parts using the ? Red recombinase system 
The oligonucleotide primers odel-pKM101_1F and odel-pKM101_2B (see 
Table 4) were used to generate the deletion construct by PCR. The PCR was 
performed using the template plasmid pKD3. Subsequently, the PCR product 
was subjected to digestion with DpnI for 1 h at 37˚ C and gel-purified. The PCR 
product was then transformed into electrocompetent E. coli HB101 cells 
containing pKM101 and the $ Red recombinase system on the helper plasmid 
pKD46-Gm (Doublet et al., 2008). These cells were previously grown in the 
presence of 1 mM arabinose and made electrocompetent. After transformation, 
the cells were incubated 1 h at 30˚ C in LB, half of the culture was plated on 
kanamycin-containing LB agar plates and incubated over night at 37˚ C. The 
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other half of the culture was left at RT over night and plated on kanamycin-
containing LB agar plates the next morning and then incubated over night at 
37˚ C. 
 
The wild-type promoter T4SS reconstitution pWT_KT4SS 
The plasmid pKM101-XmaI was digested with the restriction enzymes AscI and 
PacI, generating two fragments of 12,722 and 7714 bp. The fragments were 
separated by agarose gel electrophoresis and the larger fragment, encoding the 
T4SS and an additional 1000 bp upstream of traL/virB1, was eluted from the 
gel. The vector pETDuet-1 was also digested with the restriction enzymes AscI 
and PacI, and subsequently gel purified. A ligation was set up as described 
above, using a molar ratio of 1:1 and incubated over night at 4° C. The ligation 
was transformed into E. coli DH5! cells and plated on Amp-containing LB 
agar. 
 
2.7 Fluorescence Microscopy and Immunolabelling 
Fluorescence is a natural phenomenon where a molecule absorbs light and 
subsequently emits light at a different, usually lower frequency. In microscopy, 
this phenomenon can be used for the subcellular localisation of a protein 
tagged with a fluorescent protein or an antibody conjugated to a fluorophore.  
The green fluorescent protein (GFP) from a bioluminescent jellyfish was 
discovered in the 1950ies by Shimomura et al. (1962), and has since 
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revolutionised in situ protein detection by fluorescence microscopy. Countless 
mutations of the original GFP, as well as the discovery of fluorescent proteins 
from other species, have since resulted in proteins emitting light in a great 
variety of wavelengths, which are reviewed in Stepanenko et al. (2011). The 
chromophores are protein-derived and no co-factors are required for their 
function. In case of GFP, it is formed of a three amino acid sequence, which 
undergoes a cycle of cyclisation, oxidation and dehydration. An intermediate 
during these processes is able to emit green light of 508 nm wavelength upon 
excitation at wavelengths 396 and 475 nm. The surrounding rigid % barrel 
structure contributes to this ability. The chromophore formation is similar in all 
fluorescent proteins (see Stepanenko et al. (2011). 
The fluorescent proteins used during this study were enhanced GFP (eGFP, 
Clontech) and mCherry (Shaner et al., 2004). The eGFP protein is an optimised 
version of wild-type GFP, where the amino acids Ser65 and Phe64 were 
mutated to Thr and Leu, respectively (Zhang et al., 1996). The mCherry protein 
is a variant of the red fluorescent protein DsRed from the coral Discosoma 
spec, which has been improved regarding DsRed’s tendency for 
oligomerisation, quicker maturation and photo stability (Shaner et al., 2004). 
Antibody labelling can also be used to detect proteins within the cell. A 
specific (primary) antibody is then used to specifically bind the protein of 
interest. The antibody is then detected by a second antibody (secondary) 
conjugated to a fluorescent dye, whose epitope is directed against the IgG of 
the organism the primary antibody was raised in. In this study, the primary 
antibody was a monoclonal antibody raised in mouse directed against the 
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FLAG-tag, while the secondary antibody was directed against the IgG of mouse 
and conjugated to Alexa Fluor594.  
 
2.7.1 Microscopy 
In brightfield microscopy, the image is formed by light passing through the 
specimen. Fluorescence microscopy images are created by the emitted light of 
a fluorophore in the specimen.  
The excitation light is provided by a light source, which is then passed through 
the excitation filter to provide light of a specifically adjustable wavelength. This 
light is then reflected by a dichroic mirror and passes through the objective 
onto the specimen, which is then excited. The light emitted upon excitation 
passes back through the objective to the dichroic mirror. The dichroic mirror 
reflects all light up to a certain wavelength, while light of longer wavelength 
will pass through the mirror. Since the emitted light of a fluorophore is always 
of lower wavelength than the excitation light, the emitted light can pass 
through the mirror and create the image. Prior to reaching the eyepiece or 
camera, the light is passed through the emission filter so that only the emitted 
light of a selected fluorophore will create the image.  
 
2.7.2 Deconvolution 
Plasticity is difficult to achieve when acquiring images in one focal plane. 
Optical slicing, or Z-slices, through a specimen creates several 2D images, 
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which can later be assembled to a stack and create a 3D impression. Each 
image contains, however, information of the above and below focal planes, 
termed out-of-focus or scattered light. The result is a slightly distorted or blurry 
image, where the illuminated object appears to be of different shape. This 
effect occurs due to numerous physical properties of the microscope and the 
specimen, such as the objective or the refractive index of the specimen media, 
which reduce the ability of the microscope to depict a point-shaped light 
source. These parameters can be mathematically combined and described as 
the point-spread-function. 
An experimental approach to reduce the effect of out-of-focus light is to use 
confocal microscopy, where the excitation and emission light is restricted to a 
pinhole, only illuminating a very specific point within the specimen. This 
method requires very high light dosage, and may not be beneficial for 
specimen integrity. 
Deconvolution is a mathematical approach to cut out the information of 
scattered light in an image whereby the point-spread-function of a microscope 
is used to mathematically reverse to the actual shape of the object from the 
image where the scattered light information is still included. The point-spread-
function of the microscope can be obtained experimentally; however, it is also 
possible to estimate it using computed algorithms. In this study, the 
deconvolution algorithm developed by Zeiss and included in the ZEN software 
package was applied to acquired Z-stacks. Z-stack images were acquired every 
2 µm.  
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2.7.3 Experimental procedures 
 
Cell fixation and application to microscopy slides 
A volume of 2 ml cell culture was harvested at 1500 xg for 2 min, washed 
twice in PBS and resuspended in 150 µl PBS. To gain a final concentration of 
4% paraformaldehyde (PFA), 50 µl 16% PFA was added to the cell suspension. 
The suspension was then incubated at RT for 20 min. Cells were then harvested 
again and resuspended in an appropriate volume of water (depending on cell 
density) to create a dense cell suspension. A volume of 20µl was applied to 
Multispot microscope slides PTFE with specialised coating (C. A. Hendley 
(ESSEX) LTD) and incubated at RT for 30 min. The cells are now attached to the 
specialised coating on the slide’s spots and ready for antibody labelling. All 
following procedures were conducted by applying a 20 µl volume of all 
solutions onto the cells attached to the microscopy slide well. 
 
Cell permeabilisation and blocking 
Cells were treated with lysozyme to facilitate antibody penetration through the 
bacterial cell wall. Further, the detergent tween-20 is used to permeabilise the 
bacterial membranes. Prior to lysozyme treatment, the wells were washed with 
PBSGT buffer to adjust the osmotic pressure and prevent shock. Excess liquid 
was carefully blotted off each well using Whatman paper wedges. The cells 
were then incubated with 2 mg/ml lysozyme in PBSGT for 2 min. The 
lysozyme was washed off the slide with PBSGT, and excess liquid was again 
 80 
blotted off. Blocking conditions were optimised to 3% goat serum + 3% bovine 
serum albumin (BSA) in PBSGT, and cells were incubated at these conditions 
for 30 min at RT. After several wash steps with PBSGT and blotting off excess 
liquid from the wells, the cells were ready for antibody labelling. 
 
Antibody labelling 
Conditions for antibody labelling were optimised for each antibody.  
FLAG-tag recognition was most efficient with a 1:400 dilution of Monoclonal 
ANTI-FLAG® M2 antibody produced in mouse (Sigma Aldrich) and 1% BSA in 
PBSGT. The cells were incubated with the above-described solution for 1 h at 
RT, washed with PBSGT and excess liquid was blotted off. 
The detection of the anti-FLAG antibody was facilitated using the Alexa Fluor® 
594 Goat Anti-Mouse IgG antibody (Invitrogen). This anti-mouse antibody was 
diluted 1:300 in 1% BSA-PBSGT, and the cells were incubated in this 
condition for 30 min at RT. After rinsing each well with plenty of PBSGT and 
blotting, the samples were ready for mounting. 
 
Mounting 
A volume of 10 µl 4-88 mounting medium was applied to each well, and a 
clean cover slip covering all well was applied to the slide. The mounting 
medium was allowed to polymerise at 4° C over night prior to imaging. 
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eGFP and mCherry detection 
Cells expressing eGFP- or mCherry-fusion proteins were fixed and applied to 
microscope slides as described above. Cells that did not attach to the slide after 
30 min were washed off with PBS and excess liquid was blotted off prior to 
mounting, which was performed as described above. 
 
Imaging fluorescent samples 
All images were acquired using the Zeiss Axio Observer.Z1 fluorescence 
microscope at 100x magnification (ECPlam-Neofluar 100x/1.30 Oil M27 
objective) using an AxioCam Mrm3 S/N 3884 camera. The exposure time was 
adjusted for each image. Images with the purpose of intensity comparison were 
acquired using the same exposure time. 
 eGFP was imaged in the green channel (Emission wavelength: 500-550 nm, 
Excitation wavelength 450-490 nm), while mCherry and Alexa Fluor594 
labelled proteins were imaged in the red channel (Emission wavelength: 570-
640 nm, Excitation wavelength 433-558 nm). 
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3 Results I – The IncN Conjugation System pKM101 
The plasmid pKM101 is a deletion variant of the self-transmissible plasmid 
R46, promoted by the insertion sequence element IS46 (Hall, 1987). The 
plasmid pKM101 contains the two tra regions (see Figure 9) encoding the T4SS 
and the Relaxosome, and is therefore self-transmissible. While pKM101 
encodes resistance to ß-lactam antibiotics only, R46 further confers resistance 
to sulphonamides and streptomycin/spectinomycin (Langer & Walker, 1981). 
 
Figure 9. Plasmid map of pKM101. The T4SS region is displayed in pink and the relaxosome region in 
green. 
Self-transmissible plasmids tend to grant genetic traits that may be 
advantageous to survival of the bacteria replicating it, as is often exemplified 
by multiple antibiotic resistance genes present on these extra-genomic entities. 
The plasmid pKM101 further contains the genes mucA, mucB (nt postions 
24403-26607 in Figure 9) and uvp1 (see Figure 9, nt position 21483-22076), 
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which have been shown to enhance bacterial survival following UV radiation 
due to their activation upon DNA damage as part of the SOS response system 
(Elledge & Walker, 1983; Gigliani et al., 1989). The activity of these genes 
further results in higher survival rates and enhanced mutagenesis in response to 
chemical mutagens; therefore, pKM101 has been introduced in the Ames 
Salmonella tester strains to asses the carcinogenic properties of chemical agents 
(McCann et al., 1975). 
The two tra regions are important for conjugal transfer of pKM101, located 
between base pairs 35238-4149 transcribed in clock-wise orientation, and 
base pairs 6477-15807 transcribed in counter clock-wise orientation (see 
Figure 9, Winans & Walker 1985). 
The larger region contains the genes encoding for a T4SS and its pilus, which is 
essential for conjugation. A total of 11 genes is postulated to be necessary to 
form the double-membrane spanning protein complex. The proteins named 
TraA through to TraG and TraL through to TraO (VirB1-11) are thought to form 
the T4SS, including an extracellular pilus that is composed TraM/VirB2 and 
TraC/VirB5, and two ATPases (TraB/VirB4 and TraG/VirB11) to fuel the DNA—
protein substrate transport (reviewed in Alvarez-Martinez & Christie (2009), see 
Figure 10). 
The proteins TraN/VirB7, TraO/VirB9 and TraF/VirB10 have been shown to 
form the core complex of the pKM101 T4SS, spanning the periplasm and 
inserting in both the inner and outer membrane of E. coli (Fronzes et al., 
2009b). 
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Figure 10. Schematic depicting the organisation of tra genes in pKM101.  
 
The shorter region encodes the genes traK, traJ and traI (see Figure 10), which 
are thought to form the relaxosome of this conjugation system. TraI is 
homologous to the relaxase TrwC of the pR388 conjugation system (see 
Introduction chapter), while TraK is thought to correspond to the relaxase 
enhancer activity of TrwA in pR388. In the pKM101 conjugation system, the 
protein TraJ contains Walker A and B motifs, and is thought to play the role of 
the T4CP (homologous to the ATPase TrwB in pR388), being responsible for 
the recruitment of the DNA—relaxase substrate to the T4SS for secretion. The 
pKM101 oriT region (KoriT) is located 3’ adjacent to the relaxosome operon 
and partly overlaps with the coding sequence of traK. 
The plasmid pKM101 encodes for many genes that are unrelated to the 
conjugation process, as has been described above. Only approx. 30% of the 
plasmid actually encodes for what is thought to be the T4SS and Relaxosome 
moieties. However, it is still unknown whether some of the genes outside the 
T4SS and Relaxosome regions are required for conjugation or whether the T4SS 
traA/virB3 traC/virB5 
traD/virB6 
traN/virB7 
traE/virB8 
traO/virB9 
traF/virB10 
traG/virB11 traL/virB1 
traM/virB2 
traB/virB4 
tra region nt 6477-15807 
traK 
traJ 
traI 
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and Relaxosome regions are sufficient to drive conjugative transfer. The aim of 
this project is to (i) determine the minimal genetic requirements for 
conjugation; (ii) generate a genetically tractable T4SS, which can be (iii) 
produced for imaging purposes using electron microscopy or fluorescence 
microscopy and (iv) provide a simple assay in which structure-function 
relationships derived from structure can be assessed by site-directed 
mutagenesis of various T4SS components. 
 
3.1 The overexpression construct pKT4SS_B10cS 
The genes to build the conjugation machinery were divided according to their 
natural operon organization on pKM101, i.e. the T4SS components and the 
relaxosome components were cloned on two separate vectors compatible for 
co-expression. The pKM101 oriT sequence (KoriT) was cloned onto a third 
compatible vector, whose transfer can be monitored by antibiotic resistance. If 
the VirB1-11 homologues, the coupling protein TraJ/VirD4, the relaxase TraI 
and the enhancer TraK are sufficient for conjugation, the expression of these 
proteins should mobilise a KoriT-containing plasmid and mediate its 
conjugation into a recipient cell. 
 
3.1.1 The expression vectors 
The most important consideration when choosing the expression vectors was 
that they have compatible origins of replication, meaning that the origins of 
replication cannot be similar or the same on the three vectors. 
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The vector pAsk-IBA3C (IBA Lifesciences) was chosen to harbour the T4SS 
operon, as it has been used to successfully overexpress the T4SS core complex 
of pKM101 (Fronzes et al., 2009b). It provides Cam resistance and protein 
expression is under the control of the tet promoter, inducible using tetracycline 
derivatives such as AHT or 4-epitetracycline. It harbours the f1 origin of 
replication. 
The vector pCDFDuet-1 (Novagen) was chosen to harbour the Relaxosome 
operon, and contains the CloDF13 replicon. The vector provides Spec 
resistance and is inducible via the T7 promoter. In an E. coli BL21 background, 
the T7 polymerase can be induced using the allolactose analogue IPTG, which 
then facilitates transcription of the T7 promoter. 
The pRSFDuet-1 vector is similar to the pCDFDuet-1, but harbours the 
RSF1030 origin of replication. This vector was used to clone the KoriT 
sequence, and provides Kan resistance. Protein production from this vector is 
also T7 promoter driven and IPTG inducible in an E. coli BL21 background; 
however, this was irrelevant here as no proteins were expressed from this 
vector. 
 
3.1.2 The constructs pKoriT, pKRelax and pKT4SS_B10cS 
pKoriT 
The KoriT sequence (650 bp) was amplified from pKM101 by PCR as described 
in Methods and ligated into pRSFDuet-1. The resulting construct will provide 
Kan resistance and is depicted in Figure 10-1. 
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Figure 10-1. Plasmid map depicting the features of pKoriT. The plasmid contains the oriT region of the 
pKM101 plasmid (purple), and confers Kanamycin resistance (green). It further contains two T7 promoters 
and two lac operator sequences, as well as the coding sequence of the lac repressor lacI (blue). 
 
The PCR products shown in Figure 11A correspond to the expected size for the 
KoriT sequence, which is 667 bp. The DNA was extracted from a 1% agarose 
gel, then AscI treated and ligated into AscI-digested pRSFDuet-1 as described 
in Methods, section 2.6.5. The ligation reaction was transformed into E. coli 
Top10 cells and analysis of KanR colonies by colony PCR showed KoriT 
presence in clone pKoriT #9 (data not shown). Subsequent analysis by Sanger 
sequencing showed the correct ligation of KoriT into pRSFDuet-1, resulting in 
the plasmid pKoriT. 
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pKRelax 
The operon containing the genes traK, traJ and traI (5198 bp) was amplified 
from pKM101 and ligated into pCDFDuet-1. The resulting construct will 
position the traKJI operon under the control of the promoter Plac, which is 
inducible with the molecular mimic of allolactose IPTG, and provides Spec 
resistance (see Figure 10-2). 
 
Figure 10-2. Plasmid map depicting the features of pKRelax. The plasmid contains the traIJK region, 
which is thought to form the relaxosome of the pKM101 plasmid under the control of T7 promoter, and 
confers spectinomycin resistance (green). It further contains the lac operator sequence, as well as the 
coding sequence of the lac repressor lacI (blue). 
 
Figure 11B shows the PCR products amplified from the plasmid pKM101. The 
expected size for traKJI was 5198 bp. DNA fragments of several sizes were 
amplified during all PCR reactions; however, in both cases distinct fragments of 
the expected size were generated. Those fragments were subsequently purified 
from an agarose gel, AscI/XhoI treated, ligated into AscI/XhoI digested 
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pCDFDuet-1 and transformed into E. coli Top10 cells as described in Methods, 
section 2.4.2. 
 
Figure 11. PCR products generated from pKM101 using (A) primers OpKoriT_AscI_1F and 
OpKoriT_AscI_2B and (B) traIJK_AscI_1F and traIJK_XhoI_2B. The expected sizes of KoriT and the 
Relaxosome operon are 650 bp and 5198 bp, respectively. 
 
SpecR colonies were analysed by colony PCR using the primers otraJ_RT_1F 
and otraJ_RT_2B. The PCR reaction was expected to amplify a DNA fragment 
of 418 bp from the gene traJ. A fragment of this size could be amplified from 
clones #1-6, #9, #10, #12 and #13 (data not shown). The plasmids isolated 
from clones #3, #4, #9 and #12 were analysed by Sanger sequencing, which 
confirmed the correct ligation of the traKJI operon into pCDFDuet-1. Plasmid 
isolated from clone #4 was used for subsequent experiments. 
 
 
7 
3. Results 
 
3.1. Cloning of the oriT sequence from pKM101 and pR388 into 
the vector pRSFDuet-1 – pKoriT and pRoriT 
The PCR products amplified from pKM101 and pR388 are shown in Figure 3. 
pKM101 oriT was expected to be 667 bp in size (to form pKoriT), while pR388 
oriT was expected to be 420 bp in size (to form pRoriT). The PCR products 
generated correspond to the expected size for the respective oriT sequences. 
They were then treated, ligated into pRSFDuet-1 and transformed into 
E. coli Top10 as described in Materials & Methods. Analysis of Kanamycin-
resistant colonies by colony PCR showed one positive clone for pKoriT (#9) and 
four positive clones for pRoriT (#4, #8, #9, #10).  
 
Figure 3. oriT PCR products. A. pKM101 PCR product. B. pR388 PCR product. 
 
The plasmids isolated from pKoriT #9 and from pRoriT #4, #8, #9, #10 were 
sent off for sequencing and it was confir d hat the correct fragment had been 
ligated into pRSFDuet-1. 
 
3.2. Cloning of the relaxosome and T4CP from pKM101 and 
pR388 into the vector pCDFDuet-1 
Figure 4 shows the PCR products amplified from the plasmids pKM101 and 
pR388. The expected size for traIJK was 5198 bp, while trwABC was expected 
to be 4850 bp. DNA fragments of several sizes were amplified during both PCR 
reactions. However, in both cases distinct fragments of the expected size were 
generated. Those fragments were subsequently purified from agarose gels in 
order to use only the fragment of appropriate size. Those fragments were 
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treated, ligated into pCDFDuet-1 and transformed into E. coli Top10 as 
escribed in aterials & Methods. 
 
 
Figure 4. A. pKM101 traIJK PCR pr duct. B. pR388 trwABC PCR product. 
Spectinomycin-resistant clones for the pCDFD_traIJK_AscI/XhoI plasmids were 
analysed by colony PCR using the primers otraJ_RT_1F and otraJ_RT_2B. The 
PCR reaction was expected to amplify a DNA fragment of 418 bp from the gene 
traJ. Figure 5 shows that a fragment of this size could be amplified from clones 
#1-6, #9, #10, #12 and #13. 
 
 
Figure 5. Colony PCR to test for insertion of traIJK operon into pDCFDuet-1. Numbers indicate clone numbers. 
 
The plasmids isolated from clones #3, #4, #9 and #12 were sent off for 
sequencing and it was confirmed that the correct fragment had been ligated into 
pCDFDuet-1. Clone #4 was used for subsequent experiments. 
Plasmids isolated from clones obtained from ligating the fragment trwABC into 
pCDFDuet-1 were subjected to control restriction digests using the enzymes 
AscI and XhoI with conditions as described in Materials & Methods. Figure 5 
shows the restriction patterns for those plasmids. The correctly cloned plasmid 
is expected to generate fragments of 4844 bp and 3551 bp. The fragments 
generated are all of approximately 3000 bp in size. 
B 
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pKT4SS_B10cS 
Dr Harry Low kindly provided the construct pKT4SS_B10cS; it was generated 
using a restriction free cloning method after Van den Ent & Löwe (2006).  
The construct contains the VirB1-VirB11 homologues from pKM101 from the 
ATG start codon of traL/virB1 to the stop codon or traG/virB11 under the 
control of the tet promoter cloned into pAsk-IBA3C, conferring Cam resistance. 
Protein production from this vector is induced via the tet promoter, using 
tetracycline derivatives such as AHT and 4-epitetracycline for induction. The 
plasmid further contains a Strep tag fused to the C-terminus of TraF/VirB10 
(resulting in the protein TraF/VirB10cS), and the KoriT nick site cloned after 
traG/virB11. 
 
Figure 11-1. Plasmid map depicting the features of pKT4SS_B10cS. The plasmid contains the tra region, 
which is thought to form the Type IV Secretion System of the pKM101 plasmid under the control of the tet 
promoter, and confers chloramphenicol resistance. It further contains the tet repressor sequence, as well 
as the oriT nick site. 
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3.1.3 Conjugation assay pKT4SS_B10cS, pKRelax and pKoriT 
The conjugation assay determines the transport of a plasmid from a donor cell 
to a recipient cell by assessing the antibiotic resistance of cells. It is paramount 
for this assay that donor and recipient strains are distinguishable by distinct 
antibiotic resistance genes. If a plasmid is transported during conjugation, this 
will result in a strain with a new combination of antibiotic resistance, forming 
the so-called transconjugant colonies. The E. coli strain DH5? carries the Nal 
resistance on its genome, which makes this strain very convenient as a 
recipient strain because it is not a commonly used antibiotic in cloning vectors. 
Escherichia coli strain DH5?  was therefore used as a recipient strain 
throughout the work presented here. 
Initially, it was important to determine whether the cognate pKM101 
conjugation machinery will mobilise pKoriT for transport. Conjugation assays 
were performed to analyse whether the native pKM101 plasmid will suffice to 
transport the KoriT-containing pKoriT construct to a recipient cell. 
For this purpose, the donor strain E. coli HB101 containing pKM101 was co-
transformed with pKoriT or pRSFDuet-1 (serving as a negative control), leading 
to AmpR/KanR donor strains. The conjugation assay was performed as described 
in Methods, using E. coli strain DH5? (NalR) as the recipient strain. NalR/KanR 
transconjugant colonies could only be observed when conjugation was 
performed with pKM101- and pKoriT-containing cells, whereas no NalR/KanR 
colony growth was observed upon DH5?conjugation with pKM101- and 
pRSFDuet-1-containing HB101 cells. 
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The conjugation culture of DH5! with pKM101 and pRSFDuet-1 was further 
plated on Nal/Amp containing media to test for functionality of pKM101 
transfer, where ample transconjugant colony growth could be observed. This 
experiment served as a proof of principle that pKoriT is specifically recognised 
as substrate by the pKM101 T4SS. 
To test whether the plasmid pKT4SS_B10cS is conjugation proficient, cells 
were co-transformed with the constructs pKT4SS_B10cS, pKRelax and pKoriT, 
resulting in a donor strain that is CamR/SpecR/KanR. Over-night cultures of 
donors and DH5! were diluted into fresh LB medium without antibiotics, and 
grown shaking at 37° C. At an OD600 of approximately 0.3, 4-epitetracycline or 
AHT and IPTG were added to the culture to varying final concentrations. After 
1 h conjugation time, the pKoriT transfer efficiency was determined by 
counting NalR/KanR colonies. 
The plasmids pKT4SS_B10cS, pKRelax contain all the genes we hypothesised 
might be necessary for conjugation; however, initial experiments co-expressing 
the plasmids pKT4SS_B10cS, pKRelax and pKoriT and induction with 1 µg 
AHT and 1 mM IPTG did not lead to NalR/KanR transconjugant colonies. 
The induction of protein expression may influence the correct assembly of the 
T4SS, as well as the timing of the experiment upon induction. An induction 
experiment using the inducers AHT, 4-epitetracycline and IPTG in varying 
concentrations was conducted to assess this possibility. AHT induces the tet 
promoter by irreversibly binding the Tet repressor protein, while 4-
epitetracycline binds the tet repressor in a reversible fashion. An induction with 
4-epitetracycline is therefore thought to be weaker than induction with AHT. 
 93 
4-epitetracycline concentrations of 0.7 µg, 0.5 µg and 0.1 µg with a constant 
IPTG concentration of 0.5 mM were tested, as well as AHT concentrations of 
0.7 µg, 0.5 µg and 0.1 µg with a constant IPTG concentration of 0.5 mM. 
Further, the experiment included varying IPTG concentrations of 0.7 mM, 
0.5 mM and 0.1 mM IPTG with a constant AHT concentration of 0.5 µg. No 
NalR/KanR transconjugant colony growth could be observed under any of the 
above-mentioned conditions (data compiled in table 6-1).  
Table 6-1. Induction experiments using the inducers IPTG, 4-epitetracycline and anhydrotetracycline in 
varying concentrations, conducted with cells transformed with pKT4SS_B10cS + pKRelax + pKoriT.  
Inducer  
Transconjugants 
IPTG [mM] 4-epitetracycline [µg] Anhydrotetracycline 
[µg] 
0.5 0.1 - 0 
0.5 0.5 - 0 
0.5 0.7 - 0 
0.5 - 0.1 0 
0.5 - 0.5 0 
0.5 - 0.7 0 
0.05 0.1 - 4 
0.1 0.1 - 0 
0.25 0.1 - 0 
0.5 0.1 - 0 
 
During the above-described experiment, whole cell samples were taken for 
Western Blot analysis using anti-Strep antibodies to analyse whether the 
TraF/VirB10cS protein is expressed (see Figure 12). The samples contained 
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similar amounts of whole cells according to OD600 measurements, and and 
samples were prepared as described in Methods. The TraF/VirB10cS protein is 
expected to be approx. 40 kDa in size. 
 
 
Figure 12. Western Blot using anti-Strep antibodies of samples taken during conjugation assay with 
varying concentrations of inducer. Lanes 1-3: 0.5 mM IPTG and 0.7 µg 4-epitetracycline (lane 1), 0.5 
µg 4-epitetracycline (lane 2), 0.1 µg 4-epitetracycline (lane 3). Lanes 4-6: 0.5 µg AHT and 0.7 mM IPTG 
(lane 4), 0.5 mM IPTG (lane 5), 0.1 mM IPTG (lane 6). Lanes 7-9: 0.5 mM IPTG and 0.7 µg AHT (lane 7), 
0.5 µg AHT (lane 8), 0.1 µg AHT (lane 9). 
 
A specific signal for the Strep tag can be observed in cell samples in lanes 
1, 2, 3 and 5 (Figure 12), running at a size of approximately 60 kDa. The pre-
stained protein marker used in this experiment was calibrated using mass 
64  kDa 
4-epitetracycline IPTG AHT 
37  kDa 
lane     1       2       3        4       5        6      7     8            9     
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spectrometry data and it was confirmed that in the gel system used 
TraF/VirB10cS indeed runs at approx. 60 kDa. The behaviour of the marker 
proteins may be influenced by the dye used. The specificity of the signal is 
high; therefore, it can be assumed that the Strep tag signal corresponds to the 
TraF/VirB10cS protein. The Strep tag signal present in lane 5 is inconsistent 
with the result presenting in lane 8, since identical induction conditions 
(0.5 mM IPTG and 0.5 µg AHT) were used in both cultures. 
The most consistent results were observed in the 4-epitetracycline induction 
series, with the highest level of expression observed at low 4-epitetracycline 
and medium IPTG concentration (lane 3). Consequently, a conjugation 
experiment was undertaken using 0.1 µg 4-epitetracycline and varying 
concentrations of IPTG (0.05, 0.1, 0.25 and 0.5 mM) to induce the protein 
production. The conjugation assay resulted in four NalR/KanR transconjugant 
colonies on the 0.05 mM IPTG plate, and one on the 0.1 mM IPTG plate. 
These colonies were analysed by colony PCR regarding the presence of KoriT, 
and the result is shown in Figure 13A. In lanes 1, 2 and 4, a PCR product 
corresponding to the expected size of 667 bp can be seen. These colonies were 
used to inoculate liquid Nal/Kan cultures, and plasmid was isolated from these 
cultures. The plasmids were digested with AscI, and fragments of the expected 
sizes for pKoriT (3829 and 659 bp) were observed in all cases (Figure 13B). The 
additional smeared, large signal (exceeding 5000 bp) may be undigested 
pKoriT. 
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Figure 13. Analysis of transconjugant clones after conjugation assay with pKT4SS_B10cS, pKRelax and 
pKoriT. +C is the positive control where pKoriT was used as template DNA. A) Colony PCR with KoriT 
specific primers. Lanes 1-5 corresponds to clones 1-5. B) AscI restriction digest of plasmid isolated from 
transconjugants clones 1-5 (lanes 1-5).  
 
All subsequent conjugation assays were performed using 0.1 µg 4-
epitetracycline and 0.05 mM IPTG. The assay was repeated in the same way 
20 times without transconjugant colony growth on Nal/Kan-containing media. 
All these assays were performed using the same strain co-transformed with the 
plasmids pKT4SS_B10cS, pKRelax and pKoriT. For the following conjugation 
assays, each culture was freshly transformed with the plasmids prior to 
performing the conjugation assay. One of the performed mating assays with 
fresh transformants resulted in many NalR/KanR, apparent transconjugant 
colonies; however, the presence of pKoriT in these transconjugants could not 
be determined by PCR or restriction digests. Furthermore, this result could not 
be reproduced in the following 46 mating assays with fresh transformants, or 
with the previously generated strain. 
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3.1.4 Generating pKT4SS_B10cS_oriT-rm 
The putative KoriT nic site was included in the plasmid pKT4SS_B10cS 
following the 3’ end of traG/virB11. The possibility arises that the relaxosome 
would recognise and process pKT4SS_B10cS at this nic site, and thereby 
interfere with the expression of the T4SS proteins. Removing the KoriT nic site 
sequence from the plasmid should eliminate this possibility. The method of 
choice for this cloning step was the SLIM cloning method, designed for 
deletions (see Methods for a detailed description). 
The plasmid was PCR amplified resulting in PCRs 1 (using oligonucleotides 
oFt_oriT-rm and oRs_oriT-rm) and 2 (using oligonucleotides oFs_oriT-rm and 
oRt_oriT-rm), each with an expected size of 13,246 bp. Figure 14A shows the 
PCR products after gel purification, which corresponded to the expected size. 
 
Figure 14. Cloning of pKT4SSB10cS_oriT-rm. A) PCR products obtained using primers oFt_oriT-rm and 
oRs_oriT-rm for PCR 1 (lane 1), and oFs_oriT-rm and oRt_oriT-rm for PCR 2 (lane 2) with template 
pKT4SS_B10cS, expected size is 13,246 bp. B) NdeI control digest of pKT4SS_B10cS_oriT-rm clones 1-7 
(lanes 1-7, respectively) and positive control +C pKT4SS_B10cS. The expected pattern for pKT4SS_B10cS 
is 4212, 3319, 2493, 1975 and 1247 bp. 
10000 bp 10000 bp 
3000 bp 
1000 bp 
1500 bp 
2000 bp 
lane/clone       1    2    3     4    5    6     7         +C      PCR          1            2 
A B 
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Both PCR products were then used for SLIM hybridization (see Methods 
chapter 2.6.2) and transformation.  
Transformation of the SLIM hybridisation reaction into E. coli TOP10 resulted 
in the formation of only 7 colonies. Plasmid was isolated from each clone and 
digested with NdeI for analytical purposes, which is shown in Figure 14B. If the 
expected fragment pattern of 4212, 3319, 2493, 1975 and 1247 bp is 
observed, it is likely that the correct plasmid has been produced. Figure 14B 
shows the restriction pattern observed for the plasmids isolated from clones 1-7 
corresponds to the expected pattern of pKT4SS_B10cS_oriT-rm.  
In clones 1-4, the restriction digest shows the expected pattern for 
pKT4SS_B10cS_oriT-rm. However, it is impossible to distinguish the parent 
plasmid pKT4SS_B10cS from pKT4SS_B10cS_oriT-rm, since only 26 bp were 
removed. Additional Sanger sequencing of the plasmid isolated from clone 4 
showed that the KoriT sequence had been removed successfully. 
 
3.1.5 Conjugation assays with pKT4SS_B10cS_oriT-rm, pKRelax and pKoriT 
The plasmid pKT4SS_B10cS_oriT-rm was transformed into electrocompetent 
E. coli BL21StarTM cells, since transformation of this clone into the BL21 strain 
did only result in very small colonies that did not grow in liquid media. 
Escherichia coli BL21StarTM cells are engineered for higher messenger 
ribonucleic acid (mRNA) stability due to a mutation in the rne131 gene 
encoding RNaseE. Transformation of pKT4SS_B10cS_oriT-rm into the 
BL21StarTM strain did result in the formation of colonies in some occasions; 
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however, often no growth in liquid cultures could be achieved with some of 
these colonies. 
Over-night cultures were prepared for subsequent generation of 
electrocompetent cells and co-transformation with pKRelax and pKoriT.  of 
pKT4SS_B10cS_oriT-rm, plasmid was isolated from some of the over-night 
cultures and analysed by NdeI restriction digest as to whether they contain the 
correct plasmid. Figure 15 shows the NdeI-digested plasmids from isolated 
from four colonies (clones 1-4). Only plasmid isolated from clone 4 displayed 
the expected fragment pattern of 4212, 3319, 2493, 1975 and 1247 bp. The 
remainder of this over-night culture was used to inoculate the culture used for 
generating electrocompetent cells for co-transformation with pKRelax and 
pKoriT. 
Generally, transformation and cell growth of pKT4SS_B10cS_oriT-rm proved to 
be difficult. Cells harbouring the plasmid pKT4SS_B10cS_oriT-rm showed slow 
growth, and no growth upon induction. On many occasions, no growth 
occurred upon inoculation of single colonies into 5 ml over-night cultures. 
These characteristics increased when co-transformed with the plasmids 
pKRelax and pKoriT, and in many cases no growth occurred upon inoculation 
with single colonies for overnight cultures. 
CamR/SpecR/KanR colonies were used to inoculate over-night cultures, and used 
to inoculate the donor conjugation culture 1:10. They were grown to an OD600 
of approximately 0.3 and protein production from Ptet and Plac was induced 
by the addition of 0.5 µg 4-epitetracycline and 0.5 mM IPTG. Thereafter, no 
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culture growth could be observed. The conjugation assay was performed 2 h 
thereafter. 
 
Figure 15. Control digest of pKT4SS_B10cS_oriT-rm isolated from BL21StarTM clones 1, 2, 3 and 4 with 
NdeI. The expected pattern for pKT4SS_B10cS_oriT-rm is 4212, 3319, 2493, 1975 and 1247 bp. 
 
Cells were washed off the filter paper and diluted. Subsequently, they were 
plated on media selective for donors (Cam, Spec and Kan) and transconjugants 
(Nal and Kan). 
NalR/KanR transconjugant colonies were obtained when E. coli BL21StarTM 
cells were co-transformed with the plasmids pKT4SS_B10cS_oriT-rm, pKRelax 
and pKoriT (see table 7). However, conjugation was still observed when no 
inducer was added to the cultures, although at lower rates. 
Induction severely reduced the donor cell count on Cam-, Spec- and Kan- 
containing plates although similar amounts of donor cells were used in each 
repeat. The transconjugant cell count is similar in induced and not induced 
conjugation cultures.  
 
3000 bp 
1000 bp 
lane/clone    1       2       3       4              +C      
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Table 7. Conjugation efficiency pKT4SS_B10cS_oriT-rm + pKRelax + pKoriT induced and not induced. 
Conjugation efficiency equals the amount of transconjugants colonies divided by the number of donor 
colonies. Dilutions of each repeat were averaged to derive conjugation efficiency. 
Induced Repeat Cell type Approx. cell 
count/ml 
Conjugation Efficiency 
 
 
+ 
 
1 Transconjugants 361 0.06 
Donors 6123 
2 Transconjugants 3123 0.4 
Donors 8484 
 
 
- 
1 Transconjugants 14*103 0.007 
Donors 2*106 
2 Transconjugants 707 0.0002 
Donors 4*106 
 
Plasmids isolated from transconjugant colonies were analysed by AscI 
restriction digest, expecting fragments of 3829 and 659 bp for pKoriT. Although 
additional DNA fragments are visible after the digest, the plasmid pKoriT is 
present in the cells (see Figure 16). When conjugation cultures were plated on 
Spec and Nal, colony growth was also observed, pointing to the fact that 
pKRelax may also be transported during conjugation. This may be explained by 
the fact that the coding sequence for TraK overlaps with the a part of oriT 
sequence and is therefore present on pKRelax. 
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Figure 16. AscI restriction digest of plasmid isolated from transconjugant colonies. Clones 1 and 2 were 
produced from induced cells, while clones 3 and 4 were produced from not induced cells. The positive 
control (+C) is pKoriT. Expected fragments for pKoriT: 3829 bp, 659 bp 
 
3.2 The pKM101 deletion construct pKM101-XmaI  
Since the conjugation assay with pKT4SS_B10cS did not result in reproducible 
mobilisation of pKoriT, and pKT4SS_B10cS-oriT-rm was notoriously difficult to 
propagate in E. coli, the possibility was to be examined whether other factors 
encoded on pKM101 may be of vital function during conjugation, or indeed 
maintain plasmid stability of T4SS containing plasmids. Therefore, we 
attempted to progressively remove some of the non-T4SS and non-Relaxosome 
regions in the native pKM101 plasmid while simultaneously testing for 
retaining its conjugation proficiency. 
The XmaI restriction site is present twice on pKM101. XmaI cuts pKM101 at 
nucleotide position 4886 and 25322 (see Figure 17), resulting in two fragments 
of 20436 and 15836 bp in size. Genes that are thought to be important for 
replication (repA and its binding site), the Amp resistance gene (oxa2) and the 
tra region forming the T4SS will be located on the 20436 nt fragment. The 
10000 bp 
3000 bp 
1000 bp 
lane/clone  +C   1     2     3      4 
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Relaxosome encoding genes and KoriT will be located on the 15836 nt 
fragment. In the event of an intramolecular re-ligation event of the 20436 nt 
fragment, a replication proficient plasmid conferring AmpR should be formed, 
retaining the T4SS encoding genes.  
 
 
Figure 17. Plasmid map of pKM101 and the deletion variant pKM101-XmaI showing the differences of 
these two plasmids (T4SS tra region is displayed in pink/purple, and relaxosome oriT and tra regions are 
displayed in blue/cyan). Red arrow indicates the area in pKM101 which is not present in pKM101-XmaI. 
Area deleted in pKM101-XmaI 
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Figure 17 shows the plasmid map of pKM101-XmaI in comparison to pKM101, 
where the deleted moiety if displayed by red arrows. The relaxosome 
components may then be complemented with pKRelax and pKoriT to form 
conjugation proficient E. coli strains, which allows for testing the functionality 
of pKRelax, as well as the modification relaxosome genes using PCR-based 
mutagenesis.  
 
3.2.1 Generating pKM101-XmaI 
The pKM101 deletion derivative pKM101-XmaI was generated as described in 
Methods. Figure 17A shows the XmaI digested pKM101 DNA before (lane 1) 
and after (lane 2) isopropanol precipitation. The expected sizes of fragments 
generated by XmaI digest were 20436 bp and 15836 bp, which approx. 
corresponds to the size of DNA fragments depicted in Figure 17A. It may be 
possible that the two fragments migrate as one band on the gel due to their 
large size, although the size difference between them is ca. 5000 bp. It is, 
however, unlikely that undigested plasmid is in this DNA sample, because 
such a species would migrate at a distinctly different size. 
Transformation of the ligation reactions made with undiluted, 1:10, 1:100 and 
1:1000 dilutions of XmaI-digested pKM101 DNA resulted in approx. 
40 colonies on each plate. Liquid cultures for clones 1-4 (undiluted ligation), 
clones 5 and 6 (1:10 diluted), clones 7-10 (1:100 diluted) and clones 10-14 
(1:1000) were inoculated; however, only clones 1-4 from the undiluted ligation 
plate grew in liquid, Amp-containing medium.  
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The total DNA was precipitated after from the restriction digest of pKM101 
with XmaI, and used to set up the ligation reactions. Therefore, it is possible 
that either the complete pKM101 simply re-ligated from the two initial 
fragments, or pKM101-XmaI is formed upon intramolecular re-ligation of the 
20436 bp fragment. PCR analysis was therefore performed to test for the 
presence of T4SS genes (present in pKM101-XmaI), and the absence of 
Relaxosome genes (not present in pKM101-XmaI). 
PCR primers virB6/traD_RT_1F and virB6/traD_RT_2B specific for traD/virB6 
(see Table 4 and Figure 17, present in re-ligated pKM101-XmaI) and traI_RT_1F 
and traI_RT_2b specific for traI (see Table 4 and Figure 17, not present in re-
ligated pKM101-XmaI) was performed to assess the resulting plasmids as to 
whether they are pKM101 or pKM101-XmaI. The plasmid pKM101 was used in 
comparison, and as positive control. 
The results are shown in Figure 18B. All lanes containing a PCR reaction 
performed with traD/virB6-specific primers show a DNA fragment of the 
expected size (442 bp, Figure 18 lanes 1, 3, 5, 7 and 9) that is identical to the 
positive control (Figure 18B, lane 9). No PCR product was generated in any 
PCR reaction using traI-specific primers (Figure 18, lanes 2, 4, 6, 8 and 10).  
Since the traI-specific PCR was also negative in the pKM101 positive control, 
the traI-specific PCR was repeated and additional relaxosome-specific PCR 
reactions were performed using traJ-specific primers (see Table 4 and 
Figure 16, traJ_RT_1F and traJ_RT_2B). The DNA isolated from the potential 
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pKM101-XmaI clones was used as template DNA, as well as pKM101 and 
pKRelax as positive control templates. 
These results are shown in Figure 18C. In this case, a positive result for traI and 
traJ could be observed from the positive control plasmids pKM101 and 
pKRelax (expected sizes: traI – 605 bp; traJ – 439 bp, see Figure 18C, lanes 9-
12), whereas no PCR products were generated when pKM101-XmaI was used 
as template (Figure 18C, lanes 1-8). The PCR results therefore show that a 
pKM101 variety was created that contains the traD/virB6 gene, but neither the 
traI- nor the traJ- encoding regions. 
 
 
Figure 18. Generating pKM101-XmaI. A) pKM101 DNA after digestion with XmaI (lane 1: before 
isopropanol precipitation, lane 2: after isopropanol precipitation). B) traD/virB6- and traI-specific PCR 
reaction. Lanes 1 and 2: traD/virB6 and traI PCR clone 1, lanes 3 and 4: traD/virB6 and traI PCR clone 2, 
lanes 5 and 6: traD/virB6 and traI PCR clone 3, lanes 7 and 8: traD/virB6 and traI PCR clone 4, lanes 9 
and 10: traD/virB6 and traI PCR pKM101 (positive control). Lanes 11-14: KpnI restriction digest of 
plasmid isolated from potential pKM101-XmaI clones 1, 2, 3 and 4 (expected fragment size: 14437 and 
5999 bp). Lane 15: KpnI restriction digest of pKM101 (expected fragment size: 25654, 5999 and 
4619 bp). C) Repeated relaxosome specific PCR. traI and traJ specific PCR reactions for clone 1 (lanes 1 
and 2), clone 2 (lanes 3 and 4), clone 3 (lanes 5 and 6) and clone 4 (lanes 7 and 8). Lanes 9 and 10: traI 
and traJ specific PCR reactions using pKRelax as template. Lanes 11 and 12: traI and traJ specific PCR 
reactions using pKM101 as template. 
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A restriction digest using the enzyme KpnI was used to ascertain the PCR 
results that, indeed, pKM101-XmaI was generated. KpnI was expected to 
generate two fragments of 14437 and 5999 bp when cutting pKM101-XmaI, 
while pKM101 digestion with KpnI should generate three fragments of 25654, 
5999 and 4619 bp in size. Figure 18B shows the result of the restriction digest. 
Three fragments were generated for pKM101 (Figure 18B, lane 15), while only 
two fragments are visible for the pKM101-XmaI clones 1-4 digestion 
(Figure 18B, lanes 11-14). The results show the expected fragment sizes for 
pKM101-XmaI, and we can assume that this deletion variant has been created 
successfully. 
 
3.2.2 Conjugation assay with pKM101-XmaI, pKRelax and pKoriT 
Initial experiments were undertaken to determine the conjugation efficiency of 
pKM101 for comparative purposes. Escherichia coli BL21(DE3) cells harbouring 
pKM101 were used as donor strains (AmpR), and DH5? cells were used as the 
recipient strain (NalR). Resulting transconjugant are expected to be AmpR/NalR.  
Conjugation assays were performed as previously described. The conjugation 
cultures were diluted 10-4, 10-5 and 10-6, and plated on LB agar containing Nal 
and Amp. The conjugation efficiency for pKM101 is approx. 0.5, as is shown in 
Table 8.  
 
 108 
Table 8. Conjugation efficiency of the plasmid pKM101. 
Cell type Approx. cell count/ml Conjugation efficiency 
Transconjugants 196*106  
0.5 
Donors 391*106 
 
To analyse whether pKM101-XmaI will be able to facilitate transport of pKoriT 
when complemented with pKRelax, E. coli BL21(DE3) pKM101-XmaI cells 
were co-transformed with pKoriT, and either pRRelax or pCDFDuet-1, resulting 
in a donor strain that is AmpR/SpecR/KanR. Conjugation assays were performed 
as described previously and conjugation cultures were subsequently diluted, 
and plated on media containing Nal and Kan selecting for pKoriT 
transconjugants, and Amp/Spec/Kan for donors. Further, a BL21(DE3) donor 
strain harbouring pKM101 for pKoriT was used as a positive control.  
The results are shown in Table 9. Cells containing pKM101 were able to 
transport pKoriT with wild-type efficiency (on average 0.9). Cells transformed 
with pKM101-XmaI and pKRelax still showed efficient transport of pKoriT, 
although the efficiency was slightly reduced (approx. 0.4). These results show 
that pKM101-XmaI is not conjugation proficient if no relaxosome components 
are present in trans (donor strain harbouring pKM101-XmaI, pCDFDuet-1 and 
pKoriT). Upon complementation with pKRelax, however, conjugation 
proficiency can be restored to almost wild-type level (donor strain harbouring 
pKM101-XmaI, pKRelax and pKoriT). 
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Table 9. Transport efficiency for pKoriT. Conjugation assay results from E. coli BL21(DE3) pKM101-XmaI 
+ pKRelax + pKoriT, pKM101-XmaI + pCDFDuet-1 + pKoriT and pKM101 + pKoriT. Conjugation 
efficiency equals the amount of transconjugants colonies divided by the number of donor colonies. 
Dilutions of each repeat were averaged to derive conjugation efficiency. 
Strain Repeat Cell Type Approx. cell count/ml Conjugation Efficiency 
 
 
pKM101-XmaI 
+ pKRelax 
+ pKoriT 
1 Transconjugants 3.5*106 0.3 
Donors 11.4*106 
2 Transconjugants 4*106 0.4 
Donors 10.7*106 
3 Transconjugants 3.5*106 0.4 
Donors 8.3*106 
 
 
pKM101-XmaI 
+ pCDFDuet-1 
+ pKoriT 
1 Transconjugants 0 0 
Donors 0.7*106 
2 Transconjugants 0 0 
Donors 0.7*106 
3 Transconjugants 0 0 
Donors 0.7*106 
 
 
pKM101 
+ pKoriT 
1 Transconjugants 2.5*106 1.5 
Donors 1.6*106 
2 Transconjugants 0.9*106 0.4 
Donors 2.2*106 
3 Transconjugants 3.6*106 1 
Donors 3.6*106 
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3.3 Further minimisation attempts of pKM101 
The plasmid pKM101-XmaI is 20436 nt in size, and still contains many genes 
which are thought to be irrelevant for conjugation. Methods to accomplish 
large deletions from the chromosome usually use homologous recombination 
approaches. Such an approach could be used to further delete genes from 
pKM101, as well as pKM101-XmaI. One example is a study by Doublet et al. 
(2008), where such an approach was used to delete a pathogenicity island on 
the Salmonella genome.  
In order to genetically access pKM101 and achieve a minimal conjugation 
system from the native pKM101 plasmid, attempts were made to modify 
pKM101 using such a homologous recombination-based method, the ? Red 
recombinase system (see Methods section 2.6.3). The method of choice was a 
one-step inactivation and deletion protocol based on PCR products published 
by Datsenko & Wanner (2000). The aim was to delete the region downstream 
of repA until the beginning of KoriT (nt positions 23484-34680 in Figure 9), 
which contains genes thought to be irrelevant for conjugation (see Figure 9). 
For this purpose, the PCR product del-pKM101 was generated, containing the 
5’ and 3’ flanking regions of the deletion target at its 5’ and 3’ ends. Using the 
plasmid pKD3 as template and the oligonucleotides odel-pKM101_1F odel-
pKM101_2B (see Table 4), a fragment of the expected size (1135 bp) could be 
generated (see Figure 19). 
This PCR product was transformed into E. coli HB101 cells, which also 
contained pKM101 and pKD46-Gm. However, no KanR colonies could be 
generated if the cells were plated after 1 h of incubation. The culture that was 
 111 
left at room temperature over night without antibiotics and subsequently plated 
on kanamycin-containing agar gave rise to four colonies. Liquid cultures were 
inoculated and plasmid DNA isolated; however, no DNA was visible on 
agarose gel electrophoresis. 
 
 
Figure 19. Four identical PCR products del-pKM101 to delete parts of pKM101 by homologous 
recombination (expected size 1135 bp). 
 
Several attempts to generate KanR colonies using the ? Red recombinase 
system, such as varying donor strains from HB101 to Top10 (cannot metabolise 
arabinose) or changing induction conditions to higher arabinose concentrations 
did not result in KanR colonies.  
 
 
3000 bp 
2000 bp 
1500 bp 
1500 bp 
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3.4 The wild-type promoter construct pWT_KT4SS 
Attempts at further trimming down the pKM101 using the ? Red recombinase 
system, and thereby establishing a method that could potentially be used for 
pKM101-XmaI, proved to be difficult. We therefore sought to investigate 
another way of identifying the minimal requirements for conjugative transfer. 
We reasoned that one possibility for our failed attempts described in section 
3.1 was that the proteins were over-expressed. Over-expression can be 
problematic, particularly because a number of T4SS and the T4CP are proteins 
inserting in the membranes and thus rely on specific machineries (the Sec or 
Tat complex for inner membrane proteins, and Bam complex for outer 
membrane proteins) to do so. By over-expressing the T4SS and relaxosome 
proteins, we might have incidentally clogged or jammed these machineries. 
Thus, we thought of revisiting the experiments described in section 3.1, but this 
time including the native promoters to drive protein expression. 
The restriction enzymes AscI and PacI cut pKM101-XmaI once each at nt 
positions 325 and 13047 (see Figure 20). The PacI restriction site is located 
approx. 2000 nt 5’ to the virB1 start codon, and the AscI restriction site is 
located approximately 250 nt 3’ to the traG/virB11 stop codon. Digestion with 
those two enzymes will therefore result in two fragments of 12722 and 7714 
bp in size, with the entire T4SS operon located on the 12722 nt fragment, 
including approx. 2000 bp upstream of the traL/virB1 start codon. This 
additional region contains the coding region for korB, and should also contain 
the wild-type promoter region of the T4SS.  
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Figure 20. Plasmid map of pKM101-XmaI highlighting the PacI/AscI fragment (enclosed in red arrows) 
cloned into pETDuet-1 to form pWT_KT4SS. 
 
This fragment could then be ligated into AscI/PacI cut replication and antibiotic 
resistance backgrounds, such as the vector pETDuet-1 (Novagen). The resulting 
plasmid would then be 17841 bp in size. If the plasmid were functional when 
complemented with pKRelax, it would mean a significant step towards making 
the pKM101 T4SS manageable. Although the size would not be much reduced, 
the T4SS would then reside in a well-defined vector background. From such a 
construct, the indigenous promoter would drive the T4SS production, while 
pETDuet-1 T7 promoter would not be used to drive the T4SS expression. 
 
!"#$%&'()#*%+),(%-./01#,23%4("%-5/67/899%
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3.4.1 Generating pWT_KT4SS 
The plasmid pKM101-XmaI was digested with the enzymes AscI and PacI, 
generating two fragments of 12722 and 7714 bp (see Figure 21). The larger 
fragment was gel extracted, ligated into PacI/AscI-digested pETDuet-1 and 
transformed into E. coli Top10 cells. Figure 21 shows an analytical PacI/AscI 
restriction digest of plasmids isolated from the resulting AmpR colonies. Apart 
from plasmid isolated from clone 1, all plasmids show the expected fragment 
pattern of 12,722 and 5119 bp. PCR results specifically amplifying fragments 
from each of the tra genes thought to comprise the T4SS further confirmed that 
all genes from the tra operon are present on this plasmid (data not shown). 
We can therefore assume that the plasmid pWT_KT4SS was created 
successfully. 
 
 
Figure 21. pWT_KT4SS restriction digest with AscI and PacI. Two fragments of 12,722 and 5119 bp are 
expected. 
 
 
lane/clone    1      2      3      4      5       6       7      8      9    10 
3000 bp 
4000 bp 
10000 bp 
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3.4.2 Conjugation assay with pWT_KT4SS, pKRelax and pKoriT 
To test whether pWT_KT4SS contains all components necessary for 
conjugation, E. coli BL21StarTM cells harbouring pWT_KT4SS were co-
transformed with the plasmids pKoriT, and either pKRelax or pCDFDuet-1. The 
resulting donor strain was AmpR/SpecR/KanR. Relaxosome production was 
induced with 1 mM IPTG at an OD600 of approximately 0.3. Culture growth 
was observed after induction, and the conjugation assay using DH5? as a 
recipient strain (NalR) was performed at a donor strain OD600 of approximately 
0.6, at 1 h after induction.  
Cells were washed off the filter paper and diluted. Subsequently, the 
conjugation cultures were plated on media selective for donors (Amp, Spec 
and Kan) and transconjugants (Nal and Kan). Table 10 shows the results of this 
experiment. 
Complemented with pKRelax and pKoriT, pWT_KT4SS is conjugation 
proficient. Induction seems to affect the efficiency, as without induction it 
appears to be approx. 100 times lower (see Table 10). When conjugation 
cultures were plated on Spec and Nal, colony growth was also observed, 
indicating that pKRelax is also transported during conjugation (data not 
shown). The efficiency of pKoriT transport is similar to wild-type pKM101 and 
pKM101-XmaI complemented with pKRelax. 
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Table 10. Conjugation efficiency with pWT_KT4SS, pKRelax and pKoriT Conjugation efficiency equals 
the amount of transconjugants colonies divided by the number of donor colonies. Dilutions of each 
repeat were averaged to derive conjugation efficiency. N.d. = not determined 
Strain Repeat Cell Type Approx. cell count/ml Conjugation Efficiency 
 
Induced 
pWT_KT4SS 
+ pKRelax 
+ pKoriT 
1 Transconjugants 0.2*106 0.01 
Donors 28*106 
2 Transconjugants 1*106 0.4 
Donors 2.5*106 
 
Not induced 
pKM101-XmaI 
+ pCDFDuet-1 
+ pKoriT 
1 Transconjugants 0.14*106 0.0005 
Donors 324*106 
2 Transconjugants 0.07*106 0.0003 
Donors 202*106 
 
 
3.5 Discussion 
This project set out to determine the minimal requirements for conjugation 
with the pKM101 system, and to produce a T4SS expression platform, which is 
(i) fully functional in conjugation, (ii) genetically accessible and (iii) 
overproduced for structural studies. 
The plasmid pKoriT was designed to monitor conjugation proficiency of a 
strain containing the further T4SS and relaxosome components by conferring 
Kan resistance. Initial conjugation experiments using E. coli strains co-
transformed with pKM101 and pKoriT produced transconjugant colonies that 
were NalR/KanR, thereby confirming that pKoriT is indeed mobilisable by the 
pKM101 conjugation system. 
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The over-expression construct pKT4SS_B10cS did not reliably produce 
transconjugant colonies when co-transformed with pKRelax and pKoriT. Initial 
experiments using induction conditions of 1 µg AHT and 1 mM IPTG did not 
lead to NalR/KanR transconjugant colonies. An induction experiment using 
different inducer concentrations (4-epitetracycline and AHT for T4SS induction 
and IPTG for relaxosome induction) was conducted in combination with a 
Western blot testing for the expression of the traF/virB10 gene. Although no 
transconjugant colonies were observed under any conditions in this 
experiment, the Western blot results showed that TraF/VirB10-expression was 
strongest in the 0.1µg 4-epitetracycline, 0.5 mM IPTG condition (see 
Figure 12). The Western blot experiment showed no signal for the varying AHT 
conditions using 0.5 mM IPTG (Figure 12, lanes 7, 8 and 9); however, a signal 
was obtained under the condition 0.5 µg AHT and 0.5 mM IPTG (Figure 12, 
lane 5). This condition is identical to the condition presented in Figure 12, 
lane 8. This inconsistency creates difficulties interpreting the results from these 
conditions; although, repeating the conjugation assay under conditions where 
the TraF/VirB10 Strep tag signal was strongest on the Western blot resulted in 
four transconjugant colonies. This result was, however, not reproducible.  
Removing the oriT nic site from the plasmid facilitated the reproducibility of 
conjugation proficiency (see Table 7), but also drastically reduced cell viability. 
The conjugation efficiencies were approximately 0.06 and 0.4 for two repeats 
of induced pKT4SS_B10cS_oriT-rm, while the conjugation efficiency for not 
induced cultures was approx. 0.007 and 0.0002 for the two repeats. Notably, 
the donor cell counts for the induced cultures are 300-500 times lower than for 
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the not-induced culture, and the transconjugant cell count is also higher in the 
not-induced culture. The reason may be that more cells were used as input in 
the not-induced culture, although OD600 measurements were used to compare 
the culture’s growth and similar mounts of cells were used according to these 
measurements. Further, no growth can be observed upon induction. It is 
therefore possible that the increased efficiency of induced cells may be 
attributed to the loss of donor cells upon induction. The induced donor cells 
might not be viable enough to divide after plating due to the stress of 
induction, but still be able to conjugate. 
DNA restriction analysis of total plasmid isolated from transconjugant colonies 
showed multiple DNA fragments, compared to only two expected bands for 
pKoriT. This result indicates that pKRelax may also be transported during 
conjugation as the oriT sequence partially overlaps with the traK gene. The 
strongest band was, however, corresponding to the size expected for pKoriT 
(see Figure 13, +C pKoriT positive control). A further experiment where 
conjugation cultures were also plated on Nal/Spec containing media was 
conducted, and NalR/SpecR transconjugant colonies indicates that pKRelax was 
also transported to the recipient cells. The plasmid pKT4SS_B10cS_oriT-rm is 
genetically instable and difficult to transform, as was shown by restriction 
analysis of transformants (Figure 14) and transformant colonies often appeared 
small and did subsequently not grow in liquid media. The metabolic burden 
imposed on the bacteria by overexpressing the T4SS may be a contributing 
factor. 
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Further, a report by Winans & Walker (1985b) identified two lethal gene 
products on pKM101, previously named kilA and kilB. These gene products 
were later identified as being allelic to traL/virB1 and traE/virB8 (Pohlman et 
al., 1994; Moré et al., 1996). The authors further identified two promoter 
regions, one preceding traL/virB1 and another immediately adjacent to 
traN/virB7, which are negatively regulated by the korA and korB gene 
products, thereby counteracting the lethality of traL/virB1 and traE/virB8. The 
plasmid pKT4SS_B10cS_oriT-rm contains the korA gene (it lies between 
traL/virB1 and traM/virB2), but not the korB gene (it lies between upstream of 
traL/virB1). The korB gene lays immediately antecedent to traL/virB1 and was 
therefore not included in pKT4SS_B10cS. The absence of the negative regulator 
protein korB may cause further stress to the cells, as well as genetic instability 
of pKT4SS_B10cS_oriT-rm. 
The above-discussed problems with the over-expression construct 
pKT4SS_B10cS suggests the possibility that other factors encoded on pKM101 
are required for plasmid stability and efficient conjugation. Therefore, further 
plasmids were generated to achieve the reconstitution of the pKM101 T4SS, 
initially without overexpression. The aim was to minimise pKM101 in size to 
render it genetically accessible. Therefore, the deletion variant pKM101-XmaI 
was successfully created. Among other traits, the relaxosome and oriT moieties 
were deleted. The plasmid does therefore not retain self-transmissibility; 
however, it was shown that it is still conjugation proficient when 
complemented with pKRelax and pKoriT, but pKoriT was not transported when 
no relaxosome components were present (table 9). The plasmid is conjugation 
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proficient with comparable conjugation efficiencies to the wild-type pKM101 
(table 8). While pKM101-XmaI is considerably smaller (20436 bp) than 
pKM101 (36272 bp), it is still too large for routine PCR-based modification and 
still contains many genes we believe to be irrelevant for conjugation. Attempts 
to establish a method to delete large regions from pKM101 using a ? Red 
recombinase approach having failed, we could not find a way to trim the 
pKM101-XmaI plasmid further. Thus, this approach was abandoned and 
another approach was selected to achieve a minimal T4SS. 
Indeed, one of potential problems with our strategy of cloning out the tra genes 
and putting them in a different context, as described in section 3.1, is that all 
genes were under an artificial over-expressing promoter. What would happen 
if, instead, we clone out the tra genes and leave their expression control intact? 
The deletion variant pKM101-XmaI opened the opportunity to sub-clone the tra 
operon encoding the T4SS into a pETDuet-1 vector using the restriction 
enzyme AscI and PacI. The resulting construct contained the entire T4SS, and 
an additional 2000 bp upstream of traL/virB1, putting the T4SS under wild-type 
promoter control. The construct is conjugation proficient when complemented 
with pKRelax and pKoriT (see table 10), and is also stably propagated in the 
cells. The reconstitution of a fully functional and genetically accessible T4SS 
was therefore successful, although no over-expression promoter has been 
included in the construct to date. The construct will be valuable for further 
analysis of the pKM101 conjugation system. 
 121 
In the upcoming section, we investigate a conjugation system very similar to 
the pKM101, the pR388. Establishing a PCR-based assembly cloning method 
(InFusionTM, see Methods, section 2.6.1) enabled the cloning of the entire trw 
operon of the pR388 T4SS, which was then used to further analyse the minimal 
T4SS. The minimal pKM101 T4SS will be followed up in the future using the 
InFusionTM method and sequential deletions of the 2000 bp upstream of 
traL/virB1 will deliver further insights into the minimal T4SS. 
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4 Results II – The IncW Conjugation System pR388 
Efforts to reconstitute a functional, overproduced T4SS using the pKM101 were 
hampered by plasmid instability and, possibly, the need for the gene korB 
located in the region upstream of traL/virB1.  
Type IV Secretion Systems are highly versatile, and there are many homologous 
systems to be found, even among the conjugative T4SSs (Guglielmini et al., 
2013). The T4SS of the self-transmissible plasmid pR388 is closely related to 
pKM101, and is comprised of the same amount of putative components (see 
Figure 22). This T4SS was chosen to further investigate the minimal 
requirements for conjugative transfer, and production of a reconstituted and 
overproduced T4SS, as it might not have the same regulatory necessities as the 
pKM101 T4SS.  
 
Figure 22. Relationship between conjugative plasmids pKM101 and pR388 with the Ti plasmid 
from Agrobacterium tumefaciens. Homologous genes are coloured similarly. 
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The plasmid pR388 belongs to the IncW group of self-transmissible plasmids 
(Couturier et al., 1988). Apart from the conjugation machinery, the plasmid 
pR388 encodes for antibiotic resistance to trimethoprim (dfrB2) and 
sulphonamides (sul1). Figure 23 shows the general organisation of pR388. The 
regions relevant for conjugal transfer on this plasmid have been mapped on 
two distinct regions, named PilW and MobW (Bolland et al., 1990). The region 
PilW has been identified to express the genes necessary for pilus formation, and 
is therefore likely to build the T4SS of the pR388 conjugation system. 
The MobW region contains genes necessary for DNA mobilisation and 
comprises therefore the relaxosome components of the conjugation system. 
The PilW and MobW regions are transcriptional units, which are transcribed in 
opposite directions but located in close proximity (Figure 23). 
 
 
Figure 23. Plasmid map of pR388. The region previously termed PilW is pictured in green colours, the 
region previously termed MobW is depicted in pink. 
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As with pKM101 plasmid, a total of 14 genes organised in two operons are 
postulated to be involved in conjugation, and these are homologous to the 
T4SS and relaxosome components of pKM101. The two operons were termed 
trw and their genes named trwA through to trwN (see Figure 22). The operon 
trwABC encodes for the relaxosome genes, with TrwA expected to be the 
relaxase enhancer protein, TrwB the T4CP and TrwI the relaxase. The genes 
trwD/virB11 to trwN/virB1 are likely to encode the T4SS components. The 
organisation of the trw operons and the nomenclature relationship with the 
pKM101 conjugation system and the archetypal A. tumefaciens vir operon of 
the Ti plasmid is depicted in detail in Figure 22.  
 
4.1 Examining the minimal requirements for conjugative transfer: 
generating the construct pRT4SS, pRRelax, and pRoriT 
The approach to examining the minimal requirements for conjugative transfer 
was identical to the previously described efforts for pKM101, i.e. take the virB 
gene homologues and relaxosome-encoding genes out of the plasmid context 
and clone them into a laboratory plasmid. The two trw operons encoding the 
Relaxosome (MobW, trwABC) and the T4SS (PilW, trwN/virB1-trwD/virB11) 
were to be cloned on two separate, compatible vectors.  As for pKM101, the 
vectors pAsk-IBA3C (confers Cam resistance) was chosen to express the T4SS, 
while the Relaxosome components were cloned into pCDFDuet-1 (confers 
Spec resistance). The pR388 oriT sequence (RoriT) was cloned into the 
pRSFDuet-1 vector, whose transport will be monitored by the transmission of 
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Kan resistance. Please see section 3.1.1 for a more detailed description of these 
expression vectors. 
Previous efforts to clone the whole trw operon encoding for the T4SS of pR388 
using a restriction-free cloning method have been unsuccessful (van den Ent & 
Löwe, 2006). Therefore, an entirely new approach was selected to carry out 
this challenging cloning exercise. The method of choice was the Gibson 
assembly, as described in Methods (Gibson et al., 2009). This powerful method 
allows the seamless joining of PCR products only requiring a 15 bp overlap at 
each end. Three enzymes catalyse the process (see Methods chapter, Figure 6).  
For this purpose, the oligonucleotides otrwop_pAsk_IF_1F and 
otrwop_pAsk_IF_2B were used to amplify the entire PilW trw operon after the 
start codon of trwN/virB1 until the stop codon of trwD/virB11, using pR388 as 
template DNA. A 15 bp overhang identical to the ATG region of the vector 
pAsk-IBA3C was added to the 5’ ends of each primer. The PCR product is 
expected to be 10125 bp in size and is shown in Figure 24A. The vector pAsk-
IBA3C was PCR-amplified using the oligonucleotides opAsk-lin_ATG_1F and 
opAsk-lin_ATG_2B, and thereby linearized at the ATG start codon. The 
resulting PCR product is shown in Figure 24B and the InFusionTM reaction was 
performed as described in Methods. 
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Figure 24. Cloning of pRT4SS. A) Gel purified PCR product amplified from pR388 using primers 
otrwop_pAsk_IF_1F and otrwop_pAsk_IF_2B. B) PCR product amplified from pAskIBA-3C using primers 
opAsk-lin_ATG_1F and opAsk-lin_ATG_2B. C) NotI/PvuII restriction digest of plasmid isolated from 
clones 1, 6 and 9. Expected size for pRT4SS: 5028, 3906, 2586 and 1603 bp. D) Colony PCR results for 
clones 1-9 using primers pASK-3C_1F_9100 and pAsk3C_SQ_2B. Expected size if pRT4SS is present: 
1332 bp. 
 
Colonies were screened by colony PCR using oligonucleotide primers pASK-
3C_1F_9100 (gene specific primer for trwD/virB11) and pAsk3C_SQ_2B 
(binding on the vector after the trw operon if cloning was successful). 
Successful insertion of the trw operon should result in a PCR product of 
1332 bp, while no PCR product should be obtained if the trw operon insertion 
was unsuccessful. Figure 24D shows the results for the colony PCR. A PCR 
product of approx. 1300 bp was generated from clones 1, 6 and 9. Plasmid 
from these clones was isolated and subjected to a restriction digest using the 
enzymes NotI and PvuII. A fragment pattern of 5028, 3906, 2586 and 160 bp 
3000 bp 
10,000 bp 
3000 bp 
clone/lane:  1          2          3          4         5                     6             7         8          9 
1500 bp 
3000 bp 
clone/lane:          1               6             9 
3000 bp 
1000 bp 
2000 bp 
A B C 
D 
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should be observed if pRT4SS was generated successfully. Figure 24C shows 
that the expected pattern was visible for DNA isolated from all three clones. 
Subsequent Sanger sequencing showed the correct assembly of all trw genes 
into the vector pAsk-IBA3C.  
 
4.2 Conjugation assay with pRT4SS, pRRelax and pRoriT 
As previously described for pKT4SS_B10cS, the conjugation assay determines 
the ability of a T4SS to transport an oriT-containing plasmid by assessing 
antibiotic resistances present in donor and recipient cells before and after 
conjugation. If a strain with the expected combination of antibiotic resistances 
occurs after conjugation, the T4SS under scrutiny can be assumed to function 
properly. In this work, the mobility of the RoriT-containing plasmid pRoriT, 
which confers Kan resistance, is monitored. The donor strain is resistant to Cam 
(from pRT4SS), Spec (from pRRelax) and Kan (from pRoriT), while the recipient 
strain DH5?is NalR. If pRoriT is successfully transported by the T4SS, DH5? 
transconjugant strains should appear which have newly acquired the pRoriT 
plasmid and are therefore KanR. 
BL21StarTM DE3 was co-transformed with pRT4SS, pRoriT and pRRelax or 
pCDFDuet-1 (functioning as the negative control), thereby creating a 
CamR/SpecR/KanR donor strains. Overnight cultures for donors and DH5! 
recipient strains (NalR) were diluted and grown at 37° C with Cam, Spec and 
Kan to an OD600 of approx. 0.5. A total of 1 µg of 4-epitetracycline and 1 mM 
IPTG was added, and cells were incubated for another hour prior to performing 
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the conjugation assay. Cell cultures were washed in LB without antibiotics 
before mixing them for conjugation. Cells were then plated on LB agar 
containing Cam, Spec and Kan to select for donors (containing pRT4SS, 
pRRelax or pCDFDuet-1 and pRoriT), and on Nal and Kan to select for 
transconjugants.  
Initial conjugation assays showed ample growth of NalR/KanR colonies when 
DH5! was conjugated with strains containing pRT4SS, pRRelax and pRoriT, 
and no NalR/KanR colony growth was observed when pRRelax was substituted 
with pCDFDuet-1; however, no donor colonies on plates containing 
Cam/Spec/Kan were observed on the equivalent dilutions. Analysis of plasmid 
DNA isolated from transconjugants by RoriT-specific PCR and AscI restriction 
digest nevertheless showed presence of pRoriT in transconjugant colonies, as 
shown in Figure 25.  
 
Figure 25. Analysis of DNA isolated from transconjugants 1-4 obtained from conjugation assay with 
pRT4SS, pRRelax and pRoriT by AscI restriction digest and PCR specific for oriT. Expected pattern for AscI 
digest: 3829 and 412 bp. Expected size of PCR fragment amplified with oligonucleotides 
opRoriT_AscI_1F and opRoriT_AscI_2B: 428 bp. 
PCR/AscI PCR/AscI PCR/AscI PCR/AscI PCR/AscI 
3000 bp 
500 bp 
TC         1              2           3             4                pRoriT 
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The DNA isolated from all transconjugants resulted the same pattern in PCR 
and AscI restriction digest as the positive control of isolated pRoriT DNA. Since 
the strains carrying these plasmids were also resistant to Nal, it can be assumed 
that those are genuine transconjugants. 
Further conjugation assays produced similar results. However, incubation of 
the donor plates for a longer time resulted in colony growth on the donor 
plates. They were, nevertheless, far fewer in numbers than transconjugant cells. 
Experiments were conducted to assess whether the transport of pRoriT to the 
recipient cell results in loss of the plasmid in the donor strain due to a 
replication defect. Conjugation cultures were therefore plated on agar 
containing Cam only (selecting for donors harbouring pRT4SS), Cam and Spec 
(selecting for donors harbouring pRT4SS and pRRelax/pCDFDuet-1), and Cam, 
Spec and Kan (selecting for donors harbouring pRT4SS, pRRelax/pCDFDuet-1 
and pRoriT). If pRoriT cannot be replicated after transport to recipient cells, 
donor colony growth should still be abundant on Cam and Spec containing 
plates. Further, the effect of adding inducer to the cell culture was investigated 
with the identical experiment, except that no 4-epitetracycline or IPTG was 
added to the donor culture prior to conjugation.  
The results of this experiment are shown in Table 11. Plasmid loss after 
conjugation does not seem to occur, since the cell counts in donors and 
transconjugants do not reduce in the same proportion between the different 
antibiotics. Induction, however, seems to be majorly responsible for the 
reduction of donor cell counts, which is most likely due to the deleterious 
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effect of overproducing the T4SS and/or the relaxosome components. Growth 
however still occurs after induction in conjugation cultures. 
Table 11. Conjugation assay cell counts to assess plasmid loss in donor cultures after conjugation, and 
influence of inducer added prior to conjugation assay on donor and transconjugant cell counts. Cam = 
chloramphenicol, Kan = kanamycin, Nal = nalidixic acid, TC = Transconjugants, D = Donors 
Induction Repeat Cell type Antibiotic on Plate Cell count/ml Conjugation 
Efficiency 
[TC/D] 
 
 
 
 
 
+ 
 
 
1 
 
Donors 
Cam 1.7*106  
 
82 
Cam + Spec 1.1*106 
Cam + Spec + Kan 0.9*106 
Transconjugants Nal + Kan 74*106 
 
 
2 
 
Donors 
Cam 9.6*106  
 
29 
Cam + Spec 6.3*106 
Cam + Spec + Kan 2.8*106 
Transconjugants Nal + Kan 81*106 
 
 
 
 
 
- 
 
 
1 
 
Donors 
Cam 64*106  
 
0.3 
Cam + Spec 58*106 
Cam + Spec + Kan 55*106 
Transconjugants Nal + Kan 16*106 
 
 
2 
 
Donors 
Cam 72*106  
 
0.3 
Cam + Spec 78*106 
Cam + Spec + Kan 56*106 
Transconjugants Nal + Kan 17*106 
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The conjugation efficiency was determined as approx. 0.3 in not induced 
cultures, as opposed to approx. 50 on average in induced cultures. 
Conjugation efficiency was determined by donor colony count divided by 
transconjugant cell count. In this case, this efficiency calculation produced 
large numbers, as donor cells appear to die after conjugation. Ideally, 
transconjugant count would not exceed the donor count and therefore, the 
maximum efficiency should be 1. For future conjugation efficiency data, 
determining the total recipient count and using this number instead of donor 
cell counts to calculate the transport efficiency may result in more appropriate 
numbers, and better reflect the actual efficiency of conjugative transfer. 
Conjugation assays were performed and cultures were subsequently also plated 
on LB agar containing Nal only. Colony count on those plates should 
correspond to the total DH5! recipient count added to the conjugation assay.  
The results are presented in table 12 and show that using the recipient cell 
count for efficiency determination is more appropriate, as it shows how many 
times pRoriT is transported to a recipient cell. 
Table 12. Conjugation experiment to compare efficiency numbers derived from division of 
transconjugant (TC) cell counts by either recipient (R) or donor (D) cell count, and to assess the 
influence of inducing agent 4-epitetracycline (EpiT) and IPTG. 
EpiT + IPTG Repeat Efficiency TC/R Efficiency TC/D 
 
+ 
1 0.4 129 
2 0.35 108 
 
- 
1 0,03 0.5 
2 0.01 1.7 
 132 
 
Further, recipient cells are not in contact with the inducing agent and are also 
not affected by it. 
 
4.3 Additional functional studies: assessing pilus assembly 
Another criterion for the establishment of a functional T4SS is the production of 
pili. The ability of the T4SS to form pili on the cell surface can be assessed by 
two methods. One would be electron microscopy, as pili have previously been 
visualised by such means (Bradley & Cohen, 1976). A simpler and more 
specific method would however be to employ bacteriophages for the task of 
assessing pilus assembly. Bacteriophages are bacterial viruses that infect a 
certain host, sometimes using a host-specific entry pathway. One such entry 
pathway can be a T4SS associated pilus, and some phages specifically infect 
cells harbouring a specific T4SS. Experiments using bacteriophage R17, which 
specifically infects host cells harbouring the F-like conjugative plasmids, have 
shown that a fully assembled relaxosome is required in the host cell to facilitate 
phage entry (Lang et al., 2011). A further criterion for phage adsorption and 
subsequent entry into the host is a fully assembled T4SS pilus (Valentine & 
Strand, 1965). Phage adsorption is further dependent on VirB5-like protein, and 
mutations can disrupt efficient phage infection even though conjugation is still 
functional (Yeo et al., 2003). Testing T4SS constructs for phage sensitivity may 
provide valuable insight into the assembly processes of the T4SS. 
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The pR388 conjugation system belongs to the IncW group of pili (Bradley & 
Cohen, 1976). The literature reports that bacteriophages PR3, PR4 and PRD1 
use the pR388-associated pilus as their entry pathway into the host cell (Olsen 
et al., 1974; Bradley & Rutherford, 1975). The phages PR3 and PR4 were 
unavailable; therefore, the phage PRD1 was used in this study. Bacteriophage 
PRD1 is a broad host range icosahedral ds DNA phage that infects 
Enterobacteriaceae harbouring conjugative plasmids from the IncN, W and P 
incompatibility groups. The phage belongs to the Tectiviriidae family and 
contains a membrane below its capsid. 
 
4.3.1 Assessing T4SS pilus visibility 
The pR388 T4SS pilus is thought to be formed by the major subunit TrwL/VirB5 
and TrwJ/VirB5, and pili had been observed in previous studies by Bradley & 
Cohen (1976) by staining whole cells with antibodies against pili. By 
overexpression of the T4SS with pRT4SS, pRRelax and pRoriT, the possibility 
arises that cells expressing the system could be multi-piliated. The appendages 
should be visible on the cell surface in the electron microscope. Whole cells 
from induced cultures were therefore loaded onto copper grids and the 
negative stain agent phosphotungstic acid titrated to pH 7 using potassium 
hydroxide (K-PTA) was applied. After a wash step in water, the grids were air-
dried and images were acquired on the Tecnai T10 microscope. The images 
are shown in Figure 26A and B. Figure 26C shows an image of pR388 pili 
taken from Bradley & Cohen (1976) for comparative purposes. When taken 
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from liquid cultures, no pili could be observed on the cell surface (Figure 26A 
and B). 
 
Figure 26. Negative-stain electron microscope images of whole E. coli cells. Arrows mark cell surface 
appendages. A) and B) Negative-stain electron microscope images of whole E. coli BL21StarTM DE3 cells 
expressing pRT4SS, pRRelax and pRoriT (scale bar 0.5 µm). C) Electron micrograph of E. coli CR34(R388) 
stained with antibodies against W-pili taken from Bradley & Cohen 1976. D), E) and F) Negative-stain 
electron microscope images of whole E. coli BL21StarTM DE3 cells expressing pRT4SS, pRRelax and pRoriT 
during conjugation with E. coli DH5! (scale bar 10 nm). 
W-pili belong to the group of rigid pili and conjugation is only efficient on 
solid surfaces (Bradley, 1980). A copper grid was therefore dropped face down 
onto a filter paper with conjugating bacteria and subsequently stained with K-
PTA and air-dried immediately. Images were taken on the Tecnai T10 
microscope and are shown in Figures 26D, E, and F. Appendages were visible 
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in all images shown, with Figure 26F showing an appendage protruding from 
the cell surface.  
 
4.3.2 Phage susceptibility 
The appendages visible between cells could be T4SS pili; however, they 
cannot be distinguished from other cell appendages such as flagella or other 
types of pili, e.g. Type I pili. Phage infection assays were carried out to further 
investigate whether these cells produce T4SS associated pili. 
The phage assay was carried out as described in Methods. Escherichia coli 
BL21Star® cells were transformed with either pR388, 
pRT4SS + pRRelax + pRoriT, pRP4, or no plasmid and infected with PRD1 
phage containing sterile-filtered lysate obtained from Professor Dennis 
Bamford, University of Helsinki. After over-night incubation, plaque formation 
was assessed.  
In the initial experiment, plaques formed on all other plates where cells 
containing T4SS plasmids were, and no plaque formation was observed on the 
E. coli BL21Star® plate. Figure 26-1 shows the results of this experiment. Cells 
in Figure 26-1A are E. coli BL21Star cells and no plaques occurred on this 
plate, whereas on Figures 26-1B and C, where cells BL21Star were transformed 
with pR388 and pRT4SS + pRRelax + pRoriT, plaques in the cell lawn are 
clearly visible. Upon repetition, however, opaque plaques also appeared on 
the E. coli BL21Star® plates. 
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Figure 26-1. Phage PRD1 susceptibility assay. Black arrows indicate plaques formed by PRD1 
infection. A. Plate containing a lawn of Escherichia coli BL21Star cells. B. Plate containing a 
lawn Escherichia coli BL21Star cells transformed with plasmid pR388. C. Plate containing a 
lawn Escherichia coli BL21Star cells transformed with plasmids pRT4SS + pRRelax + pRoriT. 
 
A concentrically round plaque is formed by a single phage. PRD1 phage was 
therefore purified by re-isolation from clear plaques on plates using cells 
harbouring the plasmids pRT4SS + pRRelax + pRoriT. The procedure was 
performed for 10 individual plaques. The purified phage was then used to 
infect BL21Star cells with and without pRT4SS + pRRelax + pRoriT. Plaque 
formation on newly infected cell cultures were then assessed as to whether 
plaques were formed on cell cultures containing the plasmids 
pRT4SS + pRRelax + pRoriT, and not forming plaques on BL21Star® cells. Even 
though 3 further isolation steps were performed, no phage culture that only 
infected cells harbouring the T4SS could be isolated and opaque plaques were 
observed all BL21Star® plates.  
 
A B C 
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4.4 Discussion 
The above described results show that the pR388 T4SS was successfully 
reconstituted in an over-expression vector background. The minimal 
requirements for pR388 conjugation were delineated as being the genes 
trwN/virB1-trwD/virB11, as well as trwABC. Further, the plasmid pRT4SS is 
only 13123 bp in size, which is easily genetically tractable by standard PCR 
methods. 
We showed that the plasmid pRT4SS is conjugation proficient when 
complemented with pRRelax and pRoriT. The conjugation efficiency of pRT4SS 
+ pRRelax + pRoriT (approx. 0.4, see table 12) is comparable to that of wild-
type pR388, which is published at approx. 0.4 when determined from 
transconjugant cell count per donor cell count (Guynet et al., 2011). Plasmid 
isolated from transconjugant colonies contained only pRoriT, which was 
shown by restriction digest (Figure 25). Presence of RoriT in transconjugants 
was further shown by specific a PCR amplifying RoriT (Figure 25). These 
experiments further outline the minimal requirements for conjugation as being 
the genes TrwN/VirB1 to TrwD/VirB11, as well as TrwA, TrwB and TrwC. 
The donor cell-count after conjugation is consistently much lower than the 
recipient cell count (see Table 10), although equal amounts of cells were used 
according to OD600 measurements. This factor resulted in conjugation 
efficiencies largely exceeding 1, which could either be caused by donors 
transporting pRoriT to several recipients or impaired donor viability, with the 
latter being more likely. 
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The relaxase protein processes the plasmid pRoriT, and a single strand is 
transported to the recipient cell leaving single stranded pRoriT DNA in the 
donor cell that must be replicated. A replication defect of the oriT plasmid, or a 
partitioning defect may be the reason for poor donor cell survival. Donors are 
usually plated on Cam, Spec and Kan to select for pRT4SS, pRRelax and 
pRoriT. A plating experiment where conjugation cultures are plated on Cam 
only, Cam and Spec only, and Cam, Spec and Kan tested for possible plasmid 
loss. Donor numbers did, however, not significantly decrease with the different 
combinations of antibiotics (see Table 11). 
The experiment further tested for the influence of induction on donor cell 
counts. The donor cell count was significantly higher in not-induced cells than 
in induced cell, and conjugation efficiencies reflect this tendency. While 
conjugation efficiency in not-induced cells was determined to be approx. 0.3, 
induced cells showed a conjugation efficiency exceeding 50. This is mainly 
due to lower donor cell counts compared to not-induced cells. When 
transconjugant cell counts are compared to recipient cell counts, the efficiency 
data suggests that induced cells conjugate approx. 10 times more efficiently 
than not-induced cultures (see Table 12), which makes the data more 
comparable to published results.  
Identifying pili on pRT4SS expressing bacteria proved to be difficult. Although 
appendages were visible on negative stain EM images (see Figure 26), it was 
impossible to conclusively show that the appendages actually corresponded to 
T4SS associated pili. The bacteriophage PRD1 did not further elucidate the 
nature of these visible appendages, as PRD1’s specificity for T4SS-carrying 
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E. coli was low and the phage consistently infected the strain BL21Star without 
any T4SS plasmids. An assumption was that the phage sample might have been 
contaminated. After several attempts of phage purification, however, the phage 
still infected BL21Star and could therefore not be used to conclusively show 
the presence of T4SS pili. 
  
 140 
5 Results III – Localisation Studies with the IncW 
Conjugation System pR388 
The localisation patterns of bacterial membrane proteins can be associated to 
their function, and give insight into their association with other functionalities 
in the cell. Localisation studies with the A. tumefaciens Vir T4SS have shown 
that it is localised in a distinct helical pattern around the cell periphery (Aguilar 
et al., 2010). This helical assembly pattern has been shown for the fusion 
proteins GFP-VirB8 and VirD4-GFP, and several substrate proteins fused to 
fluorescent proteins of this T4SS. All fusion proteins were further shown to be 
functional by tumorgenesis assays.  
The protein GFP-VirB8 is responsible for the distinct localisation of the T4SS, as 
it assembles in the same helical pattern without any other T4SS components 
present in the cell. The study further assessed that the T4SS co-localises with 
the protein MinD, a cytoskeletal protein known to form helical arrays in E. coli 
(Aguilar et al., 2010). The pKM101 core complex does, however, not 
spontaneously assemble in a helical array around the cell perimeter. FLAG tags 
inserted in the TraF/VirB10 were visualised by immunofluorescence and did 
not display a helical pattern (Chandran et al., 2009).  
The assembly of membrane protein complexes often requires a discrete 
sequence of proteins to be inserted into the bacterial membranes. The Type III 
Secretion System is one such example, where the rigid secretin ring is inserted 
into the outer membrane first, assisted only by its pilotin (Diepold et al., 2010). 
Similar observations were made with the secretin assembly from the Type II 
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Secretion System (Buddelmeijer et al., 2009). Other membrane components are 
then added stepwise towards the inner membrane. In the T3SS, two structural 
membrane ring components are added to the secretin ring progressing from the 
outer towards the inner membrane. These assembly processes are required 
before any of the cytoplasmic ring components containing ATPases and further 
structural components can assemble. The assembly process is however not 
dependant on ATPase activity. Some proteins are, however, not required for 
the basal structures to assemble, although they are essential for functionality. 
Some components appear to be beneficial for the assembly process, or have a 
stabilising effect on the fully assembled structure. Distinct proteins are thereby 
required to insert into the membrane first before others can be added to form 
the functional membrane protein complex (Diepold et al., 2010).  
The assembly order was unravelled using fluorescently labelled proteins and 
observing their localisation in the bacterial membrane. The effects of deleting 
other components of the Type III Secretion System on the localisation of a 
fluorescently labelled component can then be observed by fluorescence 
microscopy. If no effect is observed, the deleted protein will be assembled after 
the fluorescently labelled protein and have no impact on the assembly of the 
fluorescently labelled protein (Diepold et al., 2010).  
The assembly steps of the Gram-negative T4SSs remain elusive to date. Further, 
nothing is known about the arrangement of conjugative T4SSs on the cell 
surface. We have shown here that 14 proteins are sufficient to assemble a fully 
functional pR388-based conjugative system. Of the 11 VirB-homologues 
necessary for T4SS function, three proteins (TrwH/VirB7, TrwF/VirB9 and 
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TrwE/VirB10) are assumed to form the core complex, a central assembly 
spanning both the inner and outer membranes. This sub-assembly does not 
require any other components to be present to fold properly, and is comprised 
of 14 copies of each of the proteins (Fronzes et al., 2009b).  
The reconstituted T4SS can further answer questions regarding the role of a 
T4SS component by creating non-polar deletions or mutations in specific 
components and determining the effects regarding localisation (fluorescence 
microscopy) of the T4SS, functionality (conjugation assay) and pilus assembly 
(phage assay/negative stain EM). These assays can also provide insight into the 
assembly of this T4SS and may even be useful to investigate protein—protein 
interactions and mutations in certain components of the T4SS. 
In this study, we set out to determine the localisation of the T4SS in the cell to 
assess whether any distinct distribution occurs. If a specific pattern is visible 
within cells, the localisation output may be valuable for T4SS analysis. Further, 
we will investigate whether genetic modification of T4SS subunits, such as 
fluorescent protein tags and affinity tags, will affect the functionality of the 
reconstituted T4SS. 
 
5.1 Finding functional fluorescence fusions of the T4SS 
Efficient assessment of the T4SS’s assembly requires several components to be 
tagged with fluorescent proteins without impairing the functionality of the 
T4SS. Therefore, several T4SS components were fused with eGFP or mCherry 
and their functionality was assessed. 
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5.1.1 eGFP-TrwG/VirB8  
The initial candidate for a fluorescent fusion protein was TrwG/VirB8, as this 
protein is located in the membrane but the N-terminus protrudes into the 
cytoplasm, which is required for eGFP chromophore formation. Further, the 
VirB8 protein from A. tumefaciens has been shown to tolerate an N-terminal 
GFP fusion without causing functional impairment (Aguilar et al., 2010). 
The construct pRT4SS_eGFP-TrwG/VirB8 was created using the InFusionTM 
cloning method after the Gibson assembly, and is shown in Figure 27A (Gibson 
et al., 2009). The eGFP gene was PCR amplified from pEGFP-E1 (Clontech) 
using the primers oeGFP_trwG_1F and oeGFP_trwG_2B, which create a 15 bp 
overlap with the 5’ region of trwG/virB8 at both ends (see Figure 27A, eGFP 
PCR). 
The plasmid pRT4SS was split into two parts by PCR due to its size. This was 
achieved by generating four primers that amplify the two parts in separate 
PCRs, both resulting in PCR products with 15 bp overlap to each other at one 
end. The primer pair otrwG_RT4SS_lin_1F and ocat_lin_2B resulted in a PCR 
product starting after the start codon of trwG/virB8 and ending within the Cam 
resistance gene cat (see Figure 25A, PCR 1). The second primer pair 
otrwG_RT4SS_lin_2B and ocat_lin_1F generated a PCR product containing the 
start codon of trwG/virB8 at its 3’end and reaching until the cat gene, 
overlapping with the cat gene in the first PCR product by 15 bp (see Figure 
27A, PCR 2).  
 144 
The InFusionTM reaction was performed as described in Methods. Plasmid 
isolated from Cam resistant colonies were subjected to analytical NotI/PvuII 
digests. The expected pattern for pRT4SS_eGFP-TrwG/VirB8 is 6265, 3906, 
2586 and 1603 bp. 
 
 
Figure 27. Generating pRT4SS_eGFP-trwG/virB8. A) Schematic depicting the organisation of 
pRT4SS_eGFP-trwG/virB8. eGFP PCR (thin line in green) was amplified from pEGFP-C1 using 
primers oeGFP_trwG_1F and oeGFP_trwG_2B. PCR 1 (orange) was amplified from pRT4SS 
using primers otrwG_RT4SS_lin_1F and ocat_lin_2B. PCR 2 (red) was generated from pRT4SS 
using primers otrwG_RT4SS_lin_2B and ocat_lin_1F. B) NotI/PvuII restriction digest of 
potential pRT4SS_eGFP-trwG/virB8 clone 1-4. +C is the positive control digesting pRT4SS with 
NotI/PvuII. 
 
The result is shown in lanes 1, 2, 3 and 4 of Figure 25B, and all clones exhibit 
the expected pattern. A slight shift towards a larger size in the top band can be 
observed compared to pRT4SS, where fragment sizes of 5028, 3906, 2586 and 
1603 bp are expected (lane +C), resulting from the insertion of the eGFP gene 
 145 
before trwG/virB8. Subsequent analysis by Sanger sequencing confirmed the 
correct insertion of eGFP to create an N-terminal fusion protein with 
TrwG/VirB8. 
Initial experiments assessed whether the eGFP fusion will inhibit conjugation. 
For this purpose, E. coli C43 cells were co-transformed with pRT4SS_eGFP-
trwG/virB8, pRRelax and pRoriT, resulting in a CamR/SpecR/KanR donor strain. 
The conjugation efficiency was determined to be approx. 0.02. Conjugation is 
therefore inhibited by the GFP fusion, but not abolished. 
Subsequently, E. coli C43 cells were co-transformed with pRT4SS_eGFP-
trwG/virB8 + pRRelax + pRoriT or pRT4SS + pRRelax + pRoriT to test whether 
specific fluorescence is present resulting from the eGFP-TrwG/VirB8 fusion 
protein. For this purpose, cells of both cultures were grown to an OD600 of 0.4 
and induced with 1 µg 4-epitetracycline for 1 h. A total of 2 ml cell culture was 
then transferred to an Eppendorf tube, where cells were harvested by 
centrifugation at 1500 xg. The media was discarded and cells were washed 
twice in 1 ml PBS. The cells were then fixed in 4% PFA in PBS for 20 min at RT 
and subsequently washed twice in TBS, before resuspending in 200 µl water. A 
total of 20 µl was then applied to Multispot microscope slides PTFE (Henley, 
Essex) and incubated for 30 min.  
The eGFP protein has a single excitation peak at 488 nm and emits light at 
507 nm as a response, which is visible in the green spectrum in a fluorescence 
microscope, where images were acquired in the DIC and green channels at 0.5 
and 2.5 s exposure times, respectively. 
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Figure 28 shows E. coli cells expressing either pRT4SS + pRRelax + pRoriT 
(Figure 28A and B), or pRT4SS_eGFP-trwG/virB8 + pRRelax + pRoriT 
(Figure 28C, D and E).  
 
Figure 28. Differential interference contrast (DIC) and green channel images of Escherichia coli cells 
expressing pRoriT + pRRelax and pRT4SS (A and B) or pRT4SS_eGFP-TrwG/VirB8 (C and D). E. Zoomed 
in image of D. Scale bar = 10 ?m 
 
Green fluorescence can only be detected in cells expressing the eGFP-
TrwG/VirB8 fusion protein (Figure 28D), while no green fluorescence can be 
detected in cells expressing pRT4SS (Figure 28B). Further, the eGFP fusion 
protein is expressed in the majority of cells visible in this image. The eGFP 
protein further localises distinctly in the membrane of the cells due to its fusion 
to the TrwG/VirB8 protein (Figure 28E). 
B A 
C D E 
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It can further be assumed that the localisation of eGFP-TrwG/VirB8 protein 
represents the localisation of the T4SS, since TrwG/VirB8 is essential for 
conjugation and the construct pRT4SS_eGFP-TrwG/VirB8 is functional. The 
zoomed-in image shown in Figure 28E localisation of eGFP-TrwG/VirB8 shows 
that the T4SS forms distinct spots in the membrane of E. coli.  
Further analysis of Z-stacks acquired with pRT4SS_eGFP-TrwG/VirB8 using 
deconvolution revealed that the T4SS arranges in a helical pattern around the 
cell (Figure 29). 
 
Figure 29. Escherichia coli ells expressing pRT4SS_eGFP-TrwG/VirB8 + pRRelax + pRoriT. A) 
Differential interference contrast (DIC) image, B) eGFP fluorescence image with zoomed in 
areas showing eGFP-TrwG/VirB8 spots in the bacterial membrane. C) Individual slices of a 
deconvolved Z-stack showing the helical arrangement of eGFP-TrwG/VirB8. 
 
 
B A 
C 
!"#$"
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5.1.2 Further fluorescence fusion constructs 
The aim is to establish a system to assess the T4SS’s assembly using several 
fluorescent protein-fusion constructs requires the localisation assessment of 
various different components. These, however, must be tested for functionality 
in conjugation, as non-functional constructs may not reliably locate in the cell. 
Therefore, the constructs pRT4SS_TrwK/VirB4-eGFP, _TrwJ/VirB5-eGFP, 
_TrwI/VirB6-eGFP and _TrwE/VirB10-mCherry were generated as described 
above for pRT4SS_eGFP-TrwG/VirB8, as well as the double-labelled construct 
_eGFP-TrwG/VirB8_TrwE/VirB10-mCherry (oligonucleotides used for each 
construct are indicated in Table 13). The conjugation experiments showed, 
however, that none of these constructs were functional. 
Since many of the integral T4SS components do not tolerate fluorescent protein 
fusions, the relaxase TrwC, the substrate of the R388 T4SS, may be a suitable 
candidate for labelling. A construct creating an N-terminal mCherry fusion, as 
well as a C-terminal m-Cherry fusion with TrwC was created. The constructs 
pRRelax_TrwC-mCherry was then co-transformed with the plasmids pRT4SS 
and pRoriT, or pRT4SS_eGFP-TrwG/VirB8 and pRoriT and conjugation assays 
were performed. The construct was functional in combination with both the 
pRT4SS and pRT4SS_eGFP-TrwG/VirB8 constructs, although to a significantly 
lesser degree compared to the untagged versions (approx. 0.02). 
The imaging results with pRT4SS_eGFP-TrwG/VirB8 + pRRelax_TrwC-mCherry 
+ pRoriT are shown in Figure 30.  
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Figure 30. Escherichia coli cells expressing pRT4SS_eGFP-TrwG/VirB8 + pRRelax-TrwC-
mCherry + pRoriT. A) Differential interference contrast image B) eGFP fluorescence image C) 
mCherry fluorescence D) and E) Enlarged areas as indicated showing eGFP-B8 and TrwC-
mCherry fluorescence. 
Figure 30 A, B and C show images of cells expressing pRT4SS_eGFP-
TrwG/VirB8 + pRRelax_TrwC-mCherry + pRoriT in the DIC, green and red 
channels, respectively. The cells are expressing both the green fluorescent 
protein eGFP and the red fluorescent protein mCherry, as depicted in Figure 
30B and C. The green fluorescence is located in membrane spots, as has been 
previously observed for the constructs pRT4SS_eGFP-TrwG/VirB8. The red 
fluorescent TrwC fusion protein is located diffusely in the cytoplasm (Figure 
30E), and in some cells at the poles (Figure 30D). The plasmid pRRelax_TrwC-
mCherry showed similar results when combined with pRT4SS (data not 
shown). The TrwC-mCherry protein therefore does not co-localise with the 
T4SS, likely because it is excessively expressed, and cannot be used as an 
indicator for an assembled T4SS. Table 13 summarises all generated constructs 
and indicates their functionality. 
B A C 
D E 
!"#$"
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Table 13. Fluorescent protein fusion constructs generated with pRT4SS and pRRelax, indicating 
oligonucleotides used and their functionality on the conjugation assay. 
 
Construct name 
Oligonucleotides  
Functionality 
Template linearisation Fluorescence gene 
pRT4SS_TrwK/VirB4-eGFP olin_trwK-cT_1F 
olin_trwK-cT_2B 
oIF_trwK-eGFP_1F 
oIF_trwK-eGFP_2B 
- 
pRT4SS_TrwJ/VirB5-eGFP olin_trwJ-cT_1F 
olin_trwJ-cT_2B 
oIF_trwJ-eGFP_1F 
oIF_trwJ-eGFP_2B 
- 
pRT4SS_TrwI/VirB6-eGFP olin_trwI-cT_1F 
olin_trwI-cT_2B 
oIF_trwI-eGFP_1F 
oIF_trwI-eGFP_2B 
- 
pRT4SS_eGFP-TrwG/VirB8 otrwG_RT4SS_lin_1F 
otrwG_RT4SS_lin_2B 
oeGFP_trwG_1F 
oeGFP_trwG_2B 
+ 
pRT4SS_TrwE/VirB10-
mCherry 
olin_c-trwE_1F 
olin_c-trwE_2B 
oIF_trwE-mCh_1F 
oIF_trwE-mCh_2B 
- 
pRT4SS_eGFP-
TrwG/VirB8_TrwE/VirB10-
mCherry 
olin_c-trwE_1F 
olin_c-trwE_2B 
oIF_trwE-mCh_1F 
oIF_trwE-mCh_2B 
- 
pRRelax_trwC-mCherry oIF_trwC-mCh_F 
oIF_trwC-mCh_B 
olin_c-trwC_F 
olin_c-trwC_B 
+ 
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5.2 Immunofluorescence with the pR388 T4SS 
Tagging the R388 T4SS with fluorescent proteins abolished the function for 
most T4SS components. Immunofluorescence provides an alternative option to 
detect specific components of the T4SS within the cells. Specific antibodies to 
T4SS components were, however, not available. Therefore, the FLAG tag was 
genetically fused to components of the T4SS and the commercially available 
Monoclonal ANTI-FLAG® M2 antibody produced in mouse (Sigma-Aldrich) 
was used for detection of these tagged proteins. The FLAG-tag is a synthetic 
epitope tag with the sequence DYKDDDDK. This peptide tag was specifically 
created to facilitate the detection and purification of recombinant proteins 
using antibodies and is not a naturally occurring epitope (Hopp et al., 1988). It 
is hydrophilic and only 1012 Da in size, and therefore interferes only 
minimally with the protein it is attached to. 
 
5.2.1 FLAG-TrwG/VirB8  
The FLAG tag was positioned at the N-terminus of TrwG/VirB8 in an identical 
position as the eGFP tag, in order to whether the pattern of helical arrangement 
around the cell will be equally pronounced using the FLAG tag. The construct 
pRT4SS_FLAG-TrwG/VirB8 was generated with the InFusionTM cloning kit, 
using the oligonucleotides oIF_FLAG-trwG_1F and ocat_lin_2B for PCR1, and 
ocat_lin_1F and oIF_FLAG-trwG_2B for PCR2. The plasmid sequence was 
analysed by Sanger sequencing, which confirmed the insertion of the FLAG tag 
at the N-terminus of TrwG/VirB8. The construct was tested for functionality 
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using the conjugation assay by co-transforming pRT4SS_FLAG-TrwG/VirB8 
cells with pRRelax and pRoriT, and it conjugated at an efficiency equal to the 
non-tagged pRT4SS (approx. 0.7). 
Escherichia coli cells were grown to an OD600 of 0.4-0.5 and induced for 1 h at 
37 C Initial experiments using an in-suspension labelling approach did not lead 
to efficient labelling of FLAG-TrwG/VirB8 in cells expressing pRT4SS_FLAG-
TrwG/VirB8 + pRRelax + pRoriT. Therefore, conditions were optimised for an 
on-slide labelling approach, as described in Methods. 
Images of antibody labelled E. coli C43 cells expressing either pRT4SS + 
pRRelax + pRoriT or pRT4SS_FLAG-TrwG/VirB8 + pRRelax + pRoriT were 
acquired in the DIC and red channels. Figures 31A and B show FLAG-
TrwG/VirB8 expressing cells, while C and D show cells expressing pRT4SS.  
 
Figure 31. DIC and red channel images of immunofluorescence experiments using an anti_FLAG 
antibody produced in mouse and an anti-mouse antibody conjugated to Alexa Fluor 594 Escherichia coli 
cells expressing A) and B) pRT4SS + pRRelax + pRoriT C) and D) pRT4SS_FLAG-TrwG/VirB8 + pRRelax + 
pRoriT E) Individual slices of a deconvolved Z-stack of Escherichia coli cells expressing pRT4SS_FLAG-
TrwG/VirB8 + pRRelax + pRoriT showing the helical arrangement of FLAG-TrwG/VirB8. Scale bar = 
10 ?m.  
pRT4SS_FLAG-trwG           pRT4SS 
A B C D 
E 
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Red fluorescence, and therefore anti-FLAG AB binding, can only be observed 
in Figure 31B, while no red fluorescence is visible in Figure 31D. The AB 
staining is therefore specific for FLAG tag expression. Figure 31E shows 
deconvolved, individual slices of a Z stack acquired from cells expressing 
pRT4SS_FLAG-TrwG/VirB8 + pRRelax + pRoriT. The arrangement of the 
labelled spots is helical, similar to observations made with the construct 
pRT4SS_eGFP-TrwG/VirB8 (see Figure 29).  
 
5.2.2 TrwI/VirB6-FLAG 
FLAG and eGFP-tagged TrwG/VirB8 proteins arrange a helical manner around 
the cell periphery. Tagging a second component of the T4SS would ascertain 
the assumption that the assembled T4SS located in this specific way, and that 
the observation is not only caused by TrwG/VirB8 locating helically.  
The protein TrwI/VirB6 is an integral membrane protein with four to five 
predicted transmembrane helices (Judd et al., 2005). It is thought to be the 
structural anchor for the T4SS in the inner membrane; however, no structural 
information on this protein is available to date (also see Introduction chapter).  
The FLAG tag was positioned at the C-terminus of TrwI/VirB6, using the 
InFusionTM cloning method with the oligonucleotides oIF_trwI-FLAG_1F with 
ocat_lin_2B for PCR1, and ocat_lin_1F and oIF_trwI-FLAG_2B for PCR2. 
Sanger sequencing confirmed the correct insertion of the FLAG tag at the C-
terminus of TrwI/VirB6. The construct pRT4SS_TrwI/VirB6-FLAG was 
transformed into E. coli C43 cells carrying the plasmids pRRelax and pRoriT, 
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and tested in the conjugation assay. The transfer efficiency of this construct was 
similar to the untagged construct pRT4SS (approx. 0.6). 
Initial experiments using the TrwI/VirB6-FLAG construct were conducted using 
an identical protocol as for the pRT4SS_FLAG-TrwG/VirB8 construct. However, 
the labelling efficiency of TrwI/VirB6-FLAG was very poor and barely 
distinguishable from the negative control. Optimisation attempts, such as 
longer lysozyme treatment, different antibody concentrations and different 
detergents to permeabilise the membrane, did not lead to an improvement of 
labelling to date. Western blot experiments further showed that the antibody 
does not recognise TrwI/VirB6 as efficiently as TrwG/VirB8 (see Figure 32). 
Lane 1 (cell extract from cells expressing pRT4SS_TrwI/VirB6-FLAG) in 
Figure 32 shows a very weak signal around 35 kDa, while lane 2 shows a 
strong specific signal at 37 kDa (cell extract expressing pRT4SS_FLAG-
TrwG/VirB8). No signal can be observed when cell extract from pRT4SS 
expressing clones is used (Figure 32, lane 3). Similar amounts of cells 
according to OD600 measurements were used for this experiment. 
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Figure 32. Western blot experiment using the monoclonal ANTI-FLAG® M2 antibody produced 
in mouse (Sigma) on whole, lysed cell extract expressing pRT4SS_trwI/virB6-FLAG (lane 1), 
pRT4SS_FLAG-trwG/virB8 (lane 2) or pRT4SS (lane 3). 
 
5.3 Discussion 
We could show here that the conjugative pR388 T4SS localises in a helical 
array around the cell perimeter, similarly to the T4SS of A. tumefaciens (Aguilar 
et al., 2010). Labelling TrwG/VirB8 with eGFP on the N-terminus showed that 
the T4SS is arranged around the cell envelope in a helical manner (see 
Figure 29). The conjugation efficiency of pRT4SS_eGFP-TrwG/VirB8 was 
impaired, but not abolished. Therefore, the T4SS is assumed to be assembled 
correctly and the helical arrangement biologically relevant. Results from 
immunofluorescence experiments using the FLAG-tag at the N-terminus of 
TrwG/VirB8 underlined the helical arrangement (see Figure 31) and suggest 
180 kDa 
64 kDa 
37 kDa 
26 kDa 
lane          1        2                 3                 
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that the arrangement is not an effect of tagging TrwG/VirB8 with eGFP (see 
Figure 29).  
Assessing the localisation of further R388 T4SS components proved to be rather 
difficult, as most T4SS components did not tolerate eGFP or mCherry fusions, 
and were dysfunctional upon their addition (see Table 13). Similar effects were 
observed in the A. tumefaciens VirB T4SS (Aguilar et al., 2010). 
The substrate relaxase TrwC was, however, not affected by a C-terminal 
mCherry fusion, as was shown by the conjugation assay. Localisation 
experiments did not show a distinct localisation of the protein to the 
membrane, but showed that TrwC localises diffuse in the cytoplasm 
(Figure 30). The result is not unexpected, as TrwC is a soluble protein and not 
all TrwC proteins expressed from pRRelax will localise to the T4SS. The over-
expression of TrwC-mCherry may also contribute to the diffuse localisation. 
The labelling with fluorescent proteins suffers from the significant drawback of 
impaired function of the T4SS. Therefore, the opportunity of using 
immunofluorescence to detect the FLAG-tag in E. coli cells was explored. 
FLAG-TrwG/VirB8 was readily detectable using the monoclonal M2 ANTI-
FLAG antibody from Sigma Aldrich. Figure 31 shows the helical arrangement 
observed for FLAG-TrwG/VirB8, which confirms the helical arrangement 
observed for eGFP-TrwG/VirB8 (Figure 29) as being genuine rather than an 
artefact produced by the eGFP fusion. 
FLAG-TrwI/VirB6 could however not be labelled efficiently to date. Western 
Blot experiments using equal amounts of cells for both FLAG-TrwG/VirB8- and 
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TrwI/VirB6-FLAG-expressing clones showed that the anti-FLAG M2 antibody 
recognition of FLAG TrwI/VirB6 is much weaker than for FLAG-TrwG/VirB8 
(see Figure 32). The poor recognition may be due to the stoichiometry of 
TrwI/VirB6 and TrwG/VirB8, as TrwI/VirB6 may be present in smaller quantities 
than TrwG/VirB8. Since TrwI/VirB6 is an integral membrane protein, lipids may 
still be surrounding the protein and impair the antibody binding. In purified 
T4SS complexes, it was also impossible to determine the exact stoichiometry of 
TrwI/VirB6 compared to other T4SS components (Low et al., unpublished). 
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6 Conclusions & Outlook 
Type IV Secretion Systems are versatile machineries that secrete a wide variety 
of substrates across the bacterial cell envelope. Their core structure and 
function, however, are highly related. Conjugative T4SSs are therefore very 
attractive for the study of T4SSs, since they are relatively simple in their 
substrate range and are found in E. coli, which is easy to handle in a standard 
laboratory. 
Conjugative T4SSs are encoded on self-transmissible plasmids, alongside other 
genetic traits that may benefit bacteria in certain circumstances, such as 
multiple antibiotic resistance genes or increased UV tolerance (Winans & 
Walker, 1985a; Bolland et al., 1990). These plasmids are usually very large 
(exceeding 30 kbp), and therefore unsuitable for efficient, PCR-based genetic 
modification. Further, these plasmids encode a multitude of traits that are not 
required for conjugation, and thereby not required for the study of T4SSs. 
It is therefore of paramount importance for structural and functional studies to 
(i) delineate the minimal requirements for functional Type IV secretion, (ii) to 
isolate the T4SS to assess only the process of Type IV secretion without the 
influence of additional factors present on the plasmids, and (iii) providing 
genetic accessibility of the T4SS in order to make straight forward mutations 
without the need of complementation of the mutated component on separate 
vectors, where issues such as differences in gene dosage and expression may 
hamper the analysis. Here, two fully functional T4SSs from the conjugative 
plasmids pKM101 and pR388 could be reconstituted in a well-defined vector 
backbone that is suitable for easy manipulation. 
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The pKM101 conjugation system was reconstituted in the construct 
pWT_KT4SS, using the well-documented vector pETDuet-1. The construct 
includes approx. 2000 bp upstream of the traL/virB1 start codon, and the T4SS 
components are therefore expressed under wild-type promoter control. When 
complemented with the relaxosome components on pRRelax, the KoriT-
containing plasmid pKoriT is efficiently transported. This construct will be 
valuable for the functional analysis of the pKM101 T4SS. Further, a deletion 
construct of the native pKM101 plasmid was produced by XmaI-digest, which 
was also functional when complemented with pKRelax and pKoriT. The 
construct pKT4SS_B10cS was, however, very unstable and did not 
reproducibly produce transconjugant colonies. Removing the KoriT nic site 
from the plasmid rendered the construct more reliable in terms of 
transconjugant production; however, at the expense of plasmid stability. The 
possibility that the negative regulators KorA and KorB are required for plasmid 
stability due to toxicity of TraL/VirB1 and TraG/VirB8, as was reported Moré et 
al. (1996), is likely to have caused these effects. The plasmid pWT_KT4SS 
includes korA and korB, and is very stably maintained in cells, while 
pKT4SS_B10cS_oriT-rm only includes korA. The toxicity of the highly driven 
TraL/VirB1 expression may cause the plasmid instability.  
The reconstituted pKM101 T4SS encoded on the plasmid pWT_KT4SS bears 
much potential for the further analysis of this conjugation system, due to its 
manageable size and defined vector background. Systematic deletion of the 
2000 bp upstream of traL/virB1 can eventually lead to the determination of the 
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minimal requirements for this conjugation system. Further, the promoter region 
can be altered to an overproduction promoter for protein purification purposes. 
The pR388 T4SS (trw operon) was shown to conjugate to wild-type level (see 
Table 12), and the presence of RoriT was confirmed for resulting 
transconjugants. Here, we not only present the first fully reconstituted T4SS, 
but further delineate the minimal requirements for conjugation in the pR388 
conjugation system. This plasmid can be used for structural studies, as the 
overexpression of the T4SS components should facilitate the purification on 
complexes from the cells. Further, the manageable size of the pRT4SS plasmid 
facilitates its easy modification to create fusion proteins and add affinity tags for 
purification. The influence of such tags on the functionality can further be 
assessed using the conjugation assay, as has been shown here using 
fluorescence fusions and tags for immunodetection. Future work in progress 
will include the purification of large protein complexes using affinity tags, 
which will include several, if not all components of the T4SS. The structural 
analysis of such large assemblies will provide the next breakthrough in the 
T4SS field. 
We further report the helical arrangement around the cell perimeter of a 
conjugative T4SS, similar to the arrangement previously reported for the 
A. tumefaciens T4SS. In the A. tumefaciens T4SS, the protein TrwG/VirB8 is 
solely responsible for the helical arrangement (Aguilar et al., 2010). Further 
localisation studies regarding other T4SS components will be crucial to support 
these findings. 
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Aguilar et al. (2010) further report that the T4SS is associated to the helically 
arranged cytoskeletal component MinD, which is also present in E. coli. For the 
conjugative T4SS, such an association of the T4SS with cytoskeletal 
components provides many interesting options to consider, as many of them 
assemble around the cell perimeter in a helical fashion. 
An example is the partitioning protein ParA, which falls into the same ATPase 
superfamily as MinD, containing a deviant Walker A motif (Shih & Rothfield, 
2006). Par proteins are usually responsible for the segregation of low copy 
number plasmids during cell division, and are encoded on the plasmids 
themselves. As other cytoskeletal components, ParA has been shown to 
spontaneously polymerise in vitro and form helical arrays in vivo (reviewed in 
Shih & Rothfield (2006)). The protein ParA from Neisseria gonorrhoeae is also 
required for DNA secretion of its T4SS (Hamilton et al., 2005). 
The protein VirC2 also belongs to the MinD/ParA superfamily of ATPases, and 
is encoded on the Ti plasmid of A. tumefaciens (Atmakuri et al., 2007). It was 
shown to bind a specific sequence on the Ti plasmid and, in complex with 
VirC1, positions the relaxosome––DNA substrate to the cell poles (Atmakuri et 
al., 2007). Although this study suggests a localisation of the VirC2 and the T4SS 
towards the cell poles, this may be due to a dynamic effect of oscillation of 
VirC2 between the cell poles and a helical arrangement, as has been 
previously demonstrated for MinD and ParA (Shih et al., 2003; Ebersbach & 
Gerdes, 2004). 
If the T4SS is indeed associated to the bacterial cytoskeleton, the localisation of 
the T4SS may be dynamic and associated to the cell cycle or growth phase of 
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the bacteria. The pR388 plasmid does, however, not encode a VirC2 
homologue and its segregation may be associated to other cellular processes. 
Future work to investigate the role of TrwG/VirB8 in localising the T4SS in 
helical arrays, as well as the identification of its association partner, will 
provide further valuable insight into conjugative Type IV secretion and their 
association with other cellular functions. 
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